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Bovine mastitis causes substantial economic losses and animal welfare issues in 
the dairy industry, making the pursuit of preventative strategies a major area of focus in 
the field of dairy science. Identification of genetic markers and the investigation of 
underlying mechanisms of the genetic basis of mastitis resistance facilitate the 
development of preventative and therapeutic approaches. The main objectives of this 
dissertation research were to identify genetic markers of mastitis resistance in Holstein 
dairy cattle and to define contributions of bovine mammary epithelial cells, the milk-
secreting cells of the mammary gland, to mastitis and mastitis resistance. 
A genome-wide association study of a population of Holstein dairy cattle was 
carried out to identify genetic markers for mastitis resistance. One hundred seventeen 
single nucleotide polymorphism genetic markers were detected suggestive of genome-
wide significance. From these identified genetic markers, 27 regions within the bovine 
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genome suggestive of an association with mastitis resistance were defined, of which ten 
have not been reported previously. 
An in vitro model was used to investigate contributions of bovine mammary 
epithelial cells to the mechanisms of mastitis resistance. Differential expression of 42 
genes relevant to inflammation by primary bovine mammary epithelial cells from 
mastitis-resistant versus mastitis-susceptible cattle was observed following exposure to 
bacterial lipopolysaccharide, implicating the bovine mammary epithelial cell as an 
important cell type in mastitis resistance. 
Comparisons between primary bovine mammary epithelial cells and primary 
bovine fibroblasts revealed both similarities and differences in pro-inflammatory gene 
expression responses to lipopolysaccharide. This finding emphasizes cell type-specific 
contributions to mastitis, which should be considered when selecting an in vitro model. 
To facilitate future mastitis studies, a method for the establishment of milk-derived 
bovine mammary epithelial cell lines with extended growth potential via transfection 
with the viral protein simian virus large T antigen is described. 
Examination of the effects of exogenous administration of the enzyme 
phospholipase A2 on primary bovine mammary epithelial cells revealed altered 
expression of several pro-inflammatory genes in response to lipopolysaccharide. Because 
modulation of the inflammatory responses of bovine mammary epithelial cells has the 
potential to influence the course of mastitis, this finding highlights phospholipase A2 as a 
potential therapeutic candidate. 
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Bovine mastitis, or inflammation of the mammary gland, has substantial 
economic and animal welfare implications. A genetic basis for mastitis resistance traits is 
recognized and can be used to guide selective breeding programs. The discovery of 
regions of the genome associated with mastitis resistance, and knowledge of the 
underlying molecular mechanisms responsible, can facilitate development of efficient 
mastitis control and therapeutic strategies. The objectives of this dissertation research 
were to identify sites of genetic variation associated with mastitis resistance, and to 
define the contributions of the milk-secreting epithelial cells to mammary gland immune 
responses and mastitis resistance. Twenty seven regions of the bovine genome potentially 
involved in mastitis resistance were identified in Holstein dairy cattle. Additionally, this 
research demonstrates a role of bovine mammary epithelial cells in mastitis resistance, 
and provides guidance for the use of an in vitro model for mastitis studies. Primary 
bovine mammary epithelial cells from mastitis-resistant cows have differential expression 
of 42 inflammatory genes compared with cells from mastitis-susceptible cows, 
highlighting the importance of epithelial cells in mastitis resistance. Bovine mammary 
epithelial cells display both similarities and differences in pro-inflammatory gene 
vi 
 
expression compared to fibroblasts, and their expression of inflammatory genes is 
influenced by administration of the enzyme phospholipase A2. The growth potential of 
milk-derived bovine mammary epithelial cells in vitro can be extended, facilitating their 
use in mastitis studies, by transfection with a viral protein. Collectively, this research 
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Mastitis Definition and Pathogens 
Mastitis is the costliest disease in the dairy industry [1,2] due to loss of 
production, decreased milk quality, discarded milk, labor, veterinary treatments, mastitis-
related culls, and diagnostics [3]. Additionally, the widespread use of preventative 
measures against mastitis are an ongoing source of economic losses [4]. 
Mastitis is defined as inflammation of the mammary gland. Most commonly, 
mastitis is a result of invasion of mammary tissue by bacterial pathogens entering through 
the teat canal [5], but may also result from invasion by fungal or algal pathogens, 
mechanical trauma, chemical injury, or thermal insult [6]. Inflammation results in 
temporary or permanent loss of function due to direct microbial and/or inflammatory-
mediated damage to anatomic components, including the milk-secreting mammary 
epithelial cells (MECs). Mastitis is endemic among dairy cattle worldwide, with 
prevalence within dairy herds ranging from 5-75%, and among mammary quarters from 
2-40% [7]. 
 Bacterial infection is by far the most common cause of mastitis among dairy 
cattle. Mastitis-causing bacteria are traditionally categorized as environmental pathogens 
or contagious pathogens [5,6,8]. Classification of bacteria into one of these two 




with some bacterial strains such as environmental pathogens with host-adapted virulence 
factors [9,10]. 
Important environmental pathogens include Escherichia coli, Streptococcus 
uberis, Streptococcus dysgalactiae, Serratia spp., Klebsiella spp., and Enterobacter spp. 
[10,11]. In comparison to contagious pathogens, a higher proportion of environmental 
pathogens cause clinical, rather than subclinical, mastitis [11]. The source of 
environmental pathogens is primarily the cows’ surroundings, where these bacterial 
species are normally ubiquitous and capable of long-term survival and growth [6,10]. 
Manure, bedding, milking equipment, pre- and post-dip preparations, and flies are 
common sources [7,10]. Seasonal variation in the incidence of mastitis caused by 
environmental pathogens has been observed, with incidence increasing during hot or 
damp weather [12]. Entry of environmental pathogens into the teat canal occurs by 
propulsion during milking or by passive penetration of the teat canal. Environmental 
hygiene and pre-milking teat dipping are important management factors that impact 
levels of exposure to environmental pathogens. However, the prevalence of mastitis 
caused by environmental pathogens within individual herds is not consistently associated 
with management practices traditionally considered to reduce exposure to environmental 
pathogens [10]. Despite the widespread implementation of management practices that are 
successful in reducing the incidence of contagious mastitis, the control of environmental 
mastitis remains a substantial challenge within most dairy herds. As a consequence, 
environmental mastitis has become more common than contagious mastitis in the 




pathogens, antibiotic therapy, with the exception of treatment during the early dry period, 
is relatively ineffective in preventing mastitis caused by these pathogens [11].  
 The universally recognized contagious mastitis pathogens are Staphylococcus 
aureus, Streptococcus agalactiae, Mycoplasma spp., and Corynebacterium bovis 
[6,7,10]. Contagious pathogens are spread between cows and generally cannot persist 
long-term off the host [6,13]. Adherence factors allow colonization of the teat end or teat 
canal, and infection of the mammary gland occurs via the teat canal [13]. Hematogenous 
spread to the mammary gland or between mammary gland quarters is uncommon but has 
been reported for Mycoplasma spp. [14]. Infection most commonly occurs at milking, 
where milking equipment and workers’ hands serve as fomites in the spread of the 
bacteria between cows. 
 Mastitis, whether caused by environmental or contagious pathogens, may be 
clinical or subclinical. Clinical signs of mastitis include mammary gland edema and 
hyperemia, changes to milk appearance or consistency, and/or systemic manifestations 
such as pyrexia and obtundation [6,15]. Intramammary infection without clinically 
detectable signs is termed subclinical mastitis. Because subclinical mastitis requires 
ancillary testing for diagnosis, it may not be readily detected on-farm and so may persist 
chronically, resulting in long-term detrimental effects on mammary gland function, milk 
quality, and milk somatic cell count (SCC). Staphylococcus aureus, a contagious mastitis 
pathogen, is a particularly important cause of chronic, subclinical mastitis in dairy cattle 
that is often accompanied by large increases in SCC [16,17]. Somatic cell count is a 




used as an indicator of intramammary infection status. Somatic cell count is discussed in 
further detail below. Strategies used to detect subclinical mastitis include regular 
monitoring of SCC, milk electrical conductivity testing to detect changes in ion 
concentrations, milk bacterial culture, polymerase chain reaction (PCR)-based pathogen 
detection, and assessment of milk pH [18–20]. Several methods exist for SCC 
monitoring, ranging from cowside tests (California Mastitis Test) to more precise 
methods such as nuclear staining and optical fluorescence (Fossometric SCC; Delaval 
cell counter) [20]. 
 Escherichia coli is an environmental pathogen capable of causing mild to severe, 
usually clinical mastitis variably accompanied by systemic illness. Escherichia coli has 
been used in many bovine mastitis studies because of its importance as a mastitis 
pathogen as well as its capacity to induce a strong inflammatory response in the 
mammary gland [21]. In this dissertation, lipopolysaccharide (LPS) from E. coli was used 
in several studies to stimulate immune responses of bovine MECs. Pathogenicity of E. 
coli in intramammary infections generally is not strain-dependent [22,23], except in 
instances where host-specific virulence factors develop [9]. Pathogenicity is attributable 
predominantly to the presence of LPS, common to all E. coli strains, and is dose-
dependent [22]. Recognition of the presence of LPS by host cells occurs predominantly 
through Toll-like receptor (TLR) 4. Bound TLR4 initiates transcription of various factors 
via the NFƙB signaling pathway, ultimately resulting in production of cytokines, 
antimicrobial defense proteins, and lipid mediators. Excessive cytokine production 




associated mastitis. For example, the degree of production of the cytokine tumor necrosis 
factor (TNF) α is an important factor in determining the severity of clinical signs [24]. 
High levels of TNFα induce both local and systemic effects contributing to the morbidity 
and mortality in E. coli mastitis. Locally, TNFα promotes leukocyte-mediated tissue 
damage via its effects on leukocyte recruitment, activation, and nitric oxide production. 
Tumor necrosis factor α-induced increases in vascular permeability contribute to 
mammary gland hyperemia, edema, and altered milk composition due to leakage of 
plasma components into the milk. Systemic effects of TNFα include cardiovascular 
compromise via decreased cardiac output, systemic vasodilation, and increased vascular 
permeability; promotion of a pro-thrombotic state via endothelial cell activation; 
induction of pyrexia; and metabolic disturbances [6,25]. Other important 
proinflammatory mediators in the pathogenesis of E. coli mastitis include interleukin 
(IL)-1, IL-6, IL-8, platelet-activating factor, prostaglandins, and complement components 
[25]. 
 Mastitis caused by E. coli occurs most commonly in periparturient or early-
lactation cattle, and tends to be most severe in these animals. Intramammary infection by 
E. coli is an important cause of acute toxic mastitis in early-lactation cows [26]. 
Periparturient immunosuppression contributes to the increased incidence and severity of 
mastitis during this time. Weak or delayed neutrophil influx following intramammary 
infection is of particular relevance in E. coli infection [11,27], particularly when 




protective function in bacteria against neutrophil-dependent defenses and contributes to 
prolonged infection by these strains [11]. 
 
Innate Immunity of the Bovine Mammary Gland 
 The pathogenesis of mastitis involves complex interactions between the etiologic 
agent and host tissues, influenced by a wide variety of environmental and genetic factors 
that contribute to disease susceptibility and outcome of infection [28]. Innate immunity, 
comprising relatively non pathogen-specific host responses, plays a particularly important 
role in mastitis pathogenesis[29]. Defense mechanisms of innate immunity that are of 
particular importance in prevention and elimination of intramammary infection include 
the epithelial barrier, secretions in milk, and leukocytes [30]. 
 The teat canal is by far the most common portal of entry for mastitis pathogens 
[28]. Adaptations of the teat canal therefore comprise the first barrier to entry and 
establishment of pathogens [31,32]. Keratin and lipids continuously produced by 
keratinocytes lining the teat canal provide an impermeable barrier to most bacterial 
pathogens, and are of particular importance in forming a protective plug during 
mammary gland involution and the dry period [28,31,33]. In the lactating cow, the 
keratin plug is lost but the teat orifice closes between milkings due to the contraction of 
the teat sphincter muscle, which is responsive to acetylcholine and tension from milk fill 
[32]. Closure by the teat sphincter following milking takes up to two hours or longer 
[28,30], during which time the mammary gland is susceptible to entry by mastitis 




following milking is in part a measure to reduce mastitis incidence [34], as feeding 
activity delays lying behavior, reducing contact between the open teat end and sources of 
environmental contamination such as bedding material and manure. Continual shedding 
of teat canal keratinocytes as well as the flushing action of milk during milking provide 
additional defenses against bacterial colonization of the mammary gland [31]. 
Mammary epithelial cells lining the teat canal, ductal system, and gland acini 
provide a second line of defense. In addition to providing a dynamic physical barrier 
against bacterial entry, these cells contribute to inflammatory responses during 
intramammary infection [30]. Tight junctions between MECs are a major component of 
the physical barrier between the milk space (acinar and cisternal spaces and duct lumens) 
and the interstitial space of the mammary gland. The permeability of this barrier varies 
with lactational stage and intramammary infection status, and is influenced by factors 
such as epithelial growth factor and transforming growth factor β, which in turn are under 
hormonal control by prolactin, progesterone, and glucocorticoids [35]. Permeability is 
increased, for example, during the dry period in uninfected glands [30]. Impermeability is 
important during lactation to prevent microbial entry. However, during active 
intramammary infection, permeability is increased as a result of direct damage by 
bacterial toxins as well as the influence of pro-inflammatory mediators such as histamine, 
TNF α, and interferon γ [25,30]. Although increased permeability may compromise 
barrier function, it facilitates entry of effectors of innate immunity into the milk 
compartment. Natural (opsonic) antibodies, complement components, transferrin, and 




Mammary epithelial cells are capable of recognizing antigen from invading 
organisms through expression of pattern recognition receptors, including TLRs 2 and 4 
[36]. A soluble form of CD14 (sCD14) which binds LPS and facilitates its interaction 
with TLR4, is present in milk and is produced by MECs [28,37]. Binding of pathogen 
components to TLRs initiates a cellular signal transduction pathway that ultimately leads 
to the production of inflammatory mediators. Toll-like receptor 2 binds components of 
Gram-positive bacteria, such as lipoteichoic acid and peptidoglycan, while TLR4 binds 
mainly LPS. Initially, LPS binding protein binds LPS, subsequently forming a complex 
with sCD14. Lipopolysaccharide is then transferred to the LPS receptor complex 
composed of TLR4 and lymphocyte antigen 96 (MD2), inducing homodimerization of 
TLR4. Transmembrane signaling results in activation of nuclear factors NF-ƙB and 
activated protein-1 and initiates production of pro-inflammatory cytokines and 
chemokines [6,24,30]. Specific cytokines generated as a result of intramammary infection 
vary by pathogen, as demonstrated by in vivo and in vitro studies examining cytokine 
expression profiles of MEC challenged with various bacterial species and/or bacterial 
components [36,38,39]. 
Alveolar and ductal MECs additionally produce non-cytokine secreted factors that 
contribute to innate immunity. Lactoferrin and citrate from MECs contribute to iron 
chelation, which exerts a bacteriostatic effect on bacterial species with high iron 
requirements, such as E. coli and S. aureus. Lactoferrin additionally has bactericidal 
effects (including synergism with other bactericidal proteins), anti-inflammatory effects 




xanthine oxidase, derived from milk fat globule membranes produced by MECs, 
additionally has bactericidal effects through generation of reactive oxygen species 
[30,41]. 
Neutrophils and macrophages are the major effector leukocytes involved in the 
innate immune response against intramammary infection. In the uninfected mammary 
gland, macrophages are the predominant cell type in milk, comprising 66-88% of somatic 
cells, accompanied by low numbers of neutrophils (<105 cells/ml; 0-11% of milk somatic 
cells) [42,43]. Lymphocytes are also present, comprising 10-27% of milk somatic cells, 
and are predominantly CD8+ T-lymphocytes expressing the αβ receptor [43]. These 
populations shift with intramammary infection. 
In the acute stages of inflammation, neutrophils become the predominant cell 
type, making up >90% of the total leukocyte population in milk [42]. Neutrophils are 
recruited from circulation by inflammatory mediators produced by MECs as well as by 
other leukocytes, predominantly macrophages. Inflammatory cytokines such as TNFα 
and interleukins (ILs) stimulate the expression of endothelial selectins (E-selectin, P-
selectin) and adhesion molecule (intercellular adhesion molecule 1, vascular cellular 
adhesion molecule 1) as well as expression of neutrophil adhesion molecule Mac-1, 
enabling neutrophil migration from the circulation to sites of inflammation [6,43]. 
Migration of neutrophils in the extravascular compartment to target sites occurs along 
concentration gradients of a number of factors, including complement components C5a 
and C3a, LPS, IL-1, IL-2, and IL-8 [30]. Neutrophils act as effector cells of innate 




molecules. Bactericidal effects are mediated mainly through the respiratory burst, in 
which nicotinamide adenine dinucleotide phosphate (NADPH) oxidases produce 
superoxide anions which then dismutate into hydrogen peroxide, hydroxyl, and other 
reactive oxygen species capable of destroying bacteria [44]. Other anti-microbial 
molecules released by neutrophils include defensins, lactoferrin, and bactenecins [30,42]. 
Although neutrophil numbers are low in the healthy mammary gland, the 
concentration and viability of neutrophils in the healthy mammary gland is inversely 
related to the risk of intramammary infection and the severity of coliform mastitis. 
Additionally, the degree and rapidity of neutrophil recruitment vary between individuals 
and are important factors in the outcome of infection [45]. Factors reported to affect the 
functionality of neutrophils within the mammary gland include cow parity, stage of 
lactation, nutritional/metabolic status, and genetic factors [25,30]. Neutrophils are highly 
effective at combating bacterial infection, but their responses secondarily contribute to 
mammary gland damage as a result of the release of lysosomal contents, reactive oxygen 
species, and tissue disruption associated with trans epithelial migration [25,46,47]. 
Macrophages comprise 9-32% of milk somatic cells in acutely infected quarters 
[43]. These cells are important in pathogen recognition, antigen presentation, and 
leukocyte recruitment. Pathogens are destroyed through phagocytosis and exposure to 
reactive oxygen species (superoxide, produced from O2 by NADPH oxidase) and 
proteases. Phagocytosis is enhanced by opsonization of pathogens by complement 
components and by natural or pathogen-specific antibody that is recognized by 




mastitis is considered fairly minor in comparison with that of neutrophils [43]. More 
importantly, macrophages contribute to the innate and adaptive immune response through 
secretion of nitric oxide and inflammatory mediators as well as antigen processing and 
presentation via major histocompatibility complex (MHC) class II receptors. Activated 
macrophages secrete prostaglandins, leukotrienes, and cytokines to influence various 
aspects of the inflammatory response, including development and recruitment of other 
leukocytes. For example, IL-12 produced by macrophages enhances the development of 
CD8+ (cytotoxic) T-lymphocytes while simultaneously driving a TH1 response, 
stimulating cell-mediated adaptive immune mechanisms [6,43]. As inflammation 
resolves, macrophages participate in phagocytosis and clearing of neutrophils [46,48]. 
Macrophage function is diminished during the periparturient period, contributing to an 
increased susceptibility to intramammary infection during this time [30]. 
Lymphocyte populations with a role in the response to intramammary infection 
include natural killer (NK) cells, CD4+ and CD8+ αβ T-lymphocytes, γδ T-lymphocytes, 
and B-lymphocytes. Total lymphocytes comprise 14-24% of milk somatic cells from 
infected quarters [43]. 
Natural killer cells are a subset of cytotoxic lymphocytes capable of exerting their 
effects independently of interaction with antigen presented by MHC molecules, and are 
an important component of innate immunity [6]. Contributions of NK cells during bovine 
mastitis have not yet been fully defined, but cells with NK-like activity have been 
demonstrated in the mammary gland [26] and may be an important component of innate 




destroy injured or infected cells via recognition of decreased MHC I expression, 
increased expression of activating receptors, and decreased expression of inhibitory 
receptors by target cells, and can recognize antibody-bound cells via Fc receptor binding 
[6]. Natural killer cells are capable of secreting TNF-α and other factors that promote 
pro-inflammatory responses [29]. 
Besides NK cells, lymphocytes are primarily involved in the adaptive, rather than 
innate, immune response. The relative degree of expansion of CD8+ and CD4+ αβ T-
lymphocyte populations in response to intramammary infection varies depending on the 
causal pathogen and the stage of infection [21,49]. For example, increased lymphocyte 
numbers during intramammary infection are due primarily to CD4+ T-lymphocyte 
expansion during staphylococcal infection, whereas both CD4+ and CD8+ T-lymphocyte 
expansion occurs during streptococcal infection [49]. In the uninfected mammary gland, 
B-cell levels remain fairly consistent throughout stages of lactation. In the infected 
mammary gland, B-cell differentiation and clonal expansion occurs in response to IL-2 
secreted from CD4+ T-lymphocytes, constituting the humoral component of the immune 
response [29]. 
Depression of immunity against mastitis and other diseases during the 
periparturient and early lactation periods is a widely-recognized phenomenon in cattle 
[50,51]. Several mechanisms are involved, including decreased leukocyte function, 
altered leukocyte trafficking, changes in circulating and mammary gland leukocyte 




Important factors driving these changes include increased glucocorticoid levels 
associated with the stress of calving and nutritional and genetic factors [53]. 
 
Damage to the Mammary Gland during Mastitis 
Mastitis-induced mammary gland damage and disruption of function are 
consequences of direct effects of pathogens as well as effects from the host immune 
response, namely those associated with leukocyte responses, proteases, and inflammatory 
mediators. 
The presence of some bacterial components such as LPS can induce apoptosis in 
MECs via upregulation of pro-apoptotic factors (Bax, IL-1β-converting enzyme) and 
simultaneous downregulation of anti-apoptotic factors such as Bcl-2. Some bacteria, such 
as S. aureus, induce apoptosis of MECs and other cells through cellular injury associated 
with direct invasion [54]. Direct bacterial effects contribute also to necrosis during 
mastitis. Virulence factors of causative bacteria may include toxin production, inducing 
cell death through host cellular membrane damage or intracytoplasmic enzymatic 
activity. Some pathogens produce effector proteins such as proteinases, while others 
induce damage through the production of superantigens [55]. 
Reactive oxygen species, produced by neutrophils and macrophages during the 
respiratory burst, are an important cause of tissue injury and necrosis during mastitis. The 
purpose of the respiratory burst is to destroy bacterial pathogens, but local host cells 




to lipids, proteins, carbohydrates, and nucleic acids, and therefore exert a wide range of 
detrimental effects on exposed host cells, including MECs [55]. 
In addition to production of reactive oxygen species, neutrophils initiate cellular 
damage through degranulation. Among other constituents, granules contain neutral and 
acidic proteases such as elastase, cathepsins G, B, and D, and matrix metalloproteinase 
(MMP). These proteases are capable of damaging mammary gland membrane proteins 
and interstitial matrix components, thereby exerting damaging effects on MECs and other 
mammary gland components [33]. 
Inflammatory cytokines such as TNFα produced during mastitis contribute to 
increased vascular and MEC barrier permeability. This, in turn, facilitates entry of 
potentially damaging plasma proteins into the mammary gland. For example, plasmin and 
plasminogen concentrations in the milk increase during mastitis as a result of increased 
MEC barrier permeability. The presence of these higher concentrations is further 
compounded by release of plasminogen-activating factors from neutrophils and some 
bacterial pathogens. Plasmin exerts damaging effects on MECs through direct 
degradation of matrix proteins (fibrin, laminin) as well as through activation of MMP 
precursors. Other potentially damaging plasma proteins increased in the mammary gland 
during mastitis include MMP-9, MMP-2, 120-kDa gelatinase, and stromelysin-1. 
Degradation of matrix proteins by these proteases contributes to compromise of MEC 




Inflammatory cytokines produced during mastitis may also have direct damaging 
effects on host cells. Exposure to TNFα and IL-1 induces apoptosis in bovine endothelial 
cells and human MECs. A similar effect on bovine MECs is possible [55]. 
 
Changes to Milk during Mastitis 
 One of the most economically important consequences of mastitis is the decrease 
in milk production that accompanies the disease. Damage to MECs, and therefore 
reduced production capacity, is a result of direct damage by mastitis pathogens as well as 
injury secondary to the inflammatory response [6], as discussed above. Even with 
therapeutic intervention, milk production may be affected for several weeks following 
intramammary infection before returning to expected levels [56]. Irreversible damage can 
occur as a result of severe or prolonged intramammary infection, in which secretory cells 
may be sloughed or permanently replaced by fibrous tissue [6]. In these cases, milk 
production is affected throughout the current as well as all subsequent lactations. 
In addition to lowering the volume of milk produced, mastitis results in 
substantial changes in milk composition. Decreases occur in lactose, α-lactalbumin, fat, 
and potassium. Increased vascular permeability as a result of inflammation results in 
leakage of sodium, chloride, and plasma proteins into the milk, particularly proteins 
associated with inflammatory responses. Additional proteins are released by mammary 
epithelial cells and leukocytes. Proteins increased in milk from infected quarters include 
whey, serum albumin, immunoglobulins, transferrin, lactoferrin, and various enzymes 




glucosaminidase [57,58]. Some of these enzymes, such as plasmin, may alter milk quality 
further via cleavage of milk components such as casein both prior to and following 
milking [28,58]. The pH of milk from mastitis quarters is frequently elevated due to the 
presence of plasma components [58]. During active infection, the causative organisms, 
usually bacteria, are present in variable numbers in the milk, and may be accompanied by 
bacterial toxins [58,59]. Milk SCC rises as a result of an influx of large numbers of 
leukocytes into the milk. In cases of clinical mastitis, milk from affected quarters may 
have altered color and/or consistency, often characterized by decreased viscosity with or 
without clots due to coagulation of leukocytes and clotting factors [58]. 
 
Somatic Cell Count as an Indicator of Intramammary Infection 
Measurement of milk SCC is frequently used as a diagnostic indicator of 
mammary gland health status. As an indicator of intramammary infection, SCC is used in 
the dairy industry in public health regulatory programs as a factor in determining the 
suitability of milk for human consumption. In the US dairy industry, for example, 
requirements of the Pasteurized Milk Ordinance place a limit on the SCC of milk 
(<750,000 cells/ml in Grade A raw milk) [60]. Additionally, SCC limits are used in some 
milk quality incentive programs, since mastitis can result in altered milk composition 
(discussed previously) and decreased shelf-life [60]. These applications of SCC 
measurement demonstrate aspects of the economic importance of minimizing mastitis in 
dairy cattle, as high SCC can potentially result in decreased milk value or even exclusion 




Intramammary infection is by far the largest contributor to an increased SCC, but 
a number of other factors can also affect SCC. Variation exists in the degree of SCC 
increase between pathogens. Bacteria that elicit marked cellular responses, with resultant 
large increases in SCC, are known as major pathogens. Common examples include 
coliforms and S. aureus. Infection by major pathogens results in an average SCC of 
>600,000 cells/ml [61]. Minor pathogens result in a less pronounced cellular response 
and thus a smaller increase in SCC. Minor pathogens include Corynebacterium bovis and 
coagulase-negative staphylococci. Infection by minor pathogens can result in SCCs of 
near or even less than 200,000 cells/ml [61]. Therefore, detection of cattle infected with 
minor pathogens may be poor unless additional testing is not carried out [16]. 
 The stage of infection additionally affects SCC. In experimentally infected cows, 
SCC was highest during the acute stages of infection. Variation due to the challenge 
organism existed in the time to peak SCC after infection, but occurred within hours to 
days [62]. Somatic cell count may be elevated 10 days prior to clinical mastitis in 
naturally-infected cows [63] and can persist for variable amounts of time following 
clearance of intramammary infection [64,65]. As elevated SCC may persist after an 
infection is cleared, a cow in this stage may be falsely classified as actively infected 
despite having cleared the causative organism. 
 The stage of lactation also influences SCC. In uninfected cows, the highest SCC 
occurs at drying off, followed by directly after calving, and the lowest occurs from peak 




dilution effect [16]. Variation in this trend may be influenced by parity, as somatic cell 
linear scores in first-lactation cows may conversely be higher in early lactation [66]. 
 Hourly and daily variations in SCC occur. Hourly variations are influenced by the 
milking schedule, with the highest SCC generally detected at milk stripping and within 1-
3 hours after milking. Differences between daily high and low SCC ranges from 4- to 70-
fold for individual quarters [58]. Therefore, a single daily SCC measurement may not be 
representative of overall SCC. Day-to-day variation is particularly of relevance among 
infected cows [16]. 
Because milk somatic cells represent a component of the immune defense against 
mastitis pathogens, a low SCC (<200,000 cells per ml during intramammary infection) in 
some cattle may indicate a depressed or ineffective immune response to intramammary 
infection rather than an absence of intramammary infection. In fact, low SCC has been 
reported as a risk factor in the subsequent development of clinical mastitis [67,68]. 
Somatic cell count is a widely used but imperfect indicator of intramammary 
infection status, with the potential to be influenced by the above factors. Measures other 
than SCC have been used to determine the infection status of cows. Milk bacterial culture 
is useful and can be carried out on-farm [69]. Identification of mastitis pathogens via 
PCR or immunoassays provides an alternative to bacterial culture for detection of specific 
pathogens, and is becoming more widely available in recent years but may still be cost-
prohibitive [20]. The potential for sample contamination as well as the potential for a lack 
of bacterial shedding during intramammary infection must be considered in the 




mammary gland for changes consistent with mastitis (e.g. altered milk consistency, 
visibly inflamed mammary gland tissue) allows for detection of clinical mastitis, but 
gives no indication of subclinical mastitis. Tests for biomarkers of mastitis, such as 
measurement of milk lactate dehydrogenase levels [70], have been proposed, but the use 
of these for commercial purposes has limitations [20]. Reliable determination of infection 
status is best achieved through a combination of SCC measurement, pathogen detection, 
and examination for clinical mastitis [71]. 
 
Factors Influencing Mastitis Resistance 
An individual’s phenotype for any given trait, including disease resistance, may be 
influenced by genetic and environmental factors. The relative contribution of each of 
these factors varies by trait [6,72]. In disease resistance, environmental factors may 
include nutritional and metabolic status, age, concurrent disease, hormonal status, 
environmental temperatures, and, for infectious diseases, the type and dose of pathogen 
exposure.  Genetic factors that impact disease severity vary greatly between different 
diseases, but by definition include any variation within the genome that influences an 
individual’s susceptibility. Many traits are considered quantitative, meaning that the 
cumulative influence of and interaction between multiple genes (polygenes) determines 
the phenotype. These traits display polygenic inheritance, yielding a continuous gradient 
of phenotypes among individuals rather than distinct phenotypic categories [73]. 
Environmental factors often have substantial influences on expression patterns of the 




Mastitis resistance is a multifactorial, quantitative trait [28,72,75]. In dairy cattle, 
recognized external environmental factors influencing mastitis susceptibility are many, 
including nutritional management, housing type and management, bedding material, 
milking routine, maintenance and performance of milking equipment, season, dry cow 
management, and the use of preventative disease programs [12,76–78]. Additional, cow-
dependent, non-genetic factors include stage of lactation, reproductive status, concurrent 
disease, and metabolic status [53,76,79,80]. These factors have variable but often 
substantial effects on mastitis traits, and much research has focused on optimizing the 
management of environmental factors and milking practices in an effort to decrease 
mastitis incidence. 
Genetic factors are also known to contribute to mastitis susceptibility. Heritability for 
clinical mastitis is reported by most studies to be within the range of 0.003 to 0.17 [81–
88], but has been reported to be as high as 0.42 [89]. Heritability for subclinical mastitis 
is reported within the range of 0.04 to 0.14 [87,88], with one study reporting differences 
in heritability to subclinical mastitis based on the causative agent [88]. Heritability for 
somatic cell score (SCS; a derivative of SCC) is reported within the range of 0.01 to 
0.187 [84,90–93]. Although the heritability of mastitis traits appears to be relatively low, 
genetic selection for mastitis resistance nevertheless has been demonstrated to reduce the 
incidence of mastitis, particularly when genetic markers of mastitis traits are used 
[89,94]. Because of the potentially substantial benefits of marker-assisted selection, 
discovery of genetic markers of mastitis resistance is an ongoing pursuit within the field 




An Introduction to Genome-Wide Association Studies 
Regions of the genome associated with quantitative traits, such as mastitis 
susceptibility, are termed quantitative trait loci (QTLs). Identification of QTLs, and the 
specific variants within them associated with phenotype for a given trait, provide the 
basis for marker-assisted selection in animal breeding. 
Within QTLs, a number of recognized types of variation can influence phenotype. 
These include differences in copy numbers of genes, gene segments, or non-coding 
sequences (copy number variations, CNVs); micro- and minisatellites; and sequence 
polymorphisms [95]. Single nucleotide polymorphisms (SNPs), the most common form 
of variation [96], are sites within the genome where allelic variations in a single 
nucleotide base are present in greater than 1% of the population. They may occur in 
coding or non-coding regions, and can affect gene expression or gene products [95,97]. 
Single nucleotide polymorphisms have been associated with variations in specific 
phenotypic traits in many species, including mastitis traits in cattle. 
Single nucleotide polymorphisms significantly associated with a particular trait can 
be identified through candidate gene studies or genome-wide association studies 
(GWAS). In candidate gene studies, specific genes or genomic regions hypothesized or 
known to be relevant to the phenotype of interest are selected and genotyped. These 
genotyped regions are then examined for SNPs, and whether specific alleles of these 
SNPs vary significantly among phenotypically divergent individuals (e.g. cattle with a 
high level of susceptibility versus those with high level of resistance to a disease). 




results of previous genomic studies [97,98]. Genome-wide association studies, on the 
other hand, allow genotyping of large numbers of SNPs across the genome. Detection of 
SNPs that are significantly associated with the trait of interest is not limited to 
previously-identified regions known to be associated with the trait, thus allowing for an 
expanded potential to detect novel variants (previously unidentified SNPs) [97]. In the 
context of disease, GWAS can potentially highlight previously unknown contributions of 
specific genes or regions to disease susceptibility, thereby contributing to elucidation of 
disease mechanisms in addition to detection of novel genetic markers. Genome-wide 
association studies are appropriate if the common disease/common variant hypothesis is 
true, in which a common, complex disease is influenced by genetic variants that are 
common within the population. Complex diseases influenced by multiple loci, each with 
a small effect, are most well suited to GWAS [98,99]. 
Using GWAS, the number of SNPs genotyped varies by assay. Low-density (several 
thousand SNPs), medium-density, and high-density (hundreds of thousands of SNPs) 
arrays are available for GWAS in cattle. Increased marker density increases the power to 
detect significant associations [100], and is particularly important when numerous loci 
with small effects are studied. Even with high-density arrays, however, only a small 
proportion of the total SNPs in the genome are genotyped. Genome-wide association 
studies rely on the concept of linkage disequilibrium (LD), defined as the non-random 
association of alleles at different loci due to non-random patterns of genetic 
recombination [101]. Single nucleotide polymorphisms located together between two 




more frequently than would be expected by chance, and thus would be considered in LD 
with each other [96]. The degree of LD is commonly expressed as an r2 statistic, defined 
as the square of the correlation coefficient between the presence or absence of a specific 
allele at one locus and the presence or absence of a specific allele at a second locus [102]. 
The r2 values range from 0 to 1, where r2 = 1 indicates that specific alleles of the SNPs 
are inherited together in all individuals of the study population, whereas r2 = 0 indicates 
that the alleles are independently inherited and thus in linkage equilibrium [96]. Linkage 
disequilibrium among some groups of SNPs is strong enough that a relatively small 
number of associated allele sets, or haplotypes, account for the majority of the variation 
at that genomic region within a population. Because of LD, the causal SNP of the 
phenotypic variation does not itself need to be genotyped so long as a SNP with which it 
is in strong LD is genotyped. Genotyped SNPs in high LD with a causal SNP are called 
tag SNPs, and can be used to predict phenotype due to their LD relationship with the 
causal SNP [96,98]. In the human genome, for example, LD allows for the majority of 
genomic variation to be detected in subjects of European ancestry using 300,000 well-
chosen tag SNPs. Single nucleotide polymorphisms can be chosen for GWAS arrays 
based on existing knowledge of SNP-phenotype associations, such as that provided by 
the human HapMap project, or, more commonly, are an unbiased selection distributed 







Genome-Wide Association Study Methodology 
The first step in a successful GWAS is study population selection. Sample size is one 
factor that influences the power of detection of significant SNPs, and is particularly 
important in detection of rare variants [95,99]. Additionally, robust methods for 
phenotypic classification of individuals within the sample population are essential in 
order for true associations to be detected [99]. Due to the high expense of GWAS arrays 
and data analysis, studies may be carried out as two-stage designs, in which a relatively 
small sample size is used initially. Single nucleotide polymorphisms found to be 
significantly associated with the trait of interest within the initial sample population can 
be selected for further analysis in the second stage of the study, within an expanded 
population. Thus, the number of SNPs to be genotyped in the second stage of the study 
can be greatly reduced by eliminating SNPs with no evidence of association to the trait. 
In some studies, the initial stage is used to select specific areas of the genome to examine 
in more detail by increasing marker density at that area for the second stage of the study 
[95,98]. For single-stage studies, an approach to reduce sample size while retaining 
statistical power has been described (“selective genotyping”). In this approach, only the 
phenotypically extreme individuals (e.g. the most highly resistant and most highly 
susceptible individuals to a disease) are genotyped; the number of individuals 
characterized as phenotypically extreme should not exceed 20-25% of the population 
[103]. This approach is based on the assumption that allelic frequencies of causal variants 




population. Selective genotyping therefore provides an enrichment effect of causal alleles 
within the genotyped population [104]. 
 Genotyping is carried out using a SNP microarray following genomic DNA 
isolation and purification. Several SNP array platforms exist, with widely used arrays 
available from Affymetrix (Santa Clara, CA) and Illumina (San Diego, CA). Both are 
based on hybridization of DNA fragments containing a SNP of interest to a 
complimentary oligonucleotide probe on the array, combined with a detection chemistry 
to generate nucleotide-specific signals at each SNP site. Affymetrix arrays consist of 
short oligonucleotides affixed directly to the array chip surface. Illumina arrays are 
microbead-based, with oligonucleotide probes affixed to microbeads on the chip. 
Illumina chips are more expensive to manufacture, but have a higher specificity than 
Affmetrix arrays due to the use of longer oligonucleotide probes [99]. 
For analysis using Illumina arrays, genomic DNA is first processed by 
fragmentation and whole-genome amplification before hybridization to the array. Each 
probe on the array consists of an oligonucleotide sequence complementary to a sample 
genomic DNA sequence, with its 3’ end directly adjacent to a SNP site. Hybridization of 
genomic DNA to its complementary probe results in overhang of the genomic DNA 
fragment directly at the SNP site. Subsequently, single base extension at the 3’ end of the 
probe incorporates a labeled nucleotide complementary to the SNP allele. A wash step 
then eliminates remaining, unbound labeled nucleotides from the array. The chip is then 
scanned, and signals emitted by the labeled nucleotides are recorded. Because each of the 




oligonucleotide probes on the array are known, the signal emitted at each microbead 
position is used to determine the allele(s) present at each specific SNP site [105,106]. 
Pixel values obtained from the array scan are first converted to signal intensity values at 
each position. Signal intensities are then subjected to intensive quality control measures, 
also called low-level analyses, before the genotype (the allele present at each SNP site) 
can be called. Many factors affect signal intensities, including DNA concentration and 
differences in probe affinities between individual alleles. Genotype calling algorithms 
account for these factors, normalizing signal intensities to facilitate accurate genotype 
calling. A number of algorithms have been developed, reviewed elsewhere [98], and 
commonly employ a Bayesian approach. Genotypes that cannot be accurately called 
following these quality control measures are excluded from the data set. Ultimately, three 
signal intensities are possible, indicating that an individual is homozygous for the major 
(more common) allele, homozygous for the minor (less common) allele, or heterozygous 
[98]. 
 The data are filtered by a number of further quality control steps after genotype 
calling. Individual samples for which more than a few SNPs could not be called are 
assumed to be of poor quality and are excluded from the data set. In most studies, 
samples with a call rate of less than 97% of SNPs are excluded. Individual SNPs for 
which genotyping failed in multiple animals are also excluded from the dataset. A 
threshold of 2 to 3% is usually set, such that any SNP with a failed call rate above this is 
excluded. Additionally, SNPs for which the minor (less common) allele frequency is low 




association of these SNPs to the trait using GWAS. Single nucleotide polymorphisms 
with minor allele frequencies of less than 1 to 5% are usually excluded [98]. 
 Following quality control measures, GWAS require adjustment for familial 
relatedness between animals in order to avoid artificial inflation of significance values. 
One method to account for familial relatedness is the genomic best linear unbiased 
prediction (gBLUP) method, which generates a marker-based genomic kinship matrix for 
integration into the analysis. Covariance between individuals is determined based on 
comparison between samples of a large number of genetic markers such as SNPs, and is 
used to determine relatedness with more accuracy than pedigree-based methods [107]. 
The kinship matrix generated by gBLUP is then incorporated into mixed linear model 
analysis, with relatedness corrected for as a random effect [108]. 
 Once genotype calling, data filtering, and generation of a kinship matrix have 
been completed, data analysis can proceed. Linear regression, the single locus mixed 
model (SLMM), and the multi-locus mixed model (MLMM) are three alternative 
methods commonly used in GWAS. Of these, the mixed models incorporate both fixed 
and random effects, and thus are able to take into account familial relatedness using a 
kinship matrix, as discussed above [109,110]. The SLMM detects associations between a 
trait and individual markers, examining the relationship of each SNP to the phenotype 
independently of other SNPs [110]. The MLMM is used for complex traits influenced by 
multiple moderate- to large-effect loci, and examines interaction effects between SNPs 
throughout the genome. It employs a stepwise mixed model regression and a forward 




confounding effects of background loci across the genome. Compared with the single 
locus MLM, the MLMM generally yields lower false detection rates (FDR) and higher 
power [108,110]. 
 In mixed model analysis, a genetic model must be specified. An additive, 
dominant, recessive, or multiplicative inheritance pattern is selected based on knowledge 
from previous studies, if available [99,108]. Frequently, the inheritance pattern of the 
SNPs of interest is unknown. In these cases, the additive inheritance model is selected, as 
this has the power to detect both additive and dominant effects. Additive inheritance 
assumes a linear, uniform increase in risk for expression of the phenotype in question 
(e.g. disease susceptibility) for each copy of the risk-associated allele. In other words, if 
two alleles, a and A, exist for a particular SNP, and the A allele is associated with 
increased disease susceptibility, an animal with the genotype AA will be twice as disease-
susceptible as an animal with the Aa genotype. If an animal with the Aa genotype is three 
times more susceptible to developing the disease than an animal with the aa genotype, an 
animal with the AA genotype will be twice as susceptible than the Aa animal, or six times 
more susceptible than the aa animal. The dominant model, on the other hand, assumes 
equal risk for Aa and AA animals, while the recessive model assumes that an animal must 
have two copies of the causative allele (AA) in order to have increased susceptibility. The 
multiplicative model assumes that an animal with the genotype AA is x2 more susceptible 
than an animal with the Aa genotype. [99]. 
Depending on the study population, additional covariates (other known factors 




appropriate. These may include population stratification (e.g. different ethnic groups), 
sex, age, and study site [99,108]. 
 Due to the large number of individual statistical tests carried out in mixed model 
analysis, p-values generated by the analysis must be corrected for multiple testing. The 
Bonferroni and FDR methods are two commonly used methods. The Bonferroni 
correction adjusts the false positive rate for the number of statistical tests; the alpha value 
(significance value) is divided by the number of statistical tests run. This method assumes 
that each association test for every SNP is independent of all other tests, and therefore 
does not account for LD. The FDR method allows adjustment of the false positive rate 
through providing an estimate of the proportion of significant results that are false 
positives [99]. This method has increased power over the Bonferroni method, with an 
increasing advantage as the number of tests increase, but may overestimate false positives 
[111]. 
 The corrected p-values indicate the level of association between each SNP and the 
trait of interest. A universal threshold for genome-wide significance has not been 
established, although 5.5 x 10-8 has been suggested by the International HapMap 
Consortium [112] and has been used in many GWAS [98,113]. However, less stringent 
thresholds have been proposed to account for factors such as allele frequency [113] and 
LD [98]. Recently, guidelines for determining appropriate significance thresholds 
adapted for individual GWAS have been suggested [113]. 
 Although GWAS provide a powerful tool for genetic marker discovery, the risk of 




therefore required to validate GWAS findings, and should include replication of results in 
a separate but comparable and ideally expanded population [114]. Consideration of the 
functional relevance (known or demonstrable influences on the phenotype of interest) of 
candidate genes identified by GWAS can also assist in distinguishing false positives from 
true associations and serve as a guide for the direction of follow-on studies [115,116]. 
 
The Application of Marker-Assisted Selection for Mastitis Traits 
In livestock species, selection for health or production traits may be based on 
phenotypic measures or the use of genetic marker-assisted methods for single-gene or 
quantitative traits [117]. The potential for marker-assisted methods to improve the 
efficiency and precision of selection over conventional methods has been demonstrated in 
a number of production species. In dairy cattle, for example, marker-assisted selection for 
decreased SCS in first-lactation heifers resulted in a higher level of discrimination 
between high and low SCS heifers than did a conventional strategy relying on parental 
relative estimated breeding values for SCS [94]. Similar conventional and marker-
assisted selection strategies were used in a separate study to identify mastitis-resistant and 
mastitis-susceptible cattle [118]. In that study, primary MECs from cattle within the 
marker-assisted groups displayed marked differences in inflammatory gene expression 
between resistant and susceptible cattle following challenge by E. coli and S. aureus. In 
contrast, differences in inflammatory gene expression by MECs between resistant and 




at a single timepoint, after challenge by E. coli only. These and other studies illustrate the 
potential of marker-assisted selection in improving mastitis traits in dairy cattle. 
The search for genetic markers of mastitis traits for use in selection programs has 
focused on identification of QTLs and candidate genes. As of March 2017, the cattle 
QTL database (http://animalgenome.org/cgi-bin/QTLdb/BT/index), which catalogues 
publicly available QTLs in cattle [119], lists 244 distinct QTLs of mastitis traits. These 
include 69 QTLs for clinical mastitis, 28 QTLs for SCC, and 147 QTLs for SCS. 
Numerous candidate genes with recognized genetic variants have been proposed as likely 
contributors to mastitis traits due to their roles in the pathogenesis of mastitis. Examples 
of promising candidate genes proposed by multiple independent studies include C-X-C 
motif chemokine receptor 1 (CXCR1) [120–127], TLR4 [128–131], and TLR2 [132–
134]. C-X-C motif chemokine receptor 1 is a high-affinity receptor for IL-8. Receptor-
ligand interaction promotes cell migration, production of reactive oxygen species, and 
phagocytosis, and affects cell survival regulation and cytokine production [135]. 
Significant upregulation of CXCR1 expression occurs rapidly in the bovine mammary 
gland following intramammary infusion of bacteria [136]. Toll-like receptors 2 and 4 are 
involved in pathogen recognition [6], and are upregulated in the bovine mammary gland 
during mastitis [137]. 
Before any selection method, including marker-assisted selection, is implemented, the 
effects of selection on other traits must be considered. In some instances, selection for a 
single trait can have detrimental effects on the selection progress of separate traits [117]. 




traits has been demonstrated [93,138,139]. Linkage disequilibrium between causal 
variants of these two traits exists in some regions of the genome, with common 
haplotypes containing unfavorable alleles for one trait and favorable alleles for the other 
[138,140]. Because these two traits are both considered important in dairy cattle, care 
should be taken not to unacceptably compromise one trait for improvement of the other. 
However, selection for both traits simultaneously is possible by, for example, selecting 
for less common haplotypes that confer favorable alleles for both traits [140,141]. 
The identification and validation of genetic markers of mastitis traits, as well as their 
implementation in selective breeding programs, are not without challenges. Genome-
wide association studies provide a powerful tool for discovery of genetic markers and 
QTLs, but results must be repeatable for validation of true associations [114]. 
Identification of candidate genes can serve as a guide for follow-on studies to define the 
functional relevance of variants and can advance knowledge of disease pathogenesis. 
Additionally, in applying marker-assisted techniques to livestock improvement, the 
effects of selection for a single trait on other important health or production traits must be 
considered. 
 
Research Objectives and Findings 
 The first objective of this dissertation was to identify QTLs of mastitis resistance 
based on SNPs in Holstein dairy cattle. Phenotypic characterization of lactating Holstein 
cattle was based on monitoring for clinical mastitis and milk bacterial culture, 




extremes (highly mastitis-resistant cattle and highly mastitis-susceptible cattle) were 
identified and included in a GWAS using a selective genotyping approach. Using a 
SLMM analysis, 117 SNPs suggestive of genome-wide significance (p<1E-04) for 
mastitis resistance were identified. From these, 27 QTLs, including 10 novel QTLs, of 
mastitis resistance were identified. 
 The remaining objectives of this dissertation involved assessment of bovine MEC 
inflammatory responses. In order to accomplish these objectives, a method to establish 
primary bovine MEC lines from a small volume of bovine milk was developed. The first 
objective was to compare expression of inflammatory genes between bMECs from 
mastitis-resistant cows, before and after stimulation of an inflammatory response, to 
those of bMECs from mastitis-susceptible cows. The expression of genes relevant to 
inflammation by unchallenged and LPS-challenged bovine MECs from mastitis-resistant 
and mastitis-susceptible cattle were identified. An enhanced ability of bovine MECs from 
mastitis-resistant cattle over those from mastitis-susceptible cattle to rapidly respond to 
LPS challenge by differential expression of inflammatory genes was demonstrated. 
Secondly, the expression of pro-inflammatory genes by unchallenged and LPS-
challenged bovine MECs and bovine fibroblasts was compared, and a similar expression 
pattern of interleukin 1 beta between the two cell types but a divergent expression pattern 
of C-C motif chemokine ligand 20 was demonstrated. Next, the effect of exogenous 
phospholipase A2 (PLA2), an enzyme involved in inflammatory mediator generation, on 
the expression of pro-inflammatory genes by unchallenged and LPS-challenged bovine 




gene expression in response to LPS challenge but does not influence constitutive 
expression. Finally, a milk-derived primary bovine MEC line with an extended capacity 
for division through transfection with simian virus 40 large T antigen was established. 
This cell line, as well as the methods used in its establishment, may be used to facilitate 







A GENOME-WIDE ASSOCIATION STUDY FOR MASTITIS RESISTANCE IN 
PHENOTYPICALLY WELL-CHARACTERIZED HOLSTEIN DAIRY CATTLE 




A decrease in the incidence of bovine mastitis, the costliest disease in the dairy industry, 
can be facilitated through genetic marker-assisted selective breeding programs. 
Identification of genomic variants associated with mastitis resistance is an ongoing 
endeavor for which genome-wide association studies (GWAS) using high-density arrays 
provide a valuable tool. 
 
Results 
We identified single nucleotide polymorphisms (SNPs) in Holstein dairy cattle associated 
with mastitis resistance in a GWAS by using a high-density SNP array. Mastitis-resistant 
(15) and mastitis-susceptible (28) phenotypic extremes were identified from 224 lactating 
dairy cows on commercial dairy farm located in Utah based on multiple criteria of 
mastitis resistance over an 8-month period. Twenty-seven quantitative trait loci (QTLs) 
for mastitis resistance were identified based on 117 SNPs suggestive of genome-wide 
significance for mastitis resistance (p<0.0001), including 10 novel QTLs. Seventeen 




QTLs for teat length. One QTL includes the RAS guanyl releasing protein 1 (RASGRP1) 
gene, a candidate gene for mastitis resistance. 
 
Conclusions 
This GWAS identifies 117 candidate SNPs and 27 QTLs for mastitis resistance using a 
selective genotyping approach, including ten novel QTLs. Based on overlap with 
previously-identified QTLs, teat length appears to be an important trait in mastitis 
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Background 
Mastitis, defined as inflammation of the mammary gland, is the costliest disease 
in the dairy industry [1,2]. In the United States, the cost of bovine mastitis is estimated at 
a value of approximately 10% of total milk sales [89]. Associated costs include loss of 
production, decreased milk quality, discarded milk, labor, veterinary treatments, mastitis-
related culls, diagnostics, and preventative measures [3]. 
Conventional methods to reduce the incidence of mastitis within a herd 
encompass both management practices and selection for mastitis-resistant phenotypes. 




studies (GWAS), has led to the identification of quantitative trait loci (QTLs) associated 
with mastitis traits [75,142,143]. Genetic selection for mastitis resistance traits provides a 
valuable tool for decreasing mastitis incidence. Genetic marker-assisted selection for 
mastitis traits results in a higher level of discrimination between phenotypes and a greater 
uniformity than does conventional selection [94], highlighting the importance of 
identifying robust genetic markers for mastitis resistance. Genome-wide association 
studies are well-suited to identifying genetic markers of complex traits such as mastitis, 
enabling genotyping of large numbers of potential genetic markers, such single 
nucleotide polymorphisms (SNPs), across the genome [98,99]. Indeed, GWAS carried 
out over the past several years have identified genetic markers, candidate genes, and 
QTLs for individual mastitis traits such as somatic cell count (SCC), somatic cells score 
(SCS) and clinical mastitis [142,144,145]. Many of these studies use low- or medium-
marker density arrays to detect genetic markers [75,145,146]. High-density bovine arrays 
capable of genotyping close to one million SNPs are available for cattle and offer the 
advantage of increased genomic coverage and statistical power [144]. Studies using such 
high-density arrays have the potential to identify novel genetic markers as well as verify 
the significance of previously identified markers. 
In this study, we performed a GWAS using a high-density array to identify SNP 
genetic markers and define QTLs of mastitis resistance in Holstein dairy cows. We used a 
selective genotyping approach, identifying the most mastitis-resistant and mastitis-
susceptible animals within the sample population. This approach facilitated detection of 




extreme individuals [104]. Phenotypic characterization was based on multiple criteria of 
intramammary infection status in order to achieve more accurate characterization of 
phenotypic extremes of mastitis resistance and mastitis susceptibility than could be 
achieved with use of a single measure of mastitis alone. 
 
Methods 
 The aim of this study is to identify SNP genetic markers and QTLs of mastitis 
resistance in dairy cattle. A genome-wide association study was performed using a 
selective genotyping approach.   
 
Selection of phenotypically extreme cattle 
Cattle used in the study were adult lactating Holstein cattle from a single farm, 
and phenotypically extreme individuals of mastitis resistance and mastitis susceptibility 
were identified and selected for genotyping. Phenotypic characterization was based on a 
combination of milk bacterial culture, observation for clinical mastitis, and SCC 
evaluation over an eight-month period. Subclinical mastitis was defined as cases in which 
intramammary infection was detected by bacterial culture of milk but no changes were 
detected in the appearance of the mammary gland or milk. Clinical mastitis was defined 
as intramammary infection accompanied by clinically detectable inflammatory changes 
in the mammary gland and/or changes in the consistency or color of the milk.  
To detect of clinical and subclinical mastitis, monthly bacterial cultures were 




was carried out according to the guidelines outlined by the National Mastitis Council 
[147]. Isolation of at least one bacterial colony from a 0.01 ml inoculum of a single milk 
culture sample was considered sufficient to diagnose intramammary infection, as 
proposed by the Mastitis Research Workers [71]. Detection of clinical and subclinical 
mastitis was also based on bi-monthly veterinary clinical evaluations to detect abnormal 
mammary gland quarters or secretions; continuous monitoring for clinical mastitis by 
farm staff; and individual quarter bacterial culture of milk from suspect intramammary 
infection cases at the time of detection. Monthly SCCs were used as supplementary 
evidence for the absence of intramammary infection in animals from which no bacteria 
were isolated from milk samples and no clinical mastitis was detected. Monthly SCC 
measures were obtained from the Dairy Herd Improvement Association (DHIA). 
Chronic (continuing) cases of clinical and subclinical mastitis were distinguished 
from new cases on the basis of time elapsed between detection of sequential episodes, 
time elapsed after treatment from a previous episode, quarter(s) affected, and etiologic 
agent [148–150]. For the purposes of this study, cattle with multiple new episodes of 
mastitis were selected as mastitis-susceptible over those with few but chronic episodes. 
Criteria for classification as mastitis-resistant included an absence of clinical mastitis, an 
absence of bacteria cultured from milk samples throughout the eight-month period, and 
consistently low SCCs (<250,000 cells/ml). The criterion for classification as mastitis-
susceptible was detection of at least four separate episodes of mastitis. Episodes of 
mastitis were defined by any of: isolation of one or more mastitis pathogens from a milk 




Isolates from more than one quarter on one date contributed as many mastitis episodes as 
there were culture-positive quarters. Clinical mastitis detected in more than one quarter 




Genomic DNA of cows characterized as mastitis-resistant or mastitis-susceptible 
was isolated from ear notches or hair follicles. Isolation and purification of DNA was 




Genotype calling was carried out by the Core Facility at the University of Utah for 
SNP genotyping using the Illumina BovineHD BeadChip (part # WG-450-1002; Illumina 
Inc., San Diego, CA), an array with 777,962 SNPs that uniformly span the entire bovine 
genome. Bead chips were processed according to the Infinium protocol from Illumina, 
and scanning carried out by the iScan scanner (Illumina Inc., San Diego, CA). Quality 
control measures included removal of animals with low call rates (<96%), SNPs with low 








 Significant associations between SNPs and mastitis resistance were detected using 
a single locus mixed model approach as implemented by the SNP and Variation Suite 
software (SVS version 8.4, Golden Helix, Bozeman, MT). Familial relatedness was 
corrected for as a random effect by incorporation of a genomic best linear unbiased 
prediction (gBLUP) kinship matrix [107] into the model, constructed from genome-wide 
SNPs after pruning for linkage disequilibrium (LD). Genome-wide association mapping 
used a mixed linear model analysis [110] using the gBLUP matrix to correct for cryptic 
relatedness, with mastitis resistance/susceptibility coded as a binary phenotype. A 
genome-wide suggestive threshold was set at an uncorrected p-value of p < 0.0001, with 
p < 0.001 considered nominal. 
 
Defining QTLs 
 Quantitative trait loci were defined as described previously [142]. A QTL 
surrounding each SNP detected as significant (p < 0.0001) was defined based on local LD 
structure. Pairwise LD between the target SNP and all individual genotyped SNPs within 
1 Mb upstream and downstream was calculated using PLINK [151]. Within this region, 
visualized using the ggplot function of the R Studio statistical package [152], the furthest 
upstream and downstream SNPs in strong LD with the target SNP (r2 ≥ 0.8) were used to 
define QTLs. Quantitative trait loci comprised of a single SNP only were excluded. 
Overlapping QTLs were combined into a single QTL, defined by the furthest upstream 




bovine genome (Bos_taurus_3.1.1/bosTau8 assembly; [153]) using the University of 
California Santa Cruz (UCSC) Genome Browser tool (https://genome.ucsc.edu/) and 
dbSNP [154] to identify genes overlapping these regions. These QTLs were checked for 
overlap with known bovine QTLs using the cattle QTL database 




Mastitis-resistant and mastitis-susceptible cows in a commercial dairy herd with 
224 lactating Holstein cows were identified following monitoring for clinical and 
subclinical mastitis over an eight-month period. From this rigorous mastitis-screening 
program, 15 animals were characterized as mastitis-resistant (Table 1A) and 28 animals 
as mastitis-susceptible (Table 1B). All mastitis-susceptible cows with the exception of 
one had four confirmed cases of mastitis. One cow had three cases of mastitis confirmed 
by isolation of three separate pathogens, and one tentative case where sample 
contamination precluded definitive pathogen isolation. Cattle within the mastitis-resistant 
group ranged from second to sixth lactation, and cattle within the mastitis-susceptible 
group ranged from first to sixth lactation. Among the mastitis-resistant group, individual 
composite milk SCCs over the eight-month period ranged from 5,000 to 220,000 
cells/ml, with an average of 56,300 cells/ml. Among the mastitis-susceptible group, the 
number of clinical mastitis episodes ranged from none to three. Individual quarter and 




303,000 cells/ml. Commonly isolated bacterial species from composite and individual 
quarter milk samples from mastitis-susceptible cattle included coagulase-negative 
staphylococci, Streptococcus sp., Corynebacterium sp., and Escherichia coli. 
 
Genome-wide associations 
In order to identify SNP genetic markers and QTLs of mastitis resistance, we 
carried out a GWAS using a selective genotyping approach. Of 224 lactating Holstein 
dairy cows, we selected the top 15 most mastitis-resistant and the top 28 most mastitis-
susceptible cows for genotyping. 
Following data quality control measures, 585,949 SNPs remained for association 
testing using data from 43 animals (28 mastitis-susceptible, 15 mastitis-resistant), 
represented in Figure 1A as a Manhattan plot. Based on deviation from a linear 
relationship between observed and expected p-values, as illustrated in Figure 1B in a 
quantile-quantile plot, a p-value threshold of 0.0001 was set as suggestive of genome-
wide significance and a p-value of > 0.0001, ≤ 0.001 was considered nominal for 
association. 
One hundred and seventeen SNPs were suggestive of genome-wide significance 
(Table 2). Based on these 117 SNPs, we identified 27 QTLs of mastitis resistance, 
distributed across 14 chromosomes (2, 3, 7, 8, 10, 11, 12, 15, 16, 17, 18, 26, 27, and 28) 
and overlapping a total of 29 genes (Table 3). Of these QTLs, 10 have not been reported 
previously. Thorough phenotypic characterization using both direct (clinical mastitis and 




month period, as well as use of a selective genotyping approach, facilitated identification 
of these 10 novel QTLs. 
The three QTLs most highly suggestive of genome-wide significance (-log10(p-
value) ≥ 5.41) are located on Bos taurus autosome (BTA) 26 and overlap the sortilin 
related VSP10 domain containing receptor 3 (SORCS3) gene as well as a previously-
identified QTL for teat length. The SORCS3 gene has no known function in bovine 
mastitis. Another QTL suggestive of genome-wide significance overlaps the RAS 
guanyl-releasing protein 1 (RASGRP1) gene, a candidate gene for mastitis resistance. 
Seven hundred and sixty-three SNPs were nominal for genome-wide significance (Table 
12, Appendix), distributed across all autosomal and the X chromosome. 
Seventeen of the QTLs we identified overlap with previously identified QTLs of 
mastitis traits (somatic cell score, SCC, and clinical mastitis) and/or udder conformation 
traits (teat length, teat number, udder attachment, and udder depth; Table 4). Our findings 
reinforce the discovery of these 17 QTLs and provide supporting evidence that these 
QTLs may influence mastitis resistance. The top 3 QTLs overlap with a known QTL for 
teat length, which may provide the basis of mastitis resistance at these regions. 
 
Discussion 
We carried out a GWAS using a selective genotyping approach and a high-density 
bovine SNP array, and identified 117 SNPs suggestive of genome-wide association for 
mastitis resistance in Holstein dairy cattle. Based on these 117 SNPs, we identified 27 




The RASGRP1 gene is located within a QTL we identified on BTA10, defined by 
8 SNPs genotyped in our GWAS. RASGRP1 is involved in the regulation of lymphocyte 
development, activation, and function and in T-cell receptor signaling [156]. Differential 
expression of RASGRP1 as a result of pathogen challenge occurs in primary bMECs 
[157] and in ovine milk somatic cells [156], indicating a potential role in mastitis in 
ruminants. Overlap of RASGRP1 by one of the QTLs indicates this gene as a strong 
candidate for mastitis resistance, warranting further investigation. 
In dairy cattle, both immune functions and udder conformation traits are 
recognized factors affecting mastitis resistance [158]. Udder attachment and udder depth 
have been associated previously with SCC and clinical mastitis [159,160]. Teat 
placement has been associated with SCC [160], and various studies show conflicting 
results of the association between teat length and SCC and clinical mastitis [161]. The 
presence of supernumerary teats is considered a risk factor in bovine mastitis, and their 
surgical removal may affect subclinical mastitis incidence in heifers [162]. Seventeen 
QTLs that overlap with previously identified QTLs of udder conformation traits (teat 
length, teat number, udder attachment, and udder depth) as well as mastitis traits (somatic 
cell score, SCC, and clinical mastitis) were identified. Overall, 11 of these 17 QTLs 
overlap with QTLs for mastitis traits, and 13 overlap with QTLs for udder conformation 
traits. 
Ten of these 17 QTLs overlap with previously identified QTLs for teat length. Six 
of these, including the top 3 where the strongest association signals were detected overall, 




[158]. The remaining overlap with QTLs for teat length on BTA16 [158], BTA18 [163], 
and BTA10 [163]. This finding provides strong supportive evidence for an effect of teat 
length on bovine mastitis resistance, highlighting the importance of udder conformation 
traits as factors in the pathogenesis of this disease. 
 A notable strength of this study lies in the methods used for phenotypic 
classification, wherein multiple measures were used to determine intramammary 
infection status over time and identify mastitis-resistant and mastitis-susceptible 
phenotypic extremes. The effectiveness of selection for mastitis resistance increases 
when more than a single trait is measured for determination of intramammary infection 
status. For example, the use of SCC and clinical mastitis together is approximately 20% 
more effective than the use of either of these traits alone in selecting for mastitis 
resistance [164,165]. The use of multiple measures to detect mastitis helps to overcome 
limitations of any one method. For example, patterns of bacterial shedding in milk during 
the course of infection may affect the sensitivity of milk bacterial culture to detect 
intramammary infection [166]. Examination for clinical mastitis alone by definition 
excludes cases of subclinical mastitis, potentially excluding a substantial number of 
intramammary infections from being detected. Indirect measures such as SCC or its 
derivatives (linear score and estimated breeding values for these traits) can be influenced 
by a number of management and cow-dependent factors such as immune status, parity, 
lactation stage, diurnal variation, and sudden changes in feed or water management 
[62,65,167]. Additionally, although low SCC is commonly accepted as indicative of an 




factor in the subsequent development of clinical mastitis [67,68]. Thus, the use of SCC to 
indicate mastitis resistance could be misleading in some cases if not supplemented by 
additional measures. 
In consideration of the above limitations, phenotypic characterization was based 
on multiple criteria in order to accurately identify phenotypic extremes of mastitis 
resistance and susceptibility. Reliable determination of intramammary infection status is 
best achieved through a combination of SCC measurement, bacterial culture, and clinical 
detection [71], as used in this study. Regular monitoring using these three parameters 
facilitates detection of clinical and subclinical mastitis, including infections resulting in 
minor increases in SCC. Additionally, identification of the causative bacteria allows 
distinction between continuing and new intramammary infections, yielding a more 
accurate picture of the frequency of intramammary infection in individual cows (i.e., 
whether increased SCC or clinical mastitis over time represents an ongoing infection or 
multiple separate infections). 
All cows within the current study were within the same herd and were subjected 
to the same management conditions. Thus, effects of environmental variables on mastitis 
susceptibility are expected to be low relative to studies in which cattle from different 
farms and thereby under different environmental and management conditions are 
included. Identification of 10 novel QTLs of mastitis resistance was likely facilitated by 





A potential limitation to the current study is the relatively small sample size. Out 
of 224 lactating cows, 43 were characterized as phenotypic extremes for mastitis 
resistance or susceptibility. In GWAS, sample size is one of the factors influencing 
statistical power, and sample sizes in the thousands are often used [96]. In this study, 
meticulous phenotypic characterization was chosen at the expense of large sample size in 
order to identify individual cattle representative of phenotypic extremes. Genotyping only 
individuals that represent phenotypic extremes for a trait (no more than 20-25% of the 
sample population) can be used to detect QTLs for single traits among a small sample 
size while preserving statistical power in a selective genotyping approach [103,168]. Out 
of 224 cows, only the highest and lowest extremes for mastitis resistance of the 
population at 6.7% and 12.5%, respectively, were genotyped. The use of selective 
genotyping provides an enrichment effect, as causal and protective variants are more 
likely to be concentrated in these individuals as compared with individuals sampled 
randomly from the population. Thus, the power to detect causal and protective variants, 
particularly rare variants, is increased, although the effect size will be overestimated 
[104]. Follow-on studies to replicate results are therefore important [104]. We believe 
that, in addition to phenotypic characterization methods, the use of selective genotyping 
along with a high-density SNP array facilitated identification of the 10 novel QTLs. 
 
Conclusions 
 One hundred seventeen candidate SNPs and 27 QTLs for mastitis resistance 




three QTLs most suggestive of genome-wide significance are located on BTA26 and 
overlap SORCS3 and a previously identified QTL for teat length. Ten of the 27 QTLs 
have not been reported previously, while 17 overlap previously identified QTLs for 
mastitis or udder conformation traits relevant to mastitis. One QTL on BTA10 overlaps 
RASGRP1, considered a candidate gene of mastitis resistance requiring further study. 
Validation of these QTLs as genetic markers of mastitis resistance in an expanded 
















                                      
     
2 24.7 16-33 0 None 
6 57.8 32-84 0 None 
5 84.5 22-155 0 None 
4 48.0 21-125 0 None 
4 31.3 16-50 0 None 
3 86.3 20-150 0 None 
3 69.7 21-123 0 None 
3 70.5 19-107 0 None 
3 40.5 5-61 0 None 
3 21.4 9-47 0 None 
2 23.8 20-29 0 None 
2 100.3 35-167 0 None 
2 15.0 5-27 0 None 
2 33.6 9-69 0 None 
2 123.0 30-220 0 None 
















Pathogens1 Isolated                                     
(Number of Times) 
     
2 519.7 21-2406 1 CNS (2); CNS and St (2) 
6 217.6 146-1327 0 CNS (1); St (2): CNS and St (3) 
4 136.1 88-197 0 CNS (1); C (1); Y (1) 
4 617.3 8-1464 3 St (2); CNS and St (1); C and St (3) 
3 298.3 120-622 0 CNS (4); CNS and St (2) 
4 477.4 86-1899 0 CNS (5); CNS and E (1) 
4 391.0 210-868 2 CNS (2); CNS and St (3) 
3 463.0 270-591 2 St (6) 
3 1292.7 401-2945 0 CNS (2); CNS and St (4); E and St (1) 
3 144.2 26-332 0 St (4) 
2 49.0 16-84 0 CNS (5); CNS and C (1) 
2 704.6 6-1605 0 CNS (2); St (5) 
2 154.0 14-937 0 CNS (1); CNS and St (2); C (1) 
2 258.8 9-981 3 CNS and St (1); St (1); C (2); E (1) 
2 20.3 10-30 0 CNS (2); C and St (1); C (1) 
2 81.0 10-248 1 CNS (1); CNS and St (2); CNS and C (1) 
1 33.7 7-58 0 CNS (2); CNS and St (2); CNS and C (1) 
1 108.9 55-191 0 CNS (5) 
1 60.0 48-88 0 CNS (4); E (1) 
1 112.9 76-139 0 CNS (6) 
1 32.0 17-58 0 CNS (4) 
1 97.3 55-238 0 CNS (5) 
1 129.4 79-287 0 CNS (4) 
2 615.2 13-2676 1 CNS (4); Y (1) 
1 43.3 27-74 0 CNS (3); St (1) 
1 197.0 35-568 0 CNS (5); CNS and St (1) 
1 18.1 7-33 0 CNS (3); C (2) 
1 115.4 60-175 1 CNS (2); St (2); CNS and St (1) 
          
 1C: Corynebacterium sp.; CNS: coagulase-negative staphylococci; E: Escherichia coli; St: Streptococcus 





Table 2: Single nucleotide polymorphisms suggestive of genome-wide significance for 
bovine mastitis resistance. The allele associated with mastitis resistance is shown. 
Marker Chr1 Position -log10(p-value) Protective allele 
     
rs43503386 7 31648926 6.33 A 
rs110130285 26 26080988 5.81 G 
rs110925919 26 26081853 5.81 T 
rs135137805 26 26083915 5.81 C 
rs109051904 26 26085037 5.81 A 
rs134424973 26 26086114 5.81 G 
rs136355517 26 26202415 5.55 A 
rs137057269 26 26207987 5.55 G 
rs109151150 7 31002352 5.51 T 
rs135679846 26 26213600 5.42 C 
rs136832332 26 26214187 5.42 T 
rs135349914 26 26216213 5.42 C 
rs135745332 26 26170699 5.41 C 
rs29026516 26 26171235 5.41 G 
rs133973225 26 26190210 5.41 A 
rs42094305 26 26078080 5.14 C 
rs42094275 26 26097110 5.14 C 
rs110448143 8 103092247 4.98 G 
rs110566862 8 103096670 4.98 T 
rs134258818 26 26093838 4.92 T 
rs109674792 17 41771455 4.85 G 
rs110306521 17 41773340 4.85 A 
rs109747092 17 41775569 4.85 C 
rs110239244 17 41777130 4.85 C 
rs109757388 17 41785932 4.85 G 
rs41837662 26 28202019 4.80 T 
rs109555679 24 53848687 4.73 C 
rs41257394 18 49690172 4.64 A 
rs110711227 15 47742405 4.57 A 
rs109993951 15 47747052 4.57 A 
rs137210653 15 47752356 4.57 C 
rs109366311 15 47769743 4.57 C 
rs110973322 15 47771595 4.57 A 
rs110039012 15 47774554 4.57 C 




rs136099077 7 32661575 4.55 G 
rs133992636 7 32662549 4.55 G 
rs135340284 7 32667624 4.55 A 
rs29016545 7 32677080 4.55 T 
rs134516100 7 32678638 4.55 T 
rs41836660 26 28154738 4.55 C 
rs41604819 26 28155692 4.55 T 
rs41837669 26 28204944 4.55 G 
rs133596831 16 20614247 4.48 C 
rs133973886 2 118870124 4.47 T 
rs41858359 18 5268101 4.44 T 
rs41858365 18 5268998 4.44 T 
rs109361888 26 26164774 4.42 T 
rs135248266 9 93691403 4.42 C 
rs135549815 15 51302501 4.40 C 
rs136596564 15 51303719 4.40 C 
rs110825365 17 41777826 4.37 A 
rs137547715 3 91427052 4.35 T 
rs136877205 17 10393778 4.35 T 
rs110090917 11 96629841 4.32 T 
rs381266606 11 96715963 4.32 T 
rs136634740 11 96720014 4.32 G 
rs133879444 11 96730359 4.32 T 
rs134973228 11 96734171 4.32 T 
rs132794203 11 96739382 4.32 G 
rs134297845 11 96745000 4.32 G 
rs109277843 11 96758826 4.32 C 
rs135608670 11 96767134 4.32 T 
rs134694194 17 10162372 4.31 T 
rs109623385 10 34452835 4.29 A 
rs109758936 10 34455599 4.29 T 
rs133303871 11 86660988 4.28 T 
rs42434953 26 28796634 4.28 T 
rs42434958 26 28799734 4.28 A 
rs42434984 26 28813937 4.28 A 
rs42349819 3 91442018 4.27 A 
rs42349795 3 91449020 4.27 A 
rs109782486 7 31997138 4.25 C 
rs109397365 7 31999677 4.25 T 




rs109305062 7 32001031 4.25 C 
rs135287427 7 32001859 4.25 A 
rs132918628 7 32002610 4.25 C 
rs109653519 7 32003545 4.25 T 
rs109153790 7 32004528 4.25 C 
rs133045718 7 32005033 4.25 T 
rs137193453 7 32005542 4.25 G 
rs133716861 3 91429028 4.23 A 
rs42704013 12 76820530 4.22 A 
rs136350185 10 27915567 4.19 A 
rs41840890 26 27751543 4.17 G 
rs41840882 26 27754542 4.17 T 
rs41840873 26 27756172 4.17 G 
rs41840864 26 27762180 4.17 A 
rs137165178 26 27763096 4.17 T 
rs41840922 26 27779611 4.17 A 
rs41840912 26 27790973 4.17 G 
rs135563166 26 28157430 4.16 G 
rs41636626 26 28159060 4.16 C 
rs133999463 26 28159800 4.16 C 
rs133395250 26 28161303 4.16 G 
rs135413917 26 28161892 4.16 G 
rs133282066 26 28163345 4.16 A 
rs135170589 26 28165109 4.16 T 
rs136506930 26 28165749 4.16 G 
rs134913097 26 28167337 4.16 A 
rs137741079 26 28168568 4.16 C 
rs133840132 26 28170114 4.16 A 
rs135204195 26 28172302 4.16 A 
rs133679609 17 42208979 4.14 C 
rs41645946 11 96814663 4.12 C 
rs133086162 27 24405764 4.11 C 
rs132797061 X 10123521 4.10 T 
rs110373429 26 27935893 4.10 C 
rs110554155 4 41207992 4.08 T 
rs43506093 7 32187800 4.07 C 
rs134956968 28 30879841 4.07 G 
rs110413607 10 34258059 4.06 T 
rs41668080 12 76870470 4.05 T 




rs41879775 18 43568128 4.00 G 
rs135753929 18 43596859 4.00 A 









Table 3: Quantitative trait loci identified for bovine mastitis resistance. Overlapped genes are shown.  
Chr QTL start QTL end 
QTL length 
(bp) 




         
26 26078080 26097110 19030 7 rs110130285 5.8056407 1 SORCS3 
26 26202415 26216213 13798 5 rs136355517 5.5513441 1 SORCS3 
26 26170699 26190210 19511 3 rs135745332 5.4109618 1 SORCS3 
8 103092247 103096670 4423 2 rs110448143 4.9800087 0 None 
17 41733436 41785932 52496 10 rs109674792 4.851678 1 FAM198B 
26 28154738 28204944 50206 15 rs41837662 4.79832714 1 SORCS1 
18 49684020 49690172 6152 2 rs41257394 4.6439513 2 FBL, PSMC4 
15 47742405 47775426 33021 7 rs110711227 4.5675268 1 OR52E4 
7 32661575 32678638 17063 5 rs136099077 4.5538269 0 None 
16 20608750 20623978 15228 12 rs133596831 4.4783498 1 ESRRG 
2 118870124 118870999 875 2 rs133973886 4.4696943 1 FBXO36 
18 5268101 5268998 897 2 rs41858359 4.4439869 0 None 
15 51068247 51303719 235472 3 rs135549815 4.40396843 1 LOC618050 
17 10393778 10411003 17225 2 rs136877205 4.3453674 1 ARHGAP10 
11 96629841 96777054 147213 11 rs110090917 4.32303429 1 PBX3 
10 34258059 34455599 197540 8 rs109623385 4.2941828 2 RASGRP1, LOC104973119 
26 28796634 28813937 17303 3 rs42434953 4.276744 0 None 
3 91429028 91852910 423882 4 rs42349819 4.27157104 1 USP24 
7 31997138 32005542 8404 10 rs109782486 4.2477407 1 PRDM6 
10 27798183 28002566 204383 31 rs136350185 4.1880203 3 LOC784925, LOC785050, LOC785050 
26 27751543 27790973 39430 7 rs41840890 4.1697935 0 None 
17 42046346 42208979 162633 7 rs133679609 4.13810535 0 None 
27 24405764 24803258 397494 2 rs133086162 4.1081123 1 TNKS 
28 30834105 30879841 45736 8 rs134956968 4.07061418 2 MIR584-3, KAT6B 
12 76826267 76870470 44203 3 rs41668080 4.0468275 2 CLDN10, DZIP1 
11 102314941 102336231 21290 8 rs110442181 4.0153069 3 NTNG2, SETX, LOC101906746 







Table 4: Overlap of QTLs for bovine mastitis resistance with previously-reported QTLs1 for bovine mastitis or udder conformation 
traits. 
 
Chr QTL position (bp) Tag SNP -log10(p-value) Known QTLs Known QTL ID1 Known QTL position (bp) 
       
26 26078080-26097110 rs110130285 5.8056407 Teat length 1651 25267910-30988113 
26 26202415-26216213 rs136355517 5.5513441 Teat length 1651 26:25267910-30988113 
26 26170699-26190210 rs135745332 5.4109618 Teat length 1651 25267910-30988113 
8 103092247-103096670 rs110448143 4.9800087 None 
  
17 41733436-41785932 rs109674792 4.851678 Teat number 20841 34618653-44087629 
26 28154738-28204944 rs41837662 4.79832714 Udder attachment 4995 27602977-30988113 
    
Clinical mastitis 4994 27602977-30988113 
    
Teat length 1651 25267910-30988113 
    
Somatic cell score 2785 27602977-30988113 
    
Somatic cell score 2736 27602977-30988113 
18 49684020-49690172 rs41257394 4.6439513 Somatic cell score 18471 46178647-52998234 
    
Somatic cell score 18470 46178647-52983181 
    
Teat length 1703 44616854-55337025 
15 47742405-47775426 rs110711227 4.5675268 None 
  
7 32661575-32678638 rs136099077 4.5538269 Somatic cell score 2667 27358606-42831622 
16 20608750-20623978 rs133596831 4.4783498 Teat length 1608 12209667-26166559 
2 118870124-118870999 rs133973886 4.4696943 None 
  
18 5268101-5268998 rs41858359 4.4439869 Somatic cell score 3554 4992421-18045667 
    
Udder attachment 1701 1891819-7214579 
15 51068247-51303719 rs135549815 4.40396843 None 
  
17 10393778-10411003 rs136877205 4.3453674 None 
  
11 96629841-96777054 rs110090917 4.32303429 None 
  
10 34258059-34455599 rs109623385 4.2941828 Udder attachment 10294 10323420-79980762 
    
Teat length 10296 10323420-79980762 
    
Udder attachment 44454 34275633-34275673 
    






    
Udder depth 44459 34275633-34275673 
    
Somatic cell count 2701 22939631-40797089 
       
       
       
26 Chr26:28796634-
28813937 
rs42434953 4.276744 Udder attachment 4995 27602977-30988113 
    
Clinical mastitis 4994 27602977-30988113 
    
Teat length 1651 25267910-30988113 
    
Somatic cell score 2785 27602977-30988113 
    
Somatic cell score 2736 27602977-30988113 
3 91429028-91852910 rs42349819 4.27157104 None 
  
7 31997138-32005542 rs109782486 4.2477407 Somatic cell score 2667 27358606-42831622 
10 27798183-28002566 rs136350185 4.1880203 Udder attachment 10294 10323420-79980762 
    
Teat length 10296 10323420-79980762 
    
Somatic cell count 2701 22939631-40797089 
26 27751543-27790973 rs41840890 4.1697935 Udder attachment 4995 27602977-30988113 
    
Clinical mastitis 4994 27602977-30988113 
    
Teat length 1651 25267910-30988113 
    
Somatic cell score 2785 27602977-30988113 
    
Somatic cell score 2736 27602977-30988113 
17 42046346-42208979 rs133679609 4.13810535 Teat number 20841 34618653-44087629 
27 24405764-24803258 rs133086162 4.1081123 Clinical mastitis 2786 24311474-24427274 
28 30834105-30879841 rs134956968 4.07061418 None 
  
12 76826267-76870470 rs41668080 4.0468275 None 
  
11 102314941-102336231 rs110442181 4.0153069 None 
  
18 43568128-43596859 rs135753929 4.00357851 Somatic cell score 9904 33939994-43945245 
    
Somatic cell score 18469 11438802-46178647 
          
 
  






Figure 1A: Manhattan plot of genome-wide associations for mastitis resistance in 43 Holstein cows. The genome-wide significance 
threshold is indicated by the solid line (p < 0.0001). Bovine chromosome position is shown on the x-axis. Strength of association for a 




















BOVINE MAMMARY EPITHELIAL CELLS FROM MASTITIS-RESISTANT AND 
MASTITIS-SUSCEPTIBLE LACTATING HOLSTEIN COWS DISPLAY 




Bovine mammary epithelial cells (bMECs) are the milk-producing cells of the 
mammary gland, and are important contributors to innate immunity against 
intramammary infection. As such, differences in their innate immune responses against 
mastitis-causing pathogens may contribute to inherent differences in susceptibility to 
mastitis among individual cattle. In order to understand the immunogenetics of mastitis 
resistance conferred by bMECs, we carried out a gene expression polymerase chain 
reaction (PCR) array to characterize and compare the expression of 84 genes relevant to 
inflammation by bMECs isolated from mastitis-resistant and mastitis-susceptible 
lactating cows in response to lipopolysaccharide (LPS) from Escherichia coli. Primary 
bMEC lines were established from lactating Holstein cows characterized as mastitis-
resistant or mastitis-susceptible based on clinical mastitis incidence, milk bacterial 
culture results, and monthly milk somatic cell counts (SCC) over an eight-month period. 
Exposure to LPS for 6 hours in vitro stimulated two-fold or greater differential 
expression of 43 genes (p<0.05) in bMECs from mastitis-resistant cows, but only one 




bMECs to respond rapidly to mastitis pathogens may be a mechanism by which bMECs 
contribute to mastitis resistance. Among upregulated genes, chemokine (C-X-C motif) 
ligand 5 (CXCL5) was upregulated in bMECs from both mastitis-resistant and mastitis-
susceptible cows, while chemokine (C-X-C motif) ligand 2 (GRO1) and interleukin 8 
(CXCL8) were upregulated in bMECs from mastitis-resistant cows only. Tumor necrosis 
factor (TNF) was among the genes downregulated in bMEC from mastitis-resistant cows. 
In contrast, no significant differences in gene expression were noted between mastitis-
susceptible and mastitis-resistant bMECs under unchallenged conditions, indicating that 
constitutive expression of inflammatory genes is unlikely to be a mechanism for mastitis 
resistance mediated by bMECs. 
 
Background 
Bovine mastitis is a major source of economic loss in the dairy industry 
worldwide. Strategies to reduce the prevalence of mastitis among dairy cattle are based 
on management of environmental factors as well as selection for cattle with increased 
resistance to mastitis. A genetic basis for between-cow variation in mastitis traits, such as 
clinical mastitis and somatic cell count (SCC), is widely recognized and is reflected in the 
use of estimated breeding values for these traits to guide selective breeding programs 
[169]. Many quantitative trait loci (QTLs) for mastitis traits have been identified 
(catalogued on the cattle QTL database, http://animalgenome.org/cgi-




increasingly recognized as valuable tools in reducing the prevalence of mastitis within 
dairy herds. Cellular mechanisms underlying bovine mastitis resistance are complex, 
involving multiple cell types and pathogen-specific immune responses [79], and remain 
incompletely defined. 
An important cell type involved in immune responses to intramammary infection 
and mastitis resistance is the bovine mammary epithelial cell (bMEC). Bovine MECs are 
the milk-producing cells of the mammary gland, and also have roles in innate immunity 
through barrier functions, pathogen recognition, and production of inflammatory 
mediators, including leukocyte chemotactic factors [30]. Primary bMECs have been used 
as a model for studies of immune responses of the mammary gland [39,170,171]. In vitro 
models based on epithelial cell culture provide several notable advantages over in vivo 
systems for studying disease processes. In vitro systems allow for greater control over 
environmental variables, and provide economic and ethical advantages over in vivo systems 
[172]. Additionally, monoculture-based systems facilitate the study of the roles of individual 
cell types in disease processes, whereas differentiation between the contributions of multiple 
cell types in in vivo systems may present substantial challenges [170,172]. Epithelial 
monoculture systems have been used extensively in the study of host-pathogen interactions 
in infectious disease processes [172]. The capacity of primary bMECs to mount pathogen-
specific immune responses has been clearly demonstrated [38,157,170,171,173]. Expression 
of many inflammatory genes involved in these responses are also demonstrated in bMECs in 
vivo in response to inflammatory stimuli, reflecting the usefulness of primary bMECs as a 




Variation in the immune responses of bMECs from different individual cows have 
been demonstrated, including significant differences between the responses of bMECs 
from mastitis-resistant and mastitis-susceptible cows. For example, when primary bMECs 
isolated from animals classified as exhibiting high and low susceptibility to mastitis with 
the QTL on Bos taurus autosome (BTA) 18 were challenged by mastitis pathogens, 
differential expression of several key innate immune genes was observed, including Toll-
like receptor 2, tumor necrosis factor-alpha, interleukin-8 (IL-8), IL-6, chemokine (C-C 
motif) ligand 5, complement component C3, and lactoferrin [176]. In primary bMECs 
isolated from mastitis-resistant cows, compared to those isolated from mastitis-susceptible 
cows, a number of genes involved in leukocyte migration and acute-phase response 
signaling were expressed earlier and at higher levels following pathogen challenge [157]. 
These studies indicate an important role of bMECs in mastitis resistance that warrants 
further study. 
 The objective of this study was to compare immune responses of bMECs from 
mastitis-resistant and mastitis-susceptible cows in order to identify potential contributions of 
bMECs to mastitis resistance. The relative expression of 84 immune-related genes was 
determined by polymerase chain reaction (PCR) array, and compared between the two cell 








Lactating Holstein cows were classified as resistant or susceptible to mastitis 
based on individual incidence of clinical and subclinical mastitis over an eight-month 
period. Detection of clinical and subclinical mastitis was based on monthly bacterial and 
mycoplasma cultures of aseptically collected composite milk samples; bi-monthly 
clinical evaluations to detect abnormal mammary gland quarters or secretions; continuous 
monitoring for clinical mastitis by farm staff; bacterial culture of milk from suspect 
intramammary infection cases; and monthly SCC measurements obtained from the Dairy 
Herd Improvement Association. Milk microbial cultures were carried out according to the 
guidelines outlined by the National Mastitis Council [147]. 
The criterion for classification as mastitis-susceptible was detection of at least 
four separate episodes of mastitis. Episodes of mastitis were defined by any of: isolation 
of one or more mastitis pathogens from a milk sample, detection of clinical mastitis, 
and/or elevated composite SCC >250,000 cells/ml. Isolates from more than one quarter 
on one date contributed as many mastitis episodes as there were culture-positive quarters. 
Clinical mastitis detected in more than one quarter on one date contributed as many 
mastitis episodes as there were clinically mastitic quarters. Cattle with no clinical mastitis 
detected, consistently negative milk bacterial culture results, and consistently low 






Bovine MEC collection, isolation, and establishment 
Primary bMEC lines were established from bovine milk. Four hundred milliliters 
of hand-stripped milk were aseptically collected into an equal volume of collection media 
consisting of Hank’s Balanced Salt Solution (Sigma-Aldrich, St. Louis, MO) 
supplemented with penicillin (60 μg/ml), streptomycin (200 μg/ml), gentamycin (120 
μg/ml), and nystatin (50 mg/L). Samples were transported on ice to the laboratory. 
Bovine MEC isolation was carried out as previously reported [39,177], with some 
modifications. Briefly, 400 ml of hand-stripped milk were subjected to a series of wash 
and centrifugation steps (3000 rpm for 10 minutes each) followed by passage of the 
resuspended cell pellet through a 100 µm pore size cell strainer to separate cell pellets 
from debris and other milk components. Following a final centrifugation step, the cell 
pellet was resuspended in 5 ml of growth media consisting of HuMEC Ready Medium 
(Life Technologies, Grand Island, NY) supplemented with penicillin (60 μg/ml), 
streptomycin (200 μg/ml), gentamycin (120 μg/ml), nystatin (50 μg/ml), and 10% fetal 
bovine serum, and seeded into a T-25 culture flask. Cells were incubated at 38.5°C with 
5% CO2. After 12-18 hours, media was exchanged for fetal bovine serum-free growth 
media. Growth media was changed every 2-3 days thereafter. 
 Cells were passaged when confluency was reached using trypsin 0.05%/EDTA 
0.02% (product 59417C, Sigma-Aldrich, St. Louis, MO). Cells were maintained to the 






Cell lineage verification 
Cell lines were evaluated at all passage numbers for the cobblestone morphology 
typical of epithelial cells on monolayer culture. Epithelial lineage was verified using PCR 
to detect expression of cytokeratin 8 (KER8) [178]. Primers were designed using 
Primer3Plus (http://primer3plus.com/cgi-bin/dev/primer3plus.cgi) based on NCBI 
reference sequence NM_001033610.1 and were as follows: forward primer 
AATCAAGTATGAGGAGCTGC; reverse primer CATCCTTAACAGCCATCTCA. 
Polymerase chain reaction conditions were as follows: initial denaturation at 98˚C for 30 
seconds followed by 32 cycles of 98˚C for 10 seconds, 57 ˚C for 15 seconds, and 72˚C 
for 30 seconds. Gel electrophoresis was used to confirm the presence of PCR product. 
Sequencing of PCR product to confirm KER8 amplification was carried out by the Center 
for Integrated Biotechnology, Utah State University (Logan, UT). 
 
LPS challenge and RNA isolation 
 Second to third passage bMECs were exposed to LPS from Escherichia coli 
0111:B4 (Sigma-Aldrich, St. Louis, MO) to mimic exposure to a mastitis-causing 
pathogen. Lipopolysaccharide challenge methods were similar to those described 
previously [173]. Briefly, bMECs were split after the first or second passage into two T-
25 culture flasks. Once 50-100% confluence was reached, media was exchanged for 
growth media with or without (unchallenged) 50 µg/ml LPS. Cells were incubated at 




Following LPS challenge, bMECs were lysed and total RNA was isolated and 
purified using the Purelink RNA Mini Kit (Life Technologies, Carlsbad, CA) according 
to the manufacturer’s instructions. Spectrophotometric verification of RNA quality and 
generation of cDNA was carried out by QIAGEN Genomic Services (Frederick, MD). 
 
PCR Array 
 The QIAGEN RT2 ProfilerTM PCR Array Cow Inflammatory Cytokines and 
Receptors array (product PABT-011Z, QIAGEN, Frederick, MD) was used to profile the 
expression of 84 genes involved in inflammation. Gene expression profiling and data 
analysis were carried out by QIAGEN Genomic Services (Frederick, MD). The delta-
delta CT method was used for fold-change/regulation analysis, with data normalized 
using four internal control genes (glyceraldehyde-3-phosphate dehydrogenase; actin, 
beta; hypoxanthine phosphoribosyltransferase 1; tyrosine 3-monooxygenase/tryptophan 
5-monooxygenase activation protein, zeta polypeptide). P-values were calculated using a 
Student’s t-test of the replicate 2^ (- Delta CT) values for each gene in the groups being 
compared. Fold change/regulation values and p-values were generated for comparison of 
the following groupings: 1) unchallenged and LPS-challenged mastitis-resistant bMEC 
lines; 2) unchallenged and LPS-challenged mastitis-susceptible bMEC lines; and 3) 








Bovine MEC lines were established from five mastitis susceptible and three 
mastitis resistant cattle. Cattle within the mastitis-resistant group ranged from second to 
third lactation, and cattle within the mastitis-susceptible group ranged from second to 
sixth lactation. All bMEC lines were morphologically consistent with epithelial cells and 
expressed KER8. 
Among the mastitis-resistant group, composite milk SCC ranged from 16,000 to 
220,000 cells/ml, with an average of 75,000 cells/ml. Among the mastitis-susceptible 
group, pathogens isolated from composite and individual quarter milk samples included 
Streptococcus sp., coagulase-negative staphylococci, and Corynebacterium sp. In this 




Bovine MECs from mastitis-resistant and mastitis-susceptible cows respond to 
LPS differently. Gene expression following LPS challenge varied between mastitis-
susceptible and mastitis-resistant bMEC lines. Among mastitis-resistant cell lines, three 
genes, C-X-C motif chemokine ligand 5 (CXCL5), chemokine (C-X-C motif) ligand 2 
(GRO1), and interleukin 8 (CXCL8), were significantly (p < 0.05) upregulated by at least 
two-fold, while 40 genes were significantly downregulated by at least two-fold in LPS-




component 5 (C5), chemokine (C-C motif) receptor 5 (CCR5), and interleukin 13 (IL13) 
showed the highest magnitudes of downregulation, at -18.93-fold, -18.89-fold, and -
18.74-fold, respectively. In contrast to the mastitis-resistant group, among mastitis-
susceptible bMEC lines, only one gene, CXCL5, was differentially expressed as a result 
of LPS challenge. C-X-C motif chemokine ligand 5 was upregulated by 8.25-fold in LPS-
challenged versus unchallenged bMECs. Upregulation of CXCL5 in both mastitis-
resistant and mastitis-susceptible bMECs following LPS challenge suggests that this is a 
particularly important gene involved in the innate immune response of bMECs. A lack of 
differential expression of additional genes among mastitis-susceptible bMECs following 
LPS challenge contrasts with the differential expression of 42 additional genes by 
mastitis-resistant bMECs. This finding indicates inherent differences in the immune 
response capabilities of bMECs from the two groups. 
 
Mastitis-resistant and -susceptible bMECs show similar expression under 
unchallenged conditions. Gene expression between the mastitis-susceptible and mastitis-
resistant groups were investigated under unchallenged conditions. No genes were 
significantly differently expressed between these two groups (Table 6). Such data 
indicate that bMECs isolated from mastitis-resistant and -susceptible cows, while 
displaying distinct gene expression patterns in responding to LPS, have similar innate 
immune activities under unchallenged conditions. Therefore, it is likely that the 




successful innate immune responses to mastitis pathogens, but not on the basal level 
activities of the inflammatory genes. 
 
Discussion 
The objective of this study was to investigate the molecular and cellular 
mechanisms by which bMECs contribute to mastitis resistance. To accomplish this, we 
established multiple bMEC lines from mastitis-resistant and mastitis-susceptible cows 
and compared the expression profiles of genes relevant to inflammation between these 
two groups of bMECs using the QIAGEN’s RT2 ProfilerTM PCR Array before and after 
LPS challenge. 
No significant differences in gene expression between mastitis-resistant and 
mastitis-susceptible bMECs under unchallenged conditions were observed. This is in 
agreement with other studies that demonstrate no significant differences in the expression 
of genes relevant to inflammation between bMECs from mastitis-susceptible and 
mastitis-resistant cattle under unchallenged conditions [118,157]. Such data suggest that 
constitutive expression of genes relevant to inflammation does not drive contributions of 
bMECs to mastitis resistance. 
In contrast, expression of genes related to inflammation differed between mastitis-
resistant and mastitis-susceptible bMECs following LPS challenge. Three genes relevant 
to inflammation were significantly upregulated and 40 were downregulated in response to 
LPS challenge in mastitis-resistant bMECs, while only one gene was significantly 




demonstrates a clear difference between the responses of mastitis-resistant and mastitis-
susceptible bMECs after a 6-hour exposure to LPS. A similar effect has been previously 
demonstrated in bMECs from cattle with high and low mastitis susceptibilities based on a 
QTL and molecular marked-based selection strategy for milk somatic cell score [157]. In 
that study, bMEC lines from cattle with low mastitis susceptibility demonstrated more 
rapid and robust differential regulation of genes involved in cell death, neutrophil 
chemotaxis, complement system, leukocyte migration, and cell trafficking after challenge 
with E. coli or S. aureus than did bMECs from cattle with high mastitis susceptibility. 
Changes in the expression of some genes which were ultimately upregulated in both 
groups in response to pathogen challenge were not apparent until 24 hours after pathogen 
inoculation in bMECs from cattle with high mastitis susceptibility. In contrast, these 
genes were upregulated in bMECs from cattle with low mastitis susceptibility by 6 hours 
after pathogen inoculation, thereby demonstrating more rapid responses to pathogen 
challenge [157]. Differences in gene expression noted at 6 hours in this study may reflect 
variation in response times between mastitis-resistant and mastitis-susceptible bMECs, 
with bMECs from mastitis-resistant cattle displaying more rapid changes in expression of 
genes relevant to inflammation. This study provides further evidence that an ability for 
rapid inflammatory responses to mastitis pathogens may be an important mechanism for 
mastitis resistance mediated by bMECs. 
Three genes, CXCL5, GRO1, and CXCL8, were upregulated in either mastitis-
resistant bMECs only (GRO1 and CXCL8) or in both mastitis-resistant and mastitis-




three genes are involved in neutrophil chemotaxis and activation [179–181]. During the 
acute stages of mastitis, neutrophils surpass macrophages as the most numerous 
leukocyte type in the mammary gland, comprising >90% of the total leukocyte 
population in milk [42]. Neutrophils act as effector cells of innate immunity via 
phagocytosis of bacteria as well as through bactericidal effects of reactive oxygen species 
and other secreted factors [30,42,44]. The rapid upregulation of genes such as CXCL5, 
GRO1, and CXCL8 is therefore an expected response following LPS challenge, and 
demonstrates the ability of primary bMECs to retain pathogen recognition and 
inflammatory response capabilities, as reported by others [39,173]. 
Upregulation of CXCL5 was noted in both mastitis-resistant and mastitis-
susceptible bMECs following LPS challenge. In addition to its roles as a chemoattractant 
and activator of neutrophils, CXCL5 promotes angiogenesis [182] and fibrosis [183], two 
processes involved in tissue repair following inflammation. Expression of CXCL5 is 
upregulated in E. coli-infected bovine mammary gland tissue [184] and in primary 
bMECs exposed to LPS [173], E. coli [185,186], S. aureus [186], or Klebsiella 
pneumoniae [186]. These observations, supported by our findings, highlight CXCL5 as 
an important chemokine in bovine mastitis. Interestingly, a QTL for clinical mastitis has 
been identified in Norwegian Red cattle within 1 Mb of a cluster of genes encoding CXC 
chemokines, including CXCL5 [187], providing further evidence that that variation in 
this gene could contribute to mastitis resistance. 
Two genes involved in neutrophil recruitment, GRO1 and CXCL8, were 




bMECs from mastitis-resistant cattle may have an enhanced ability over bMECs from 
mastitis-susceptible cows to rapidly recruit neutrophils to the mammary gland following 
exposure to mastitis pathogens. In vivo, the intensity and rapidity of neutrophil 
recruitment varies between individual cows, and can contribute to the speed of bacterial 
clearance and recovery from mastitis [30]. 
Among the genes downregulated in mastitis-resistant bMECs following LPS 
challenge, downregulation of tumor necrosis factor (TNF) is particularly noteworthy. 
Tumor necrosis factor is a multifunctional, pro-inflammatory cytokine with well-known 
roles in the pathogenesis of mastitis, and is upregulated by mammary gland macrophages 
and bMECs during mastitis [188]. Similarly, TNF is upregulated in primary bMECs 
following challenge by E. coli or LPS, with most studies reporting increased expression 
by 6 hours after challenge and more marked increases after 12-24 hours [39,118,170]. In 
this study, TNF expression was not significantly different following a 6-hour LPS 
challenge in mastitis-susceptible bMECs, but was significantly different between 
unchallenged and LPS-challenged, mastitis-resistant bMECs. As discussed above, the 
time required for mastitis-susceptible bMEC to respond to LPS may exceed the 6-hour 
time period used in this study, providing a possible explanation for the lack of an 
observed change in TNF expression. 
More striking is the pattern of TNF expression difference noted among mastitis-
resistant bMECs. Tumor necrosis factor expression was significantly downregulated, 
rather than upregulated, by nearly ten-fold following LPS challenge. Tumor necrosis 




TNF induce both local and systemic effects contributing to the morbidity and mortality in 
E. coli mastitis, including promoting the development of endotoxic shock during coliform 
mastitis [189]. High milk and plasma TNF concentrations as a result of LPS-induced 
mastitis have been noted conjunction with excessive milk concentrations of nitric oxide 
and severe systemic clinical signs [190]. Conversely, inhibition of TNF expression during 
mastitis appears to have a protective effect on the mammary gland. For example, 
decreased severity of  histopathologic changes in the mammary gland in a mouse model 
of mastitis [191] and the severity of E.coli mastitis-induced local and systemic signs in 
cattle [189] were noted in conjunction with administration of treatments that decreased 
TNF expression. Given the known contributions of TNF to mastitis severity, 
downregulation could be an important mechanism for mastitis resistance. In fact, a parity-
dependent association was identified between, and polymorphism within, the TNF gene 
and clinical mastitis variables in Holstein-Friesian dairy cattle [192], further supporting a 
potential role of this gene in mastitis resistance. 
  
Conclusions 
 Bovine MECs from mastitis-resistant and mastitis-susceptible cattle display 
differences in the expression of genes relevant to inflammation in response to LPS 
challenge. Upregulation of CXCL5, a gene involved in neutrophil recruitment and 
activation, occurs in both groups, while upregulation of two additional genes involved in 
neutrophil recruitment was observed in mastitis-resistant but not mastitis-susceptible 




bMECs, including TNF, which may be beneficial in minimizing the clinical severity of 
mastitis. These results suggest that a possible mechanism for mastitis resistance provided 
by bMECs may be an enhanced capacity by mastitis-resistant bMECs as compared with 
mastitis-susceptible bMECs to respond rapidly to exposure to mastitis pathogens. 
Differences in gene expression were not observed between mastitis-resistant and mastitis-
susceptible bMECs under unchallenged conditions, indicating that immune responses 
rather than constitutive immune gene expression are more important in the contribution 




Table 5: Significant (p < 0.05) inflammatory gene expression fold-changes (2) in LPS-
challenged relative to unchallenged bMECs from mastitis-resistant and mastitis-
susceptible cows. P-values are shown. 
 
Gene Symbol Gene Fold-change P-value 
    
Mastitis-resistant bMECs   
Upregulated    
CXCL5 Chemokine (C-X-C motif) ligand 5 9.1 0.004001 
GRO1 Chemokine (C-X-C motif) ligand 2 5.84 0.001459 
CXCL8 Interleukin 8 3.76 0.008736 
Downregulated 
  
C5 Complemet component 5 -18.93 0.009573 
CCR5 Chemokine (C-C motif) receptor 5 -18.89 0.009591 
IL13 Interleukin 13 -18.74 0.012933 
PF4 Platelet factor 4 -17.81 0.009447 
CCL11 Chemokine (C-C motif) ligand 11 -17.56 0.009998 
LOC510185 Interleukin 2 receptor, beta -17.34 0.010016 
CCR2 Chemokine (C-C motif) receptor 2 -17.34 0.010016 
CXCL10 Chemokine (C-X-C motif) ligand 10 -17.3 0.010019 
CD40LG CD40 ligand -16.29 0.010186 
CCR1 Chemokine (C-C motif) receptor 1 -16.22 0.010134 
IL7 Interleukin 7 -15.74 0.010203 
CXCR1 
Chemokine (C-X3-C motif) receptor 
1 
-15.68 0.010319 
CCR4 Chemokine (C-C motif) receptor 4 -15.47 0.010258 
IL27 Interleukin 27 -15.45 0.010259 
IL3 Interleukin 3 -14.8 0.010412 
CXCR3 Chemokine (C-X-C motif) receptor 3 -14.68 0.010452 
IL16 Interleukin 16 -14.38 0.010472 
CCR8 Chemokine (C-C motif) receptor 8 -14.35 0.010453 
CX3CR1 
Chemokine (C-X3-C motif) receptor 
1 
-14.23 0.008799 
CXCL9 Chemokine (C-X-C motif) ligand 9 -13.91 0.010708 
TNFSF14 
Tumor necrosis factor (ligand) 
superfamily, member 14 
-13.51 0.009462 
CSF3 
Colony stimulating factor 3 
(granulocyte) 
-13.17 0.010952 
IL17B Interleukin 17B -13.04 0.010758 
LTB Lymphotoxin beta -12.49 0.011005 
TNFRSF11B 
Tumor necrosis factor receptor 
superfamily, member 11b 
-11.28 0.010725 




IL9R Interleukin 9 receptor -10.95 0.009601 
OSM Oncostatin M -10.34 0.011304 
IL2RG Interleukin 2 receptor, gamma -10.12 0.011248 
TNF Tumor necrosis factor -9.96 0.013403 
IL4 Interleukin 4 -9.11 0.013379 
CXCR5 Chemokine (C-X-C motif) receptor 5 -7.9 0.012634 
IL15 Interleukin 15 -6.82 0.003445 
LTA Lymphotoxin alpha -4.92 0.013147 
CXCL12 Chemokine (C-X-C motif) ligand 12 -4.46 0.04327 
TNFSF13B 
Tumor necrosis factor (ligand) 
superfamily, member 13b 
-4.16 0.040672 
IL10RA Interleukin 10 receptor, alpha -3.71 0.016316 
CCL17 Chemokine (C-C motif) ligand 17 -3.61 0.030804 
IL6R Interleukin 6 receptor -2.5 0.009601 
TNFSF4 
Tumor necrosis factor (ligand) 
superfamily, member 4 
-2.16 0.024155 




   
CXCL5 Chemokine (C-X-C motif) ligand 5 8.25 0.001102 
Downregulated 
  
None    






Table 6: Fold expression differences (2) in unchallenged bMECs from mastitis-resistant 
relative to mastitis-susceptible cattle. P-values are shown; none are significant (p < 0.05). 
Gene Symbol Gene Fold-difference P-value 
    
Higher expression   
CXCR1 Chemokine (C-X-C motif) receptor 1 2.01 0.282959 
FASLG Fas ligand 40.67 0.207079 
IL15 Interleukin 15 2.4 0.283571 
IL33 Interleukin 33 4.44 0.291716 
    
Lower expression   
BMP2 Bone morphogenetic protein 2 -4.31 0.166194 
CCL2 Chemokine (C-C motif) ligand 2 -3.84 0.242192 
CCL5 Chemokine (C-C motif) ligand 5 -4.4 0.277475 
CXCL5 Chemokine (C-X-C motif) ligand 5 -3.49 0.067625 
CXCL8 Interleukin 8 -3.06 0.25974 
GRO1 Chemokine (C-X-C motif) ligand 2 -4.09 0.112732 
HPRT1 Hypoxanthine phosphoribosyltransferase 1 -2 0.116871 
IL10RB Interleukin 10 receptor, beta -2.78 0.255559 
IL1A Interleukin 1, alpha -2.36 0.269131 
IL1R1 Interleukin 1 receptor, type 1 -2.08 0.276355 
IL1RN Interleukin 1 receptor antagonist -3.04 0.276084 
IL6R Interleukin 6 receptor -2.23 0.276033 
TBP TATA box binding protein -2.65 0.252476 
TNFSF10 Tumor necrosis factor (ligand) superfamily, member 10 -2.42 0.279517 
TNFSF13 Tumor necrosis factor (ligand) superfamily, member 13 -2.5 0.2726 
TNFSF4 Tumor necrosis factor (ligand) superfamily, member 4 -2.08 0.457644 
VEGFA Vascular endothelial growth factor A -2.73 0.063398 







PRIMARY BOVINE DERMAL FIBROBLASTS DISPLAY SIMILAR INTERLEUKIN 
1β EXPRESSION CHANGES TO PRIMARY BOVINE MAMMARY EPITHELIAL 
CELLS IN RESPONSE TO LIPOPOLYSACCHARIDE 
 
Abstract 
 Mastitis is an important disease among dairy cattle worldwide. Primary bovine 
mammary epithelial cells (bMECs) provide an in vitro model for studies of the bovine 
mammary gland, including investigations of the cellular mechanisms involved in mastitis. 
Bovine milk provides a source of viable bMECs and establishment of bMECs from this 
source is a non-invasive, repeatable method that is more practical than explant methods. 
However, establishment of primary bMECs from bovine milk is challenging due to the 
low concentration of bMECs, generally requiring a large volume of milk. Bovine 
fibroblasts (bFs) are a second resident cell type involved in immune responses to 
intramammary infection, and are readily established and maintained in culture. In order to 
systematically investigate the common or differential innate immune responses to 
mastitis-causing pathogens between bMECs and bFs, we established primary bMEC and 
bF lines from seven lactating Holstein cattle and profiled the inflammatory responses of 
bMECs and bFs to lipopolysaccharide (LPS) challenge using the Fluidigm Biomark HD 
system. Additionally, we describe a method for establishment of primary bMECs from 
bovine milk with reduced milk volume and FBS requirements. Under static 




bMECs of interleukin 1α (IL1A), IL-1 receptor antagonist (IL1RN), C-C motif 
chemokine ligand 20 (CCL20), C-X-C motif chemokine ligand 5 (CXCL5), IL-1 receptor 
1 (IL1R1), and IL-6. In response to LPS challenge, both bMECs and bFs downregulate 
IL-1β (IL1B), and bMECs additionally downregulate CCL20. Therefore, bFs could 
potentially be used as a model for bMEC IL1B responses but may not provide a universal 
model for bMEC inflammatory gene responses.  
 
Background 
Mastitis is the most prevalent production-related disease among dairy cattle and is 
associated with substantial economic impacts [193]. Decreased milk yield accounts for 
much of the cost associated with mastitis [194] and is a result of temporary or permanent 
functional compromise of the mammary gland by direct pathogen effects or 
inflammatory-mediated damage [55].  
The inflammatory response to mastitis pathogens is due to contributions from 
multiple cell types. Bovine mammary epithelial cells (bMECs), lining the teat canal, 
ductal system, and alveoli, are extensively involved in innate defenses against invading 
pathogens. In addition to providing a physical barrier against bacterial entry into 
mammary tissue via tight junctions, these cells have the capacity to initiate components 
of the inflammatory response through the production of cytokines, chemokines, and other 
secreted factors. Secreted factors with bacteriostatic, bactericidal, and/or modulatory 
effects on inflammation include lactoferrin, citrate, xanthine oxidase, arachidonic acid 




recognizing antigen from invading organisms through expression of pattern recognition 
receptors, including Toll-like receptors (TLR) 2 and 4, facilitating generation of 
pathogen-specific cytokine/chemokine profiles. Intramammary infection by Escherichia 
coli, an important mastitis pathogen, initiates the release of cytokines by bMECs, 
including interleukins (ILs), chemokines, and tumor necrosis factor (TNF) [30,195]. 
Because of the importance of bMECs in mastitis, bMEC immune responses have 
been examined in numerous in vitro and in vivo studies. In vitro studies provide a 
practical approach whereby immune responses of bMECs can be isolated from other 
mammary gland and systemic components within a highly controlled environment. 
Primary bMECs retain characteristics of MECs in vivo, including epithelial morphology, 
desmosomes, abundant tonofilaments, and formation of acinar structures [177,196], and 
gene expression of cytokeratins, casein, and whey proteins [197,198]. Additionally, 
primary bMECs are capable of eliciting pathogen-specific inflammatory responses by 
differential expression of multiple inflammatory components, including lactoferrin, IL-
1β, IL-8, TNF-α, serum amyloid A, and β-defensin [38,170]. Furthermore, the effects of 
factors such as energy balance in the donor animal on bMEC responses can be studied 
[171]. Variation in immune responses of primary bMECs from donor animals with 
differing levels of susceptibility to mastitis have been demonstrated. For example, 
primary bMECs from animals classified as  exhibiting high and low susceptibility to 
mastitis based on genotype at a quantitative trait locus for udder health traits on BTA 18 
showed differential expression of several key innate immune genes in response to 




response was initiated in primary bMECs from less susceptible animals [157]. These and 
other studies support the usefulness of primary bMECs in studies to elucidate specific 
mechanisms underlying mastitis pathogenesis, including mastitis resistance. 
Primary bMECs may be established from explant culture of mammary gland 
tissue or from isolation from bovine milk. Explant culture requires postmortem or biopsy 
tissue, the acquisition of which requires euthanasia or an invasive procedure. As stated in 
its policy on the use of animals in research, the American Veterinary Medical Association 
recommends the use of non-animal methods and “refinement of experimental methods to 
eliminate animal pain and distress” [199], which can be achieved with the use of in vitro 
models attained by minimally-invasive methods. Bovine milk provides a source of viable 
bMECs for primary culture and presents a non-invasive, repeatable, and practical 
alternative to explant methods. Previously reported methods of bMEC establishment 
from milk require collection of a large volume of milk, which may be impractical under 
some circumstances. Here, we describe a method by which bMECs can be successfully 
established from a reduced volume of milk. 
In addition to bMECs, bovine fibroblasts (bFs) are a resident component of the 
mammary gland and contribute to inflammatory responses during mastitis [200]. 
Differences in inflammatory responses of primary bFs between individual animals have 
been demonstrated to be reflective of mammary gland immune responses in vivo [201]. 
Like bMECs, bFs should be considered as potential contributors to mastitis susceptibility. 
In vitro models based on primary cell culture are vital in differentiating the 




inflammatory responses of both bMECs and bFs may contribute to mastitis susceptibility, 
defining the responses of both to inflammatory stimuli is expected to yield a more 
complete picture of the mechanisms of mastitis resistance than would the study of one 
cell type alone. Direct comparisons between the responses of these two cell types from 
the same individual cattle are needed to better define the mechanisms of mastitis 
resistance. In order to compare inflammatory responses, we isolated bMECs and bFs 
from seven lactating Holstein dairy cows and examined differences between the two cell 
types in the expression of 13 pro-inflammatory genes under unchallenged as well as 
lipopolysaccharide (LPS)-challenged conditions. 
 
Methods 
Bovine MEC collection, isolation, and establishment 
Seven primary bMEC lines were established from bovine milk using methods 
modified from those previously reported [39,177]. Milk samples for bMEC isolation 
were collected from lactating Holstein cows in the milking parlor prior to attachment of 
the milking cluster. Prior to milk collection, teat ends were cleaned and disinfected with a 
7.5% povidone-iodine solution applied with a spray bottle. Disinfectant was allowed 
approximately ten seconds contact time before being removed using a clean paper towel. 
Four hundred ml of milk was then hand-stripped from one or more mammary gland 
quarters into sterile, 1 liter-capacity plastic bottles containing an equal volume of 
collection media. Collection media consisted of Hank’s Balanced Salt Solution (Sigma-




μg/ml), gentamycin (120 μg/ml), and nystatin (50 mg/L). Samples were kept on ice 
within an insulated container for transport to the laboratory and short-term storage (up to 
four hours) prior to cell isolation. 
 In all subsequent steps where sample containers were open, samples were handled 
within a cell culture hood to maintain asepsis. Milk samples were divided into two 500-
ml capacity conical centrifuge bottles and centrifuged for ten minutes at 3000 rpm at 
room temperature. The supernatant was discarded, and the cell pellets were resuspended 
in 12 ml of fresh collection media and transferred into a 50 ml sterile conical tube. 
Resuspended cell pellets from the same individual animal were combined into the same 
50 ml tube. Samples were centrifuged for ten minutes at 3000 rpm at room temperature. 
The supernatant was discarded, and the remaining cell pellet resuspended in 24 ml of 
fresh collection media and transferred to a new 50 ml conical tube through a 100 µm cell 
strainer. Samples were centrifuged again at 3000 rpm for ten minutes at room 
temperature, and the supernatant discarded. The cell pellet was resuspended in 5 ml of 
growth media with 10% FBS, seeded into a T-25 culture flask, and incubated at 38.5°C 
with 5% CO2. Growth media consisted of HuMEC Ready Medium (Life Technologies, 
Grand Island, NY) supplemented with penicillin (60 μg/ml), streptomycin (200 μg/ml), 
gentamycin (120 μg/ml), and nystatin (50 μg/ml). After 12-18 hours, media was 
exchanged for growth media without FBS. Media was changed every 2-3 days. After 
large, coalescing colonies formed or the culture had reached confluence, cells were 
passaged using trypsin 0.05%/EDTA 0.02% (Sigma-Aldrich, St. Louis, MO). Cells were 




Bovine fibroblast collection, isolation, and establishment 
 Bovine fibroblast primary cultures were established as previously described [202], 
with some modifications, from dermal ear notch samples from the cows for which bMEC 
lines were established. Ear notches were rinsed in a 7.5% povidone-iodine solution 
followed by 70% ethanol, and transferred into collection media as described above for 
transport to the laboratory on ice. Under a cell culture hood, ear notches were minced to 2 
mm3 pieces, with exclusion of the epidermis and hair. Tissue pieces were rinsed twice 
with collection media and transferred to cell culture wells containing 0.25% trypsin. After 
a one-hour incubation at 37˚C with 5% CO2, trypsin was exchanged for growth media as 
described above with 10% FBS. Media was exchanged every 2-3 days thereafter. Once 
adherent monolayer cells morphologically consistent with fibroblasts had formed around 
explant tissue pieces, tissue was removed. Cells were passaged when confluence was 
reached as described for bMECs. Cells were maintained to the second passage, at which 
point LPS challenge was carried out. 
 
Cell lineage verification 
Verification of epithelial lineage of representative bMECs was achieved using 
observation of cell morphology and cytokeratin 8 (KER8) expression as determined by 
polymerase chain reaction (PCR). Observations of cell morphology were made at P0 and 
all subsequent passages using phase-contrast microscopy. Primers for KER8 were 
designed using Primer3Plus (http://primer3plus.com/cgi-bin/dev/primer3plus.cgi) and 




primer AATCAAGTATGAGGAGCTGC; reverse primer 
CATCCTTAACAGCCATCTCA. Polymerase chain reaction conditions consisted of 
initial denaturation at 98˚C for 30 seconds followed by 32 cycles of 98˚C for 10 seconds, 
57 ˚C for 15 seconds, and 72˚C for 30 seconds. Gel electrophoresis was used to confirm 
the presence of PCR product. Sequencing of PCR product to confirm KER8 amplification 
was carried out by the Center for Integrated Biotechnology, Utah State University 
(Logan, UT). Uniformity of cytokeratin expression was also confirmed by 
immunocytochemistry using a rabbit anti-cytokeratin, wide spectrum screening primary 
antibody (Z0622; Agilent Technologies, Santa Clara, CA), carried out by the Utah 
Veterinary Diagnostic Laboratory (Logan, UT). 
 
LPS challenge and RNA isolation 
 Bovine MECs and bFs were exposed to LPS from Escherichia coli 0111:B4 
(Sigma-Aldrich, St. Louis, MO) to mimic exposure to a mastitis-causing pathogen. 
Lipopolysaccharide challenge methods were similar to those described previously [173]. 
Briefly, bMECs and bFs were split after the second passage into two T-25 culture flasks. 
Once 50-100% confluence was reached, media was exchanged for growth media with or 
without 50 µg/ml LPS. Cells were incubated at culture conditions for 6 hours, after which 
media was removed. 
Following LPS challenge, bMECs and bFs were lysed and total RNA was isolated 
and purified using the Purelink RNA Mini Kit (Life Technologies, Carlsbad, CA) 




> 8.0) was verified using the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa 
Clara, CA). Complementary DNA was generated using the SuperScript® VILOTM cDNA 
Synthesis Kit (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions, 
with reverse transcription PCR conditions as follows: primer annealing at 25˚C for 10 
minutes, reverse transcription at 42˚C for 1 hour, and enzyme inactivation at 85˚C for 5 
minutes. 
 
Quantitative PCR for gene expression 
Relative expression of 13 pro-inflammatory genes was assessed via quantitative 
PCR (qPCR). Genes were selected based on known roles in inflammation and/or bovine 
mastitis and included Toll-like receptor 4 (TLR4), interleukin-6 (IL6), IL33, IL1α, IL1β, 
IL2 receptor subunit gamma (IL2RG), IL1 receptor antagonist (IL1RN), IL1 receptor 
type 1 (IL1R1), C-X-C motif chemokine ligand 5 (CXCL5), interleukin 8 (CXCL8), C-C 
motif chemokine receptor 2 (CCR2), C-C motif chemokine ligand 20 (CCL20), and 
chemokine (C-X-C motif) ligand 1 (GRO1). Glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) and ubiquitously expressed transcript protein (UXT) were used as reference 
genes. Primers were designed using Primer3Plus (http://primer3plus.com/cgi-
bin/dev/primer3plus.cgi) and are shown in Table 7. Efficiency of all primers was between 
80-110%. 
Quantitative PCR was performed by the Utah State University Center for 
Integrated Technology (Logan, UT) using BioMark technology (Fluidigm) and EvaGreen 




quantification as implemented by Fluidigm Real-Time PCR Analysis software 
(Fluidigm). Results were analyzed in a mixed model approach implemented in SAS® 
statistical software, Version 9.4 [203], using the “proc mixed” command, with a 
significance level set at p < 0.05. Comparisons in expression of the 13 genes were made 
between bMECs and bFs under unchallenged conditions. Additionally, expression of 
these genes was compared between unchallenged and LPS-challenged bMECs and 
between unchallenged and LPS-challenged bFs. 
 
Results 
Improved bMEC isolation methods 
Methods described for bMEC establishment include explant culture from 
mammary gland biopsies or postmortem tissue and isolation from bovine milk. 
Establishment of primary bMECs from postmortem tissue carries the disadvantage that 
further cultures at a later time cannot be obtained from the same cow. Additionally, 
slaughter of cattle solely to obtain such tissue may be economically impractical as well as 
ethically questionable. Mammary gland biopsies can overcome these problems, but are 
time-consuming and may not be practical under some circumstances, particularly if 
repeated establishment of cell lines from the same animals is required. With both these 
methods, other cell types such as bFs are isolated along with bMECs and steps must be 
taken to remove these contaminating cell types [170,176]. Establishment of primary 
bMECs from bovine milk is a non-invasive method that minimizes contamination of 




We successfully established bMEC primary cultures from bovine milk from a 
reduced volume of milk (400 ml) as compared with previously-reported methods. 
Moreover, use of hand-milking for milk collection, use of collection media supplemented 
by antimicrobials, and centrifugation speed of 3000 rpm during isolation steps were 
important factors. Additionally, use of FBS in bMEC culture media can be minimized, as 
FBS was eliminated from the culture media from the first media change onward. 
All established bMEC lines demonstrated cell and colony morphology uniformly 
consistent with their respective expected cell types. Among bMEC lines, rare to moderate 
numbers of individual, adherent cells with polygonal morphology, oval nuclei, and 
elongated cytoplasmic processes were present by 12 hours after seeding. By four days 
after seeding, colonies of 2-5 cells were observed, demonstrating the cobblestone 
arrangement and polygonal individual cell morphology consistent with MECs grown on 
monolayer [205–207]. Cultures had formed large, coalescing colonies by 21-28 days after 
seeding and were initially passaged at this time. Cellular senescence was identified by 
prominent flattening, enlargement, and nuclear vacuolation of cells in addition to a 
cessation of cell division. Senescence among a majority of cells, with no further growth 
of colonies, was observed in occasional cell lines at initial passage (P0) and P1 and these 
cultures were excluded from the LPS challenge study. However, most cell lines did not 
exhibit senescence among a majority of cells by confluence at P2. All bMEC lines 
expressed KER8. Immunocytochemistry demonstrated cytokeratin expression in the 




Primary bFs formed small colonies of spindle-shaped cells bordering explant 
tissue pieces and reached confluence within 7-10 days. All bF lines demonstrated 
uniform sheets and individual cell morphology consistent with primary fibroblasts on 
monolayer. 
Our results demonstrate that primary bMEC lines can be established from 400 ml 
of bovine milk. The use of a small volume of milk allows for a reduction in the time 
required for sample collection, improving the utility of this method. 
 
Constitutive expression of inflammatory genes differs between bMECs and bFs 
To investigate differences in constitutive expression of pro-inflammatory genes 
between bFs and bMECs, we evaluated the expression of 13 pro-inflammatory genes by 
qRT-PCR in unchallenged cell lines. Four genes, IL6, ILR1, CXCL5, and CCL20, were 
significantly (p < 0.05) more highly expressed in bMECs than bFs under unchallenged 
conditions, while two genes, IL1RN and IL1A, were more highly expressed in bFs (Table 
8). Results show that constitutive expression of a number of pro-inflammatory genes 
varies between bFs and bMECs. This finding highlights the importance of examining the 
two cell types separately when conclusions are drawn regarding possible influences of 






Expression of pro-inflammatory genes between bMECs and bFs upon LPS challenge 
Changes in the expression of 13 pro-inflammatory genes between the two cell 
types as a result of LPS challenge were compared.  
Lipopolysaccharide challenge resulted in differential expression of two pro-
inflammatory genes among bMECs and one pro-inflammatory gene among bFs. Among 
bMECs, both IL1B and CCL20 were significantly downregulated. Among bFs, IL1B was 
significantly downregulated (Table 9). The expression of the remaining 11 genes 
examined was not significantly affected by LPS challenge in either cell type. These 
findings demonstrate that in response to LPS, both cell types respond similarly with 
regard to changes in expression of IL1B, an important cytokine in bovine mastitis. The 
pattern of expression of CCL20, however, differs between the two cell types in response 
to LPS. Therefore, bFs could potentially be used as a model for bMEC IL1B responses 
but may not provide a good universal model for bMEC inflammatory gene responses. 
 
Discussion 
Primary bMEC cultures can be established from a small volume of bovine milk with 
minimal use of FBS 
Our results reinforce that bovine milk provides a source of viable bMECs that can 
be collected non-invasively and repeatedly. Challenges encountered in bMEC primary 
culture from bovine milk include recovery of an adequate number of viable bMECs and 
avoidance of culture contamination by bacterial and fungal organisms. In our experience, 




centrifugation speed of 3000 rpm during isolation steps contributed to the success of 
establishing bMEC primary cultures from a 400 ml volume of milk. 
The concentration of viable bMECs detected within milk from dairy cattle tends 
to be low [204,208]. As such, previously-reported methods for bMEC isolation from milk 
require relatively large volumes of milk, at 950 ml or greater [39,171,177], which may be 
impractical in some settings. For example, as we experienced, sampling of cows on a 
commercial farm within the milking parlor may unduly disrupt the milking schedule due 
to the time required to collect a large volume of milk. Reducing the volume of milk 
needed allows disruption to be minimized. 
In previously reported methods of bMEC establishment from milk [39,171,177], 
the technique of milk collection is unspecified. In our experience, collection of milk by 
mechanical milking equipment resulted in a lower rate of successful bMEC 
establishment, as well as a higher number of cultures discarded as a result of bacterial 
contamination, than did manual collection by hand-milking. We speculate that manual 
collection may result in less cellular damage from shearing stress to bMECs, and 
therefore a higher success rate, than does milking by mechanical means. In the setting of 
a commercial dairy farm, as was used in our study, hand milking additionally lends a 
higher degree of control over maintaining asepsis, thereby reducing bacterial and fungal 
contamination. We observed a lower frequency of bacterial contamination of bMEC 
cultures obtained through manual sampling than those obtained through mechanical 




During the initial centrifugation step in bMEC isolation, cells are separated from 
the majority of the liquid and fat components of the milk. A variable amount of fat 
separates from the liquid component and forms a layer on the surface of the milk during 
centrifugation, while cells, debris, and some fat form a pellet beneath the liquid layer. 
However, in agreement with a previous study [210], we suspect that some cells may 
become trapped in the upper fat layer of the milk during centrifugation. Dilution of the 
sample with collection media may help to minimize cell trapping by reducing the 
viscosity of the milk and the concentration of lipids, allowing cells to more easily pellet 
during centrifugation. 
We experimented with low (2000 rpm) to high (4000 rpm) centrifugation speeds 
during bMEC isolation attempts, and found that centrifugation at 3000 rpm was optimal 
for establishment of bMEC lines. We believe that low-speed centrifugation may cause 
less damage to cells, preserving viability, but may leave many cells remaining in 
suspension. High-speed centrifugation may result in a larger number of cells recovered 
from suspension, but may cause cellular damage and decreased viability (Gertrude C. 
Beuhring, personal communication). 
Antimicrobials in collection media and growth media were used to prevent 
bacterial and fungal contamination of bMEC and bF cultures. Prior to the use of 
antimicrobial-supplemented collection media, we observed a higher rate of contamination 
of bMEC and bF cultures at initial establishment or early passages. Although milk 
samples for bMEC establishment were collected with asepsis in mind, some level of 




microscopically visible acellular debris embedded within the cell pellet following 
centrifugation. We expect that the use of antimicrobials helped to control bacterial and 
fungal proliferation in milk and ear notch samples prior to seeding of isolated cell pellets 
or explant tissue, respectively, into antimicrobial-supplemented growth media. Overall, 
evidence of bacterial contamination was uncommon when milk was collected manually. 
However, fungal contamination of cultures at early passages was common in both bMEC 
and bF lines when no collection media was used or when amphotericin B was used as an 
antifungal. As a result, we substituted nystatin for amphotericin B in both collection and 
growth media. Concurrently, the source of the iodine disinfectant used to clean teats prior 
to sampling was switched from the on-farm pre-dip solution to a solution prepared 
aseptically in the laboratory. The use of this iodine disinfectant was also added to the bF 
isolation protocol, wherein ear notches were rinsed with the iodine solution prior to 
ethanol rinsing. The implementation of these changes successfully prevented fungal 
contamination in bMEC and most bF lines. 
In previously reported methods of bMEC isolation and culture from milk, FBS or 
fetal calf serum (FCS) is used in the culture media at concentrations of 5-10% in growth 
media in order to facilitate cell-substrate attachment and achieve sustained growth of 
bMECs [38,39,170,177]. However, the use of serum in cell culture media has a number 
of disadvantages. The components of serum, as well as their concentrations, are 
incompletely defined, and may exhibit large lot-to-lot variation. Serum is additionally a 
potential source of hemoglobin, endotoxin, and microbial contaminants, all of which have 




inhibit the growth of some epithelial cell types, including human mammary epithelial 
cells [206,212]; a similar effect on bMECs is possible. Furthermore, the presence of 
serum in media may influence inflammatory cytokine secretion or bioactivity by bMECs 
[213]. These considerations, in addition to the expense and ethical concerns regarding the 
collection of serum from bovine fetuses, justify development of cell culture methods that 
minimize or eliminate the use of serum in cell culture [211,214]. Human MECs have 
been cultured successfully in serum-free media, and may in fact be more easily cultured 
using alternatives to FBS [206]. In our studies, we found that FBS is required for initial 
attachment of bMECs, as reported previously [177]. However, using a specialized serum-
free media developed for human MEC culture, we were able to eliminate FBS from the 
growth media from the first media change onward. 
Isolation of bMECs from bovine milk has some disadvantages, such as a low 
number of cells relative to what can be achieved through explant culture [177]. However, 
in studies that do not require a large number of cells, isolation from milk provides a 
number of advantages over explant culture. The modifications described here to 
previously-reported milk isolation methods improve the versatility of bMEC isolation 
from milk by reducing the volume of milk needed and minimizing the requirement for 
serum. 
 
The use of bFs in mastitis studies 
 Fibroblasts are a component of the bovine mammary gland and respond to 




mammary gland-derived bFs from donor animals with and without intramammary 
infection display differential expression of genes involved in cell junction and adhesion, 
immune response, and biosynthesis/metabolism cellular pathways, and additionally affect 
proliferation and secretion of TNF-α and IL-8 by co-cultured bMEC [215]. Dermal bFs 
exposed in vitro to LPS display increased expression of IL-8, IL-6, and some matrix 
metalloproteinases [201,216,217]. 
Similar to bMECs, individual animal variation has been observed in immune 
responses of primary bFs. Variability in IL-6, IL-8, and TLR-4 expression between 
dermal bF lines from different animals was noted upon in vitro exposure of these cells to 
LPS or IL-1β [201,216,218]. Intriguingly, responses of dermal bFs to LPS in vitro were 
predictive of the rate of mastitis resolution and return to mammary gland productive 
capacity upon intramammary infusion of Escherichia coli in lactating Holstein cows 
[201]. These findings indicate that primary bFs, like bMECs, have the potential to 
provide a suitable model for certain mastitis studies. We demonstrate that bFs and 
bMECs respond similarly to LPS challenge in their expression of IL1B, but demonstrate 
differences in CCL20 expression. 
 
IL1B is downregulated by both bMECs and bFs following LPS challenge 
  The role of IL1B in bovine mastitis is well recognized. Interleukin 1β has been 
detected in both healthy and infected bovine mammary glands [219] and is produced by 
monocytes/macrophages, bMECs, and possibly mammary gland endothelial cells 




molecule expression by endothelial cells. The relative importance of IL1B responses in 
mastitis varies by pathogen [220], but increased expression in the mammary gland is 
observed in the acute stages of mastitis caused by several important pathogens, including 
Streptococcus uberis [221], Escherichia coli [195,222], and Staphylococcus aureus 
[222]. Measurement of serum IL1B and calculation of the serum IL1RN:IL1B ratio has 
been suggested as a predictive assay for mastitis severity in cattle [219]. Our finding that 
IL1B was downregulated following LPS exposure is in contrast to many studies that 
demonstrate upregulation of IL1B in response to inflammatory stimuli, although 
downregulation of IL1B in bovine mammary tissue with mastitis has been reported [223]. 
The finding that bFs show similar IL1B responses to LPS to bMECs suggests that 
bFs could be used in place of bMECs in understanding some aspects of the immune 
responses of mastitis. Changes in IL1B expression by bFs could potentially be used as a 
tool for predicting bMEC immune responsiveness to various conditions. For example, 
bFs could be used in the initial investigation of compounds theorized to dampen bMEC 
responses and thereby reduce inflammatory-mediated damage to the mammary gland 
during mastitis. The responsiveness of bFs in place of bMECs to LPS in the presence of 
these compounds could be evaluated. Because bFs grow more readily and rapidly in 
culture than bMECs, bF-based models have the potential to improve the efficiency of 
such initial investigations, the findings of which could be used as guidance for the 






CCL20 is downregulated in bMECs but not in bFs following LPS challenge 
 CCL20 is a pro-inflammatory chemokine involved in recruitment of leukocytes 
[224]. Upregulation of CCL20 by the mammary gland and primary bMECs in response to 
mastitis pathogens has been demonstrated [225]. 
Although IL1B responses of bFs and bMECs were similar, the two cell types 
displayed distinct CCL20 responses following LPS challenge, with differential 
expression noted only in bMECs. This finding demonstrates that bFs cannot be assumed 




 Constitutive expression of IL6, ILR1, CXCL5, CCL20, IL1RN, and IL1A differ 
between primary bFs and bMECs under unchallenged conditions, indicating a need to 
examine each cell type separately in studies of constitutive mammary gland gene 
expression. Following LPS challenge, both cell types respond by downregulating IL1B, 
while CCL20 is downregulated in bMECs only. Bovine fibroblasts may therefore be of 
use as a model for bMEC IL1B expression responses during mastitis but may not be 
appropriate when the expression of some other inflammatory genes are examined. 
Primary bMEC cultures can be established from 400 ml of bovine milk and with reduced 




Table 7: Primers used for qPCR. 
Symbol Gene Primer Sequence NCBI sequence 
     
CCL20 C-C motif chemokine 
ligand 20 




     
CCR2 C-C motif chemokine 
receptor 2 




     
CXCL5 C-X-C motif chemokine 
ligand 5 




     




     
GRO1 chemokine (C-X-C 
motif) ligand 1 




     




     




     
IL1R1 Interleukin 1 receptor 
type 1 




     
IL1RN Interleukin 1 receptor 
antagonist 




     
IL2RG Interleukin 2 receptor 
subunit gamma 




     




     




     








Table 8: Genes differentially expressed between bFs and bMECs under unchallenged 
conditions. 
Symbol Gene P-value SE 
    
More highly expressed in bFs   
IL1A Interleukin 1 alpha 0.0003 1.1784 
IL1RN Interleukin 1 receptor antagonist <0.0001 1.1848 
    
More highly expressed in bMECs   
CCL20 C-C motif chemokine ligand 20 0.0003 1.36 
CXCL5 C-X-C motif chemokine ligand 5 0.0415 0.8957 
IL1R1 Interleukin 1 receptor type 1 0.0071 1.4813 
IL6 Interleukin 6 0.0026 2.1505 
        
SE: Standard Error 
 
 
Table 9: Genes downregulated following LPS challenge in bFs and bMECs. 
Symbol Gene P-value SE 
    
Downregulated in bFs   
IL1B Interleukin 1 beta 0.0322 1.2603 
    
Downregulated in bMECs   
IL1B Interleukin 1 beta 0.0009 1.2603 
CCL20 C-C motif chemokine ligand 20 <0.0001 1.36 







EXOGENOUS PHOSPHOLIPASE A2 AFFECTS EXPRESSION OF INTERLEUKIN-8 
AND CHEMOKINE (C-X-C MOTIF) LIGAND 1 BY PRIMARY BOVINE 
MAMMARY EPITHELIAL CELLS IN RESPONSE TO LIPOPOLYSACCHARIDE 
 
Abstract 
 Bovine mastitis causes substantial economic losses to the dairy industry. 
Phospholipase A2 (PLA2) is an endogenous enzyme involved in phospholipid 
metabolism in all mammalian tissues and has both pro-inflammatory and anti-
inflammatory functions as well as bactericidal characteristics. Modulation of PLA2 levels 
locally within tissue has been proposed as a therapeutic approach to various diseases, and 
evidence exists for an anti-inflammatory effect when administered as an intramammary 
treatment during murine mastitis. Little is known about the effects of exogenous PLA2 on 
the bovine mammary gland and its effects on bovine mastitis. We used an in vitro model 
to investigate the effects of exogenous PLA2 on primary bovine mammary epithelial cells 
(bMECs). We established bMEC lines from 12 lactating Holstein dairy cows and 
compared the expression of 13 pro-inflammatory genes under unchallenged and 
lipopolysaccharide (LPS)-challenged conditions with and without concurrent treatment 
with bovine pancreatic PLA2G1B. No differences in the expression of these genes were 
noted between PLA2-treated and untreated bMECs under unchallenged conditions. 
However, following LPS challenge, untreated bMECs exhibited significant (p < 0.05) 




ligand 20 (CCL20), and chemokine (C-X-C motif) ligand 1 (GRO1). In contrast, PLA2-
treated bMECs exhibited significant downregulation of IL1B and CCL20 only, indicating 
that exogenous PLA2 affects the expression of some pro-inflammatory factors in 
immune-stimulated bMECs. Further studies are required to determine whether PLA2 
affects the expression of other inflammatory genes by bMECs or other mammary gland 
cell types, or if a dose-dependent effect exists that was not apparent in this study. 
 
Background 
Bovine mastitis has a major impact on the dairy industry due to the substantial 
impacts of decreased milk yield, altered milk production, and the costs of diagnostic, 
therapeutic, and preventative measures [3,193]. Currently, the majority of dairy cattle 
with mastitis are treated with antibiotics, despite evidence indicating that bacteriological 
cure rates may not be improved with antibiotic treatment over spontaneous cure rates 
[226,227]. 
Changes in the production capacity of the mammary gland as well as alterations in 
milk composition are a result of damage to bovine mammary epithelial cells (bMECs), 
the milk-producing compartment. Damage can result from direct effects of mastitis 
pathogens on bMECs [228,229]. A substantial portion of damage, however, is a 
consequence of the host immune response itself, wherein host defense mechanisms such 
as neutrophil degranulation cause bystander-effect cellular injury [47]. Minimizing the 
damaging effects of host inflammatory responses should be considered an important 




antibiotics alone in cases of bovine mastitis, minimizing inflammation-induced host 
tissue damage relies solely on elimination of the infecting organism. Alternative 
therapeutic approaches to bovine mastitis that include strategies to minimize host-induced 
damage to mammary gland tissue are needed. 
One proposed therapeutic approach in the treatment of a number of inflammatory 
diseases in various species involves modulation of phospholipase A2 [230]. The 
phospholipase A2 superfamily of enzymes are involved in several cellular processes, 
including influencing inflammatory processes, predominantly via generation of lipid 
mediators. Inhibition of PLA2 activity has therefore been proposed in the treatment of 
inflammatory diseases [231]. However, because of the involvement of PLA2 in other 
cellular processes such as normal phospholipid metabolism, universal PLA2 inhibition 
has potentially detrimental effects, including impairment of cell viability [230]. 
Therefore, selective modulation of specific PLA2 subtypes, such as secreted PLA2 
(sPLA2), may be a more optimal approach [230]. 
Pro-inflammatory actions of sPLA2 are mediated through intrinsic enzymatic and 
bactericidal activity as well as via interaction with the PLA2 receptor expressed on 
various mammalian cell types [232,233]. Secreted PLA2 enzymatic activity results in cell 
membrane and extracellular phospholipid hydrolysis and the consequent release of 
arachidonic acid, which is subsequently converted into eicosanoids to potentiate 
inflammation [232,234]. Binding of sPLA2 to transmembrane and soluble forms of the 
PLA2 receptor (PLA2R1) evokes additional cell type-specific biological responses, 




sPLA2 enzymatic activity [232]. For some sPLA2 subtypes, such as sPLA2-1B, this 
receptor-mediated activity is particularly important, as intrinsic hydrolyzing activity 
toward intact cell membranes of sPLA2-1B is relatively weak [235]. Additional receptor-
mediated pro-inflammatory effects include influences on plasma pro-inflammatory 
cytokine levels during endotoxic shock [232]. Evidence exists for sPLA2 subtype-
specific effects upon receptor binding [232]. Interestingly, in addition to potentiating 
PLA2 function, PLA2R1-sPLA2 binding also has negative regulatory effects on PLA2 
activity. The intrinsic enzymatic activity of sPLA2 is abolished upon receptor binding 
[232], and receptor-mediated endocytosis of sPLA2 facilitates clearance of these 
enzymes [235]. Binding of sPLA2 to a circulating, soluble form of PLA2 receptor 
upregulated during endotoxic shock additionally blocks the biological functions of some 
sPLA2 subtypes [235]. 
Little information is available on the role of PLA2 in the pathogenesis of bovine 
mastitis. It is unknown whether endogenous PLA2 activity in the bovine mammary gland 
changes as a result of mastitis [236]. Effects of PLA2 noted in other species and tissues 
may be extrapolated to the bovine mammary gland only tentatively, as variation in PLA2-
receptor-binding activity is noted among different mammalian species. For example, 
PLA2 receptor binding affinity of sPLA2 subtype sPLA2-1B is high in rodents but low in 
humans, and binding of sPLA2-IIA to the PLA2 receptor does not occur in humans [235]. 
Although PLA2 activity contributes to inflammation-induced damage in some diseases, 
as discussed above, there is some evidence for an anti-inflammatory effect of sPLA2 




experimental, LPS-induced mastitis reduced inflammation despite displaying no 
bactericidal activity [233]. Additionally, the effects of murine PLA2G2D are known to 
include the production of anti-inflammatory lipid mediators [237]. Information on the 
effects of PLA2 on inflammation in bovine mammary tissue is lacking. Whether PLA2 in 
the bovine mammary gland during mastitis has beneficial or detrimental effects has yet to 
be described. 
Investigation of the effects of PLA2 on bovine mammary gland tissue will indicate 
whether further studies of PLA2 or PLA2 inhibitors as potential therapeutic agents are 
warranted. The objective of this study was to examine the effects of exogenously 
administered PLA2 on inflammatory responses of primary bMECs. To achieve this, we 
established primary bMEC lines from 12 lactating Holstein cows and compared the 
expression of 13 pro-inflammatory genes in PLA2-treated and untreated cell lines at 
unchallenged as well as LPS-challenged conditions. 
 
Methods 
Bovine MEC collection, isolation, and establishment 
Milk-derived primary bMEC lines were established from adult lactating Holstein 
dairy cows. Four hundred milliliters of hand-stripped milk were aseptically collected into 
an equal volume of collection media consisting of Hank’s Balanced Salt Solution (Sigma) 
supplemented with penicillin (60 μg/ml), streptomycin (200 μg/ml), gentamycin (120 




Bovine MEC isolation was carried out as previously reported [39,177] with some 
modifications. Briefly, milk samples were subjected to a series of wash and 
centrifugation steps (3000 rpm for 10 minutes each) followed by passage of the 
resuspended cell pellet through a 100 µm pore size cell strainer to separate cell pellets 
from debris and other milk components. Following a final centrifugation step, the cell 
pellet was resuspended in 5 ml of growth media consisting of HuMEC Ready Medium 
(Life Technologies, Grand Island, NY) supplemented with penicillin (60 μg/ml), 
streptomycin (200 μg/ml), gentamycin (120 μg/ml), nystatin (50 μg/ml), and 10% fetal 
bovine serum, and seeded into a T-25 culture flask. Cells were incubated at 38.5°C with 
5% CO2. After 12-18 hours, media was exchanged for FBS-free growth media. Media 
was changed every 2-3 days thereafter. 
 Cells were passaged when confluency was reached using trypsin 0.05%/EDTA 
0.02% (Sigma-Aldrich, St. Louis, MO). Cells were maintained to the third passage, at 
which point LPS challenge was carried out. 
 
Cell lineage verification 
Verification of epithelial and mesenchymal lineage of bMEC was achieved using 
observation of cell morphology and expression of keratin 8 (KER8). Observations of cell 
morphology were made at P0 and subsequent passages using phase-contrast microscopy. 
Colonies that demonstrated a cobblestone pattern comprised of polygonal cells with 
round to oval nuclei typical of epithelial cells were considered likely to be of bMEC 




determined via polymerase chain reaction (PCR). Primers were designed using 
Primer3Plus (http://primer3plus.com/cgi-bin/dev/primer3plus.cgi) based on NCBI 
reference sequence NM_001033610.1 and were as follows: forward primer 
AATCAAGTATGAGGAGCTGC; reverse primer CATCCTTAACAGCCATCTCA. 
Polymerase chain reactions were: initial denaturation at 98˚C for 30 seconds followed by 
32 cycles of 98˚C for 10 seconds, 57 ˚C for 15 seconds, and 72˚C for 30 seconds. Gel 
electrophoresis was used to confirm the presence of PCR product. Sequencing of PCR 
product to confirm KER8 amplification was carried out by the Center for Integrated 
Biotechnology, Utah State University (Logan, UT). 
 
PLA2 treatment, LPS challenge, and RNA isolation 
Each cell line was split into four treatment groups at the second to third passage: 
unchallenged, LPS-challenged, unchallenged with PLA2 treatment, and LPS-challenged 
with PLA2 treatment. Third-passage bMEC were exposed to LPS from Escherichia coli 
to mimic exposure to a mastitis-causing pathogen. Lipopolysaccharide challenge methods 
were similar to those described previously [173], with some modifications. Briefly, once 
50-100% confluency was reached, media was exchanged for growth media with or 
without 50 µg/ml LPS from Escherichia coli (Sigma) and/or 50 µg/ml PLA2G1B from 
bovine pancreas (product P8913, Sigma-Aldrich, St. Louis, MO). Cells were incubated at 
culture conditions for 6 hours, after which media was removed. Cells were immediately 
lysed, and total RNA was isolated and purified using the Purelink RNA isolation kit (Life 




determined using the BioAnalyzer (Agilent Technologies, Santa Clara, CA). 
Complimentary DNA was generated using the SuperScript® VILOTM cDNA Synthesis 
Kit (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions, with RT-
PCR conditions as follows: primer annealing at 25˚C for 10 minutes, reverse transcription 
at 42˚C for 1 hour, and enzyme inactivation at 85˚C for 5 minutes. 
 
Quantitative PCR for gene expression 
Relative expression of 13 genes related to inflammation were assessed via 
quantitative PCR (qPCR). Genes were selected based on known roles in inflammation 
and/or bovine mastitis and included Toll-like receptor 4 (TLR4), Interleukin-6 (IL6), 
IL33, IL8, IL1α, IL1β, IL2 receptor subunit gamma (IL2RG), IL1 receptor antagonist 
(IL1RN), IL1 receptor type 1 (IL1R1), C-X-C motif chemokine ligand 5 (CXCL5), 
CXCL8, C-C motif chemokine receptor 2 (CCR2), C-C motif chemokine ligand 20 
(CCL20), and chemokine (C-X-C motif) ligand 1 (GRO1). GAPDH was used as a 
reference gene. Primers were designed using Primer3Plus (http://primer3plus.com/cgi-
bin/dev/primer3plus.cgi) and are shown in Table 10. Efficiency of all primers was 
between 80-110%. 
Quantitative PCR was performed by the Utah State University Center for 
Integrated Technology (Logan, UT) using Fluidigm Biomark technology and EvaGreen 
detection chemistry. The ΔΔCt normalization method was used for relative quantification 
as implemented by Fluidigm Real-Time PCR Analysis software, using GAPDH as a 




statistical software, Version 9.4, using the “proc mixed” command. Comparisons in 
expression of the 13 genes were made between bMEC from the four treatment groups in 




 Primary bMEC lines were established from 12 cattle. The cellular morphology of 
all cell lines was consistent with epithelial cells on monolayer culture, and all cell lines 
expressed KER8 as determined by PCR. Quality of RNA for all cell lines had an RIN 
>7.0. 
 
Effects of PLA2 on proinflammatory gene expression by bMECs 
  In order to investigate the effects of endogenously administered PLA2 on bMEC 
inflammatory responses, we compared the expression of 13 pro-inflammatory genes by 
bMECs with and without treatment with PLA2 under unchallenged conditions and 
following LPS challenge. These results are shown in Table 11. 
None of the 14 genes were significantly differentially expressed between 
unchallenged, PLA2-treated bMECs versus unchallenged, untreated bMECs. Four of the 
13 genes were significantly differentially expressed between unchallenged and LPS-
challenged cell lines with no PLA2 treatment. These were CCL20, IL8, IL1B, and GRO1. 




these genes, CCL20 and IL1B, were also downregulated in PLA2 treated, LPS-
challenged bMEC compared with PLA2 treated, unchallenged bMEC. 
Based on these findings, exogenous PLA2 treatment does not affect constitutive 
expression of pro-inflammatory genes by bMECs. However, PLA2 has a dampening 
effect on the responses of bMECs to LPS, as indicated by a lack of differential IL8 and 
GRO1 expression responses by PLA2-treated bMECs in contrast to untreated bMECs.  
 
Discussion 
 The actions of sPLA2 in inflammation are complex, comprising both stimulatory 
and inhibitory effects on other inflammatory factors, and vary by species as well as 
tissue. We demonstrate an effect of exogenous PLA2 on pro-inflammatory gene 
expression by primary bMECs following LPS challenge but not on constitutive 
expression of these genes. Unexpectedly, several pro-inflammatory cytokines were 
downregulated in primary bMECs as a result of LPS challenge. Both IL1B and CCL20 
were downregulated regardless of PLA2 treatment. Two additional genes, IL8 and 
GRO1, were downregulated only in bMECs that were not treated with PLA2. 
The chemokine ligand CCL20, also known as macrophage inflammatory protein 
3-alpha, is involved in leukocyte migration and formation of ectopic lymphoid tissue 
during inflammation [238] as well as possessing antimicrobial activity [239]. The 
presence of CCL20 has been demonstrated in human milk early in lactation [240], 
indicating a potential role in mammary gland defenses. In cattle, upregulation of CCL20 




challenge [241]. Although little information is available on the expression of CCL20 in 
the bovine mammary gland, our study demonstrates basal expression of CCL20 by 
primary bMECs as well as its downregulation by LPS challenge, regardless of the 
presence of exogenous PLA2. 
Interleukin 1B is a pro-inflammatory cytokine present in the bovine mammary 
gland during the acute stages of mastitis caused by a number of mastitis pathogens 
[195,221,222] and is involved in neutrophil chemotaxis and adhesion [220]. Our findings 
indicate that the expression of IL1B by bMECs is not affected by exogenous PLA2. 
Downregulation of IL8 did not occur following LPS challenge in PLA2-treated 
bMECs, in contrast to untreated bMECs. Interleukin-8 is a pro-inflammatory chemokine 
involved in neutrophil chemotaxis and activation [181]. During acute bovine mastitis, 
neutrophils are the major effector leukocyte [242]. Interleukin-8 is upregulated in the 
mammary gland during mastitis [195,243] and in bMECs in vitro in response to mastitis 
pathogens [157,244]. Correlations between PLA2 and IL8 levels may exist in some 
tissues during inflammatory diseases. For example, suppression of PLA2-II during 
pancreatitis in rats resulted in decreased serum levels of IL8 and other pro-inflammatory 
cytokines [245]. Studies investigating a potential similar correlation are lacking in bovine 
mammary tissue. Our results show that exposure to increased levels of PLA2 via 
exogenous administration may affect IL8 expression by bMECs following LPS 
challenge. However, PLA2 treatment alone, in the absence of LPS, was not sufficient to 




Similarly, downregulation of GRO1 in responses to LPS challenge was prevented 
by treatment with PLA2. Chemokine (C-X-C motif) ligand 1 is a neutrophil-specific 
chemoattractant [246]. Upregulation of GRO1 has been demonstrated in the bovine 
mammary gland during mastitis [247] and in a murine model of bovine mastitis following 
LPS challenge [248]. Similar to IL8, GRO1 appears to be an important factor in in 
neutrophil chemotaxis during bovine mastitis and its expression by primary bMECs 
following LPS challenge is influenced by treatment with exogenous PLA2. 
Our findings show that exogenous PLA2 affects the expression of two neutrophil 
chemotactic factors, IL8 and GRO1, by primary bMECs. Further studies are needed in 
order to demonstrate whether exogenous PLA2 has an overall pro- or anti-inflammatory 
effect on bMECs and other bovine mammary gland cell types and the bovine mammary 
gland in vivo. 
 
Conclusions 
 This study provides preliminary evidence that exogenously-administered PLA2 
may affect the inflammatory responses of the bovine mammary gland. We demonstrated 
downregulation of four pro-inflammatory genes following LPS challenge in primary 
bMECs. In contrast, bMECs that were concurrently treated with PLA2 demonstrated 
downregulation of only two of these genes, CCL20 and IL1B. Future studies are needed 
to investigate the effects of exogenous PLA2 on the expression of additional 





Table 10: Primers used for qPCR. 
Symbol Gene Primer Sequence NCBI sequence      
CCL20 C-C motif chemokine 
ligand 20 




     
CCR2 C-C motif chemokine 
receptor 2 





     
CXCL5 C-X-C motif chemokine 
ligand 5 




     
CXCL8 Interleukin 8 F AAACACATTCCACACCTTTC NM_173925.2   
R TCTTCACAAATACCTGCACA 
 
     
GRO1 chemokine (C-X-C motif) 
ligand 1 




     
IL1A Interleukin 1 alpha F GAAGAGGATTCTCAGCTTCC NM_174092.1   
R GATGGGCAACTGATTTGAAG 
 
     
IL1B Interleukin 1 beta F CTTGGGTATCAAGGACAAGA NM_174093.1   
R TGAGAAGTGCTGATGTACCA 
 
     
IL1R1 Interleukin 1 receptor 
type 1 




     
IL1RN Interleukin 1 receptor 
antagonist 




     
IL2RG Interleukin 2 receptor 
subunit gamma 




     
IL33 Interleukin 33 F CAACCAAGAGAAAGACAAGG NM_001075297.1   
R CTCCACAGAGTGCTCCTTAC 
 
     
IL6 Interleukin 6 F ACTGCTGGTCTTCTGGAGTA NM_173923.2   
R CTTTACCCACTCGTTTGAAG 
 
     
TLR4 Toll-like receptor 4 F GCATGGAGCTGAATCTCTAC NM_174198.6   
R ATAGGGTTTCCCGTCAGTAT 
 




Table 11: Genes downregulated following LPS challenge in untreated and PLA2-treated 
bMECs. P-values are shown. 
Symbol Gene P-value SE     
Untreated bMECs 
  
IL1B Interleukin-1 beta <0.0001 0.7311 
IL8 Interleukin-8 0.0272 1.0043 
CCL20 C-C motif chemokine ligand 20 <0.0001 1.0126 
GRO1 
chemokine (C-X-C motif) ligand 
1 
0.0084 0.8879 
    
PLA2-treated bMECs 
  
IL1B Interleukin-1 beta <0.0001 0.7311 
CCL20 C-C motif chemokine ligand 20 <0.0001 1.0126 








ESTABLISHMENT OF A MILK-DERIVED BOVINE MAMMARY EPITHELIAL 
CELL LINE WITH EXTENDED GROWTH CAPABILITIES BY TRANSFECTION 




 Primary bovine mammary epithelial cells (bMECs) have been used as models of 
bovine mammary gland immunity and milk production. However, challenges associated 
with the establishment and maintenance of primary bMECs from bovine milk may limit 
their use in some studies that require long-term cell line maintenance or large numbers of 
cells. Immortalization can facilitate long-term growth of primary bMECs and thereby 
improve their versatility. In order to create an immortalized bMEC line, we established 
milk-derived primary bMECs and transfected them with a plasmid containing Simian 
Virus large T antigen (SV40 L Tag), a protein known to facilitate cell cycle progression 
and reduce apoptosis and a well-established method of primary cell immortalization. The 
transfected cell line was grown through passage 27 (P27), at which time it was 
cryopreserved, with morphologic characteristics of cellular senescence not evident in any 
cells after P9. In contrast, all cells in a non-transfected bMEC line established from the 
same initial isolation exhibited morphologic characteristics of cellular senescence and 
complete cessation of division by P11. Cellular morphologic characteristics and 




line could provide a valuable model of the bovine mammary gland with the advantage 
over primary bMECs of continued growth. Our establishment of an immortalized bMEC 
line derived from bovine milk is unique, and the methods described here could be used in 
studies that require the use of continuous cell lines from multiple cows. 
 
Background 
Bovine mammary epithelial cells (bMECs) are the milk-producing cells of the 
mammary gland, and are also important contributors to innate immunity. Primary bMECs 
provide an alternative to animal-based studies within a controlled environment, and have 
been used as a model for milk synthesis and secretion [249],the response of the mammary 
gland to mastitis-causing pathogens [250], and factors influencing mastitis susceptibility 
[204]. 
Primary bMECs may be established from explant culture or bovine milk. 
Establishment of bMECs from bovine milk provides several advantages over explant 
culture, including a decreased risk of contamination by other cell types, facilitation of 
bMEC line establishment from large numbers of animals, and decreased cost [177]. An 
additional advantage of this method that it is non-invasive, minimizing animal pain and 
distress as compared with biopsy explant methods and eliminating the need for 
euthanasia as required by explant methods using postmortem tissue. These principles are 
in keeping with the American Veterinary Medical Association’s policy on the use of 




However, a major limitation of milk-derived bMEC establishment is the low 
number of cells that can be obtained as compared with explant methods, limiting the use 
of this technique in studies that require large numbers of cells [177]. In our experience, 
many milk-derived bMEC lines rapidly undergo cellular senescence and a cessation of 
division at a low passage number (unpublished data), allowing for only a low number of 
population doublings before growth has ceased. Immortalization of primary cell lines 
provides a tool by which the division potential of cell lines can be extended. As this 
immortalization using SV40 L Tag has been proven in explant-derived bMECs 
[196,251], we chose to use this method for immortalization of milk-derived bMECs. 
In nature, the SV40 L Tag protein, produced by a simian polyomavirus, promotes 
survival and replication of the virus via increasing proliferative potential and decreasing 
apoptosis of infected host cells. Host cell expression of SV40 L Tag can result in 
tumorigenesis in vivo, and cell line immortalization in vivo [252] through alteration of the 
function of tumor suppressor and cell cycle regulatory proteins and suppression of 
apoptosis [253]. 
SV40 large T antigen affects the function of retinoblastoma proteins pRB, p107, 
and p130. In the normal cell, pRB proteins serve as a block to progression from the G1 to 
S phase of the cell cycle by binding in their hypophosphorylated state to members of the 
E2F transcription factor family, preventing E2F-mediated transcription. This block is 
lifted in the presence of cyclins E/cdk2 and D1/cdk4, which induce hyperphosphorylation 
of pRB proteins and concurrent release of E2F. The SV40 large T antigen induces release 




hypophosphorylated state, thereby sequestering the proteins so they are unavailable for 
binding to E2F. Additionally, SV40 large T antigen promotes dissociation of p130 from 
E2F-4 as well as degradation of p130 [6,252]. 
The SV40 large T antigen additionally affects p53, a tumor suppressor protein.  In 
the normal cell, p53 levels increase in response to stimuli indicative of cellular damage, 
such as when DNA damage occurs. As a transcription factor, p53 promotes transcription 
of a number of genes involved in cell cycle arrest and apoptosis, thus preventing 
damaged cells from replicating. Important genes involved include p21, bax, cyclin G1, 
and mdm2. The SV40 large T antigen, however, is hypothesized to interfere with p53-
dependent transcription via binding to p53, which results in an inability of p53 to bind 
DNA as well as preventing its degradation via the ubiquitin pathway [253]. 
Another effect of the SV40 large T antigen is through its effects on p300 and 
CREB-binding protein (CBP). In the normal cell, these proteins interact with p53, mdm2, 
and the NFƙB p65 subunit, contributing to a number of effects including p53-dependent 
transcription and degradation of p53. Additionally, CPB/p300 is known to interact with 
the E2F-1 transcription factor, increasing its transcriptional activity of factors promoting 
cell cycle progression. The SV40 large T antigen binds CPB and p300, possibly in 
association with p53, which may facilitate E2F-mediated transcription as well as 
inhibition of p53 degradation. SV40 large T antigen has also been shown to bind p400, a 
protein similar in structure to p300 and CPB, although the exact function of this protein 





Finally, SV40 large T antigen has anti-apoptotic effects due to a partial structural 
homology with the bcl-2 family’s BH1 domain. The BH1 domain is integral to the anti-
apoptotic activity of the bcl-2 proteins mainly through interaction with pro-apoptotic 
proteins Bax and Bak [254]. Additional mechanisms of SV40 large T antigen-induced 
transformation and immortalization remain to be fully defined. 
Here, we describe the method by which we created an immortalized bMEC line 
by transfecting an SV40 L Tag-containing plasmid into first-passage bMECs isolated 
from the milk of a Holstein dairy cow. This cell line was grown through passage 27 (P27) 
before cryopreservation, with no morphologic evidence of cellular senescence. Although 
morphologic features of this cell line were consistent with bMECs and cytokeratin 
expression was demonstrated, further investigation is needed to characterize this cell line 
for retention of specific bMEC characteristics. This bMEC line could potentially provide 
a useful model for bovine mammary gland studies. 
 
Methods and Results 
Bovine MEC collection, isolation, and establishment 
Bovine MECs were isolated from bovine milk using methods modified from those 
previously reported [39,177]. Briefly, 400 ml of bovine milk was collected into an equal 
volume of Hank’s Balanced Salt Solution (Sigma-Aldrich, St. Louis, MO) supplemented 
with penicillin (60 μg/ml), streptomycin (200 μg/ml), gentamycin (120 μg/ml), and 
nystatin (50 mg/L). Milk was subjected to a series of wash and centrifugation steps 




isolated by this method were seeded into a T-25 culture flask in growth media consisting 
of  HuMEC Ready Medium (Life Technologies, Grand Island, NY) supplemented with 
penicillin (60 μg/ml), streptomycin (200 μg/ml), gentamycin (120 μg/ml), and nystatin 
(50 μg/ml), with 10% fetal bovine serum (FBS). Cells were cultured at 38.5°C with 5% 
CO2. Growth media was changed after 12 hours and every 2-3 days thereafter. 
Cells were passaged after large, coalescing colonies had formed using trypsin 
0.05%/EDTA 0.02% (Sigma-Aldrich, St. Louis, MO). Growth media was removed and 
cells rinsed with one ml of wash media. One ml of trypsin solution was added and the 
culture flask returned to the incubator. Every five minutes, cell lines were observed by 
phase-contrast light microscopy for cell detachment. After the majority of cells had 
detached, the trypsin solution with suspended cells was removed, added to an equal 
volume of growth media, and centrifuged at 2000 rpm for three minutes. The supernatant 
was discarded and the cell pellet re-suspended in one ml of growth media, split, and 
seeded into 2 T-25 flasks. After reaching confluency, bMECs were trypsinized as 
described, with one flask used for transfection (transfected line) as described below and 
the other seeded directly into a new T-25 flask (non-transfected line). Cultures were 
passaged once 70-100% confluency was reached in all subsequent passages. For all 
passages in non-transfected bMECs and up to P16 in transfected bMECs, trypsinized cells 
were seeded at a 1:2 or 1:3 dilution. At P16, transfected bMECs were seeded at a 1:6 






Transfection of bMECs with SV40 L Tag 
 Bovine MECs were immortalized by transfection with a plasmid construct 
containing the SV40 L Tag amino acids 109-708 (SV40 1:pBSSVD2005, Addgene 
plasmid # 21826, David Ron) and an ampicillin resistance gene, provided within 
transformed bacteria in an agar stab preparation. Bacteria were plated onto lysogeny 
broth (LB) agar containing ampicillin. After incubation at 37°C for 12 hours, a single 
bacterial colony was transferred to vial containing 50 ml of LB and incubated at 37°C for 
a further 12 hours. Bacteria were pelleted by centrifugation at 4.4 rpm for 6 minutes and 
the supernatant discarded. Plasmids were isolated from bacteria using the QIAGEN 
Plasmid Plus Midi Prep kit (QIAGEN, Hilden, Germany). 
 First-passage bMECs were transfected with the SV40 1:pBSSVD2005 plasmid 
using the Amaxa 4D-Nucleofector kit (Lonza) and 4D-Nucleofector X Unit (Lonza) 
according to the Amaxa 4D-Nucleofector protocol for transfection of human mammary 
epithelial cells in suspension. Following trypsinization, approximately 5,000,000 cells 
were used for transfection with 5 µg of plasmid. Following transfection, cells were re-
suspended in growth media and returned to culture conditions. 
 
Cryopreservation of P27 transfected bMECs 
Following detachment of bMECs and centrifugation during trypsinization as 
described, cell pellets were re-suspended in one ml of growth media with 10% dimethyl 
sulfoxide and transferred to two 2-ml capacity cryopreservation tubes. The 




reaching -80°C. After 24 hours, cryopreservation tubes were transferred to a liquid 
nitrogen storage unit for long-term storage. 
 
Cell characterization and growth 
Verification of epithelial origin of the cultured cells was achieved through 
observations of cellular and colony morphology and cytokeratin expression. 
Cytokeratin expression was verified by immunocytochemistry in the transfected 
(P21) and non-transfected (P2) cell lines using a monoclonal mouse anti-human 
cytokeratin antibody (cytokeratin AE1/AE3, product M3515, Dako, Glostrup, Denmark) 
and an anti-mouse secondary antibody (Mouse-On-Farma AP-Polymer, product 
BRR4010, Biocare Medical, Concord, CA), with IP Warp Red chromogen (product 
IPK5024, Biocare Medical) and IP FLX hematoxylin counterstain (IPCS5006, Biocare 
Medical). Immunocytochemistry was carried out by the Utah Veterinary Diagnostic 
Laboratory (Logan, UT). Both cell lines exhibited cytokeratin expression in the majority 
of cells (Figure 2). 
Observations of cell colony morphology were made at P0 and subsequent 
passages using phase-contrast microscopy. At all passages, both cell lines demonstrated 
colony and individual cell morphology consistent with MECs on monolayer [207]. Two 
types of cells were recognized, consistent with morphology of milk-derived bMECs 
described previously [177]. The first type was characterized by small to moderate 
amounts of cytoplasm and formation of colonies. Individualized, squamous-like cells 




Characteristics of the second cell type were considered indicative of cellular senescence, 
as these cells exhibited no further division. Small numbers of senescent cells were 
observed at P0 to P9 in transfected bMECs but not thereafter. Small to moderate numbers 
of senescent cells were observed in non-transfected bMECs at P0 to P7. In subsequent 
passages, senescent cells predominated, and comprised all cells at P11. After 30 days at 
P11 with no growth observed, this cell line was terminated. The continued growth of 
transfected cells with a lack of senescent cells after P9 suggests that immortalization was 
successful in removing blocks to cell cycle progression, in contrast with non-transfected 
cells that all underwent senescence by P11 (Figure 3). Our laboratory has established 
numerous additional non-transfected bMEC lines by the methods described here, all of 
which underwent senescence at P10 or earlier (unpublished data). 
No steps were undertaken to verify SV40 L Tag expression in the transfected cell 
line to verify this mechanism as responsible for the continued growth observed. Non-
transfected bMECs were not subjected to sham transfection; therefore, we cannot rule out 
the possibility that continued growth was the result of the transfection process itself 
rather than SV40 L Tag expression. Nevertheless, promotion of cell cycle progression 
through expression of SV40 L Tag is considered most likely. 
 
Conclusions 
 We established a milk-derived bMEC line with extended growth by transfection 
with an SV40 L Tag-containing plasmid. This cell line was successfully grown to 




passages and cytokeratin expression demonstrated at P21. In contrast, a non-transfected 
bMEC line established from the same cell line split after P1 ceased further growth and 
exhibited cellular morphology consistent with cellular senescence at P11. Further 
characterization is needed on this cell line to determine whether characteristics of bMECs 
besides cytokeratin expression are preserved, to verify the expression of SV40 L Tag, and 
to determine whether growth is continuous after P27. With further characterization, this 





Figure 2: Cytokeratin expression among non-immortalized (A) and immortalized (B) 
bMECs. In both bMEC lines, the majority of cells are cytokeratin-positive. Monoclonal 




Figure 3: Growth rates of transfected and non-transfected bMEC lines from P2 to P22. 
Transfection with the SV40 L Tag-containing plasmid in the immortalized line occurred 


































Bovine mastitis results in substantial economic losses to the dairy industry 
worldwide and presents considerable animal welfare issues. As such, the development of 
strategies to decrease the prevalence of mastitis among dairy cattle is a major focus in the 
field of dairy science. Additionally, novel therapeutic approaches are needed in order to 
overcome problems associated with reliance on antibiotics as a treatment for mastitis. A 
genetic basis for mastitis resistance has previously been demonstrated. Despite relatively 
low heritability of some individual mastitis traits, genomic-based approaches to 
decreasing mastitis incidence among dairy cattle have proven effective and valuable. The 
application of genetics to guide mastitis prevention strategies relies on the identification 
of robust genetic markers of mastitis resistance as well as an understanding of the 
mechanisms underlying the relevant genetic factors. 
My dissertation research identified single nucleotide polymorphism (SNP) genetic 
factors and quantitative trait loci of mastitis resistance in Holstein dairy cattle. In 
addition, I have demonstrated that bovine mammary epithelial cells (bMECs), the milk-
producing cells of the mammary gland, may contribute to mastitis resistance, display 
distinct responses from primary bovine fibroblasts (bFs), and respond to exogenously-
administered phospholipase A2 (PLA2) through differential expression of pro-




derived primary bMECs with extended division potential through transfection with a viral 
protein. 
Through a genome-wide association study (GWAS) using a selective genotyping 
approach and a single-locus mixed model (SLMM), I identified 117 SNPs suggestive of 
genome-wide significance for mastitis resistance. From these 117 SNPs, I identified 27 
quantitative trait loci (QTLs) potentially associated with mastitis resistance, including ten 
QTLs that have not been reported previously. The remaining QTLs overlap with 
previously identified QTLs of mastitis or udder conformation traits, including several 
QTLS for teat length, suggesting that this trait is potentially important in mastitis 
resistance. Additionally, I identified a candidate gene, RAS guanyl releasing Protein 1, 
which may be involved in bovine mastitis and is overlapped by a SNP suggestive of 
genome-wide association in this study. The cows used in this study were rigorously 
phenotypically characterized using multiple measures of intramammary infection status 
over an eight-month period. Identification of the most mastitis-resistant and mastitis-
susceptible animals within the sample population for use in a selective genotyping 
approach GWAS may have facilitated identification of the ten novel QTLs. 
A subset of the cattle genotyped in the GWAS were selected for establishment of 
milk-derived primary bMECs. I used a polymerase chain reaction (PCR) array covering 
84 bovine genes relevant to inflammation to examine inflammatory responses of bMEC 
from mastitis-resistant and mastitis-susceptible cattle. The constitutive expression of 
these 84 genes did not differ between bMECs from mastitis-resistant and mastitis-




mastitis-resistant bMECs demonstrated differential regulation of 43 genes, while mastitis-
susceptible bMECs demonstrated differential regulation of one gene only. This gene, 
chemokine (C-X-C motif) ligand 5, was upregulated in both groups and is involved in 
neutrophil chemotaxis and activation. The differences observed between mastitis-
resistant and mastitis-susceptible bMECs in this study suggest that rapid differential 
expression of inflammatory genes by bMECs in response to inflammatory stimuli may 
comprise one mechanism of mastitis resistance in cattle. 
To compare the expression of bMEC and bFs, two cell types present in the 
mammary gland, I examined the expression of 13 pro-inflammatory genes by primary 
bMECs and bFs isolated from the same cattle. These two cell types display differences in 
the constitutive expression of six of these genes. As a result of LPS challenge, both cell 
types upregulated interleukin-1β, while only bMECs upregulated C-C motif chemokine 
ligand 20. Thus, both similarities and differences exist in the responses of these two cell 
types to inflammatory stimuli. Because challenges exist in the establishment and 
maintenance of primary bMECs, the use of primary bFs could be considered for some but 
not all types of bovine mastitis studies. 
Phospholipase A2 is an enzyme involved in generation of inflammatory mediators 
in mammalian tissues. I demonstrated that PLA2 influences the expression of pro-
inflammatory genes by primary bMECs, reducing their responsiveness to LPS. Whereas 
four pro-inflammatory genes out of 13 examined were differentially regulated following 
LPS challenge in untreated cells, only two of these genes were differentially regulated 




This finding highlights PLA2 as a candidate for future studies to investigate its potential 
effects on mastitis severity in cattle. 
Cessation of primary bMEC division at early passage numbers presents a major 
limitation to their use in some studies requiring large numbers of cells or long-term 
maintenance. I describe the establishment of a milk-derived bMEC line with extended 
division potential through transfection with simian virus large T antigen (SV40 L Tag), a 
protein known to influence progression of the cell cycle and apoptosis. This bMEC line 
demonstrated continued division that far exceeded that of a non-transfected line derived 
from the same animal, with continued division and an absence of morphologic evidence 
of cellular senescence through passage 27 as compared with complete cellular senescence 
by passage 11 in the non-transfected line. The methods used to establish this bMEC line, 
as well as the cell line itself, could facilitate future studies using the bMEC model. 
Collectively, the findings of this dissertation research contribute to knowledge of 
genetic factors of mastitis resistance in dairy cattle, the underlying molecular mechanisms 
that may be involved, and the use and versatility of a primary bMEC-based model for 
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[Internet]. 1998;45:65–71. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/9557128 
13. Fox LK, Gay JM. Contagious mastitis. Vet. Clin. North Am. Food Anim. Pract. 
[Internet]. 1993 [cited 2017 Mar 22];9:475–87. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/8242453 
14. Bennett RH, Jasper DE. Bovine Mycoplasma mastitis from intramammary 
inoculation of small numbers of Mycoplasma bovis: Microbiology and pathology. Vet. 
Microbiol. 1977;2:341–55.  
15. Pinzón-Sánchez C, Ruegg P. Risk factors associated with short-term post-treatment 
outcomes of clinical mastitis. J. Dairy Sci. [Internet]. 2011 [cited 2017 Mar 20];94:3397–
410. Available from: http://ac.els-cdn.com/S002203021100333X/1-s2.0-
S002203021100333X-main.pdf?_tid=e46855fc-0d7e-11e7-9d85-
00000aacb362&acdnat=1490022610_4fde8153d785e2150f36d228e3be64e8 
16. Renau JK. Effective Use of Dairy Herd Improvement Somatic Cell Counts in Mastitis 
Control. J. Dairy Sci. 1986;69:1708–1720.  




Staphylococcus aureus or coagulase-negative staphylococci intramammary infection 
during the first month of lactation on somatic cell count and milk yield in heifers. J. Dairy 
Sci. [Internet]. 2010 [cited 2017 Mar 20];93:2989–97. Available from: 
http://linkinghub.elsevier.com/retrieve/pii/S0022030210003085 
18. Kamal RM, Bayoumi MA, Abd El Aal SFA. Correlation between some direct and 
indirect tests for screen detection of subclinical mastitis. Int. Food Res. J. [Internet]. 2014 
[cited 2017 Mar 20];21:1249–54. Available from: http://www.ifrj.upm.edu.my/21 (03) 
2014/59 IFRJ 21 (03) 2014 Abd El 648.pdf 
19. Koskinen MT, Wellenberg GJ, Sampimon OC, Holopainen J, Rothkamp A, Salmikivi 
L, et al. Field comparison of real-time polymerase chain reaction and bacterial culture for 
identification of bovine mastitis bacteria. J. Dairy Sci. [Internet]. 2010 [cited 2017 Mar 
20];93:5707–15. Available from: http://ac.els-cdn.com/S002203021000620X/1-s2.0-
S002203021000620X-main.pdf?_tid=4dc9c0be-0d82-11e7-a9b7-
00000aab0f27&acdnat=1490024076_34d23c9d2e181426b695dec94ceabc48 
20. Viguier C, Arora S, Gilmartin N, Welbeck K, O’Kennedy R. Mastitis detection: 
current trends and future perspectives [Internet]. Trends Biotechnol. 2009 [cited 2017 
Mar 23]. p. 486–93. Available from: http://ac.els-cdn.com/S0167779909001127/1-s2.0-
S0167779909001127-main.pdf?_tid=1120876e-0fdb-11e7-9f6a-
00000aacb35d&acdnat=1490282101_075698f3c099dcb95a243dea34426b7d 
21. Schukken YH, Günther J, Fitzpatrick J, Fontaine MC, Goetze L, Holst O, et al. Host-




Immunopathol. 2011;144:270–89.  
22. Burvenich C, Bannerman DD, Lippolis JD, Peelman L, Nonnecke BJ, Kehrli ME, et 
al. Cumulative Physiological Events Influence the Inflammatory Response of the Bovine 
Udder to Escherichia coli Infections During the Transition Period. J. Dairy Sci. [Internet]. 
BioMed Central; 2007 [cited 2016 Dec 27];90:E39–54. Available from: 
http://linkinghub.elsevier.com/retrieve/pii/S0022030207720593 
23. Bean A, Williamson J, Cursons RT. Virulence Genes of Escherichia coli Strains 
Isolated from Mastitic Milk. J. Vet. Med. Ser. B [Internet]. 2004 [cited 2017 Jan 
31];51:285–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15458491 
24. Wellnitz O, Bruckmaier RM. The innate immune response of the bovine mammary 
gland to bacterial infection. Vet. J. 2012. p. 148–52.  
25. Burvenich C, Van Merris V, Mehrzad J, Diez-Fraile A, Duchateau L. Severity of E. 
coli mastitis is mainly determined by cow factors [Internet]. Vet. Res. 2003 [cited 2017 
Feb 1]. p. 521–64. Available from: https://hal.archives-ouvertes.fr/hal-00902764 
26. Sordillo LM, Campos M, Babiuk LA, Campos M, Rossi CR, Campos M, et al. 
Antibacterial activity of bovine mammary gland lymphocytes following treatment with 
interleukin-2. J. Dairy Sci. [Internet]. Elsevier; 1991 [cited 2016 Dec 27];74:3370–5. 
Available from: http://www.ncbi.nlm.nih.gov/pubmed/1744266 
27. Shuster DE, Lee EK, Kehrli ME. Bacterial growth, inflammatory cytokine 




after calving, compared with cows at midlactation. Am. J. Vet. Res. [Internet]. 1996 
[cited 2017 Mar 22];57:1569–75. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/8915431 
28. Ezzat Alnakip M, Quintela-Baluja M, Böhme K, Fernández-No I, Caamaño-Antelo S, 
Calo-Mata P, et al. The Immunology of Mammary Gland of Dairy Ruminants between 
Healthy and Inflammatory Conditions. J. Vet. Med. [Internet]. Hindawi Publishing 
Corporation; 2014 [cited 2016 Dec 1];2014:1–31. Available from: 
http://www.hindawi.com/journals/jvm/2014/659801/ 
29. Sordillo LM, Shafer-Weaver K, DeRosa D. Immunobiology of the Mammary Gland. 
J. Dairy Sci. Elsevier; 1997;80:1851–65.  
30. Rainard P, Riollet C. Innate immunity of the bovine mammary gland. Vet. Res. 2006. 
p. 369–400.  
31. Paulrud CO. Basic Concepts of the Bovine Teat Canal. Vet. Res. Commun. 
2005;29:215–45.  
32. Witzel DA. Rhythmic Contractions of the Teat Sphincter in the Bovine. J. Dairy Sci. 
[Internet]. 2016 [cited 2017 Jan 31];48:251–2. Available from: 
http://dx.doi.org/10.3168/jds.S0022-0302(65)88208-X 
33. Mehrzad J, Desrosiers C, Lauzon K, Robitaille G, Zhao X, Lacasse P. Proteases 
Involved in Mammary Tissue Damage During Endotoxin-Induced Mastitis in Dairy 






34. Peeler EJ, Green MJ, Fitzpatrick JL, Morgan KL, Green LE. Risk Factors Associated 
with Clinical Mastitis in Low Somatic Cell Count British Dairy Herds. J. Dairy Sci. 
[Internet]. 2000 [cited 2017 Feb 1];83:2464–72. Available from: 
http://linkinghub.elsevier.com/retrieve/pii/S0022030200751381 
35. Nguyen DA, Neville MC. Tight junction regulation in the mammary gland. J. 
Mammary Gland Biol. Neoplasia [Internet]. 1998 [cited 2017 Mar 20];3:233–46. 
Available from: http://www.ncbi.nlm.nih.gov/pubmed/10819511 
36. Yang W, Zerbe H, Petzl W, Brunner RM, Günther J, Draing C, et al. Bovine TLR2 
and TLR4 properly transduce signals from Staphylococcus aureus and E. coli, but S. 
aureus fails to both activate NF-κB in mammary epithelial cells and to quickly induce 
TNFα and interleukin-8 (CXCL8) expression in the udder. Mol. Immunol. 
2008;45:1385–97.  
37. Labéta MO, Vidal K, Nores JER, Arias M, Vita N, Morgan BP, et al. Brief Definitive 
Report Innate Recognition of Bacteria in Human Milk Is Mediated by a Milk-derived 
Highly Expressed Pattern Recognition Receptor, Soluble CD14. J. Exp. Med [Internet]. 
2000 [cited 2017 Mar 19];0:1807–12. Available from: 
http://www.jem.org/cgi/current/full/191/10/1807 
38. Strandberg Y, Gray C, Vuocolo T, Donaldson L, Broadway M, Tellam R. 




bovine mammary epithelial cells. Cytokine. 2005;31:72–86.  
39. Wellnitz O, Reith P, Haas SC, Meyer HHD. Immune relevant gene expression of 
mammary epithelial cells and their influence on leukocyte chemotaxis in response to 
different mastitis pathogens. Vet. Med. (Praha). 2006;51:125–32.  
40. Ellison RT. The Effects of Lactoferrin on Gram-Negative Bacteria. Springer US; 
1994 [cited 2017 Mar 20]. p. 71–90. Available from: 
http://link.springer.com/10.1007/978-1-4615-2548-6_8 
41. Sato E, Mokudai T, Niwano Y, Kohno M. Kinetic analysis of reactive oxygen species 
generated by the in vitro reconstituted NADPH oxidase and xanthine oxidase systems. J. 
Biochem. [Internet]. Oxford University Press; 2011 [cited 2017 Mar 19];150:173–81. 
Available from: https://academic.oup.com/jb/article-lookup/doi/10.1093/jb/mvr051 
42. Sordillo LM. Factors affecting mammary gland immunity and mastitis susceptibility. 
Livest. Prod. Sci. 2005. p. 89–99.  
43. Riollet C, Rainard P, Poutrel B. Cells and cytokines in inflammatory secretions of 
bovine mammary gland. Adv. Exp. Med. Biol. [Internet]. Boston: Kluwer Academic 
Publishers; 2000 [cited 2017 Jan 31];480:247–58. Available from: 
http://link.springer.com/10.1007/0-306-46832-8_30 
44. Bokoch GM, Knaus UG. NADPH oxidases: Not just for leukocytes anymore! Trends 
Biochem. Sci. 2003. p. 502–8.  




Bovine Coliform Mastitis. J. Dairy Sci. [Internet]. 2004 [cited 2017 Mar 20];87:4150–62. 
Available from: http://linkinghub.elsevier.com/retrieve/pii/S0022030204735584 
46. Sladek Z, Rysanek D, Ryznarova H, Faldyna M. Neutrophil apoptosis during 
experimentally induced Staphylococcus aureus mastitis. 629 Vet. Res [Internet]. 2005 
[cited 2017 Mar 20];36:629–43. Available from: 
http://www.vetres.org/articles/vetres/pdf/2005/04/v4075.pdf 
47. Akers RM, Nickerson SC. Mastitis and its impact on structure and function in the 
ruminant mammary gland. J. Mammary Gland Biol. Neoplasia [Internet]. Springer US; 
2011 [cited 2017 Mar 20];16:275–89. Available from: 
http://link.springer.com/10.1007/s10911-011-9231-3 
48. Aitken SL, Corl CM, Sordillo LM. Immunopathology of Mastitis: Insights into 
Disease Recognition and Resolution. J. Mammary Gland Biol. Neoplasia [Internet]. 
Springer US; 2011 [cited 2017 Mar 20];16:291–304. Available from: 
http://link.springer.com/10.1007/s10911-011-9230-4 
49. Soltys J, Quinn MT. Selective recruitment of T-cell subsets to the udder during 
staphylococcal and streptococcal mastitis: analysis of lymphocyte subsets and adhesion 
molecule expression. Infect. Immun. [Internet]. American Society for Microbiology 
(ASM); 1999 [cited 2017 Jan 31];67:6293–302. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/10569740 
50. Trevisi E, Zecconi A, Bertoni G, Piccinini R. Blood and milk immune and 




index. J. Dairy Res. [Internet]. 2010 [cited 2017 Mar 20];77:310–7. Available from: 
https://www.cambridge.org/core/services/aop-cambridge-
core/content/view/S0022029910000178 
51. Trevisi E, Amadori M, Cogrossi S, Razzuoli E, Bertoni G. Metabolic stress and 
inflammatory response in high-yielding, periparturient dairy cows. Res. Vet. Sci. 
[Internet]. 2012 [cited 2017 Mar 20];93:695–704. Available from: 
http://linkinghub.elsevier.com/retrieve/pii/S0034528811004619 
52. Wenz JR, Fox LK, Muller FJ, Rinaldi M, Zeng R, Bannerman DD, et al. Factors 
associated with concentrations of select cytokine and acute phase proteins in dairy cows 
with naturally occurring clinical mastitis. J. Dairy Sci. [Internet]. Cambridge University 
Press, New York, NY; 2010 [cited 2017 Mar 19];93:2458–70. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/20494154 
53. Waller KP. Mammary Gland Immunology Around Parturition. Biol. Mammary Gland 
[Internet]. Boston: Kluwer Academic Publishers; 2002 [cited 2017 Jan 31]. p. 231–45. 
Available from: http://link.springer.com/10.1007/0-306-46832-8_29 
54. Dego OK, van Dijk JE, Nederbragt H. Factors involved in the early pathogenesis of 
bovine Staphylococcus aureus mastitis with emphasis on bacterial adhesion and invasion. 
A review. Vet. Q. [Internet]. 2002 [cited 2017 Jan 31];24:181–98. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/12540135 
55. Zhao X, Lacasse P. Mammary tissue damage during bovine mastitis: causes and 




Nov 21]. p. 57–65. Available from: 
http://www.animalsciencepublications.org/publications/jas/abstracts/86/13/13 
56. Fogsgaard K, Løvendahl P, Bennedsgaard T, Østergaard S. Changes in milk yield, 
lactate dehydrogenase, milking frequency, and interquarter yield ratio persist for up to 8 
weeks after antibiotic treatment of mastitis. J. Dairy Sci [Internet]. 2015 [cited 2017 Mar 
22];98. Available from: http://ac.els-cdn.com/S0022030215006414/1-s2.0-
S0022030215006414-main.pdf?_tid=6eebf3d6-0f2e-11e7-9d13-
00000aacb35e&acdnat=1490207956_62ea94b8a3303d2c594020a2cd210129 
57. Urech E, Puhan Z, Schällibaum M. Changes in Milk Protein Fraction as Affected by 




58. Harmon RJ. Physiology of Mastitis and Factors Affecting Somatic Cell Counts. J. 
Dairy Sci. Elsevier; 1994;77:2103–12.  
59. Oliver SP, Calvinho LF. Influence of Inflammation on Mammary Gland Metabolism 
and Milk Composition. J. Anim. Sci. [Internet]. American Society of Animal Science; 
1995 [cited 2017 Mar 21];73:18. Available from: 
https://www.animalsciencepublications.org/publications/jas/abstracts/73/suppl_2/18 
60. Barbano DM, Ma Y, Santos MV. Influence of Raw Milk Quality on Fluid Milk Shelf 






61. Pantoja JCF, Hulland C, Ruegg PL. Dynamics of somatic cell counts and 
intramammary infections across the dry period. Prev. Vet. Med. [Internet]. Elsevier; 2009 
[cited 2017 Oct 9];90:43–54. Available from: 
http://www.sciencedirect.com/science/article/pii/S0167587709000786?via%3Dihub 
62. Harmon RJ, Anderson KL, Kindahl H, Petroni A, Smith AR, Gustafsson BK, et al. 
Physiology of mastitis and factors affecting somatic cell counts. J. Dairy Sci. [Internet]. 
Elsevier; 1994 [cited 2016 Nov 2];77:2103–12. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/7929968 
63. Deluyker HA, Gay JM, Weaver LD, Bakken G, Gudding R, Bunch K, et al. 
Interrelationships of somatic cell count, mastitis, and milk yield in a low somatic cell 
count herd. J. Dairy Sci. [Internet]. Elsevier; 1993 [cited 2016 Nov 2];76:3445–52. 
Available from: http://www.ncbi.nlm.nih.gov/pubmed/8270687 
64. Blum SE, Heller ED, Leitner G. Long term effects of Escherichia coli mastitis. Vet. J. 




65. Schultz LH. Somatic Cells in Milk-Physiological Aspects and Relationship to 




66. Quist MA, LeBlanc SJ, Hand KJ, Lazenby D, Miglior F, Kelton DF. Milking-to-
Milking Variability for Milk Yield, Fat and Protein Percentage, and Somatic Cell Count. 
J. Dairy Sci. 2008;91:3412–23.  
67. Suriyasathaporn W, Schukken YH, Nielen M, Brand A. Low Somatic Cell Count: a 
Risk Factor for Subsequent Clinical Mastitis in a Dairy Herd. J. Dairy Sci. [Internet]. 
2000 [cited 2017 Jan 31];83:1248–55. Available from: 
http://linkinghub.elsevier.com/retrieve/pii/S0022030200749915 
68. Waage S, Sviland S, Ødegaard SA. Identification of Risk Factors for Clinical Mastitis 
in Dairy Heifers. J. Dairy Sci. 1998;81:1275–84.  
69. Lago A, Godden S, Bey R, Ruegg P, Leslie K. The selective treatment of clinical 
mastitis based on on-farm culture results: I. Effects on antibiotic use, milk withholding 
time, and short-term clinical and bacteriological outcomes. J. Dairy Sci. [Internet]. 2011 




70. Chagunda MG, Larsen T, Bjerring M, Ingvartsen KL. L-lactate dehydrogenase and 
N-acetyl-beta-D-glucosaminidase activities in bovine milk as indicators of non-specific 






71. Dohoo IR, Smith J, Andersen S, Kelton DF, Godden S. Diagnosing intramammary 
infections: Evaluation of definitions based on a single milk sample. J. Dairy Sci. 
2011;94:250–61.  
72. Morris CA. A review of genetic resistance to disease in Bos taurus cattle. Vet. J. 
2007;174:481–91.  
73. Quantitative trait [Internet]. [cited 2017 Mar 23]. Available from: 
http://www.nature.com/subjects/quantitative-trait 
74. Finegold DN. Multifactorial (Complex) Inheritance [Internet]. [cited 2017 Mar 23]. 
Available from: http://www.merckmanuals.com/professional/special-subjects/general-
principles-of-medical-genetics/multifactorial-complex-inheritance 
75. Tiezzil F, Parker-Gaddis KL, Cole JB, Clay JS, Maltecca C. A genome-wide 
association study for clinical mastitis in first parity US Holstein cows using single-step 
approach and genomic matrix re-weighting procedure. PLoS One [Internet]. Public 
Library of Science; 2015 [cited 2016 Dec 27];10:e0114919. Available from: 
http://dx.plos.org/10.1371/journal.pone.0114919 
76. Barkema HW, Schukken YH, Lam TJGM, Beiboer ML, Benedictus G, Brand A. 
Management Practices Associated with the Incidence Rate of Clinical Mastitis. J. Dairy 
Sci. 1999;82:1643–54.  
77. Barnouin J, Bord S, Bazin S, Chassagne M. Dairy Management Practices Associated 




Dairy Sci. 2005;88:3700–9.  
78. Green MJ, Bradley AJ, Medley GF, Browne WJ. Cow, Farm, and Management 
Factors During the Dry Period that Determine the Rate of Clinical Mastitis After Calving. 
J. Dairy Sci. 2007;90:3764–76.  
79. Sordillo LM, Streicher KL. Mammary gland immunity and mastitis susceptibility. J. 
Mammary Gland Biol. Neoplasia [Internet]. Kluwer Academic Publishers-Plenum 
Publishers; 2002 [cited 2016 Dec 27];7:135–46. Available from: 
http://link.springer.com/10.1023/A:1020347818725 
80. Sordillo LM, Contreras GA, Aitken SL, Aitken SL, Karcher EL, Rezamand P, et al. 
Metabolic factors affecting the inflammatory response of periparturient dairy cows. 
Anim. Heal. Res. Rev. [Internet]. Cambridge University Press; 2009 [cited 2017 Feb 
1];10:53–63. Available from: 
http://www.journals.cambridge.org/abstract_S1466252309990016 
81. Govignon-Gion A, Dassonneville R, Baloche G, Ducrocq V, Carlén E, Emanuelson 
U, et al. Multiple trait genetic evaluation of clinical mastitis in three dairy cattle breeds. 
animal [Internet]. Cambridge University Press; 2016 [cited 2016 Nov 2];10:558–65. 
Available from: http://www.journals.cambridge.org/abstract_S1751731115002529 
82. Zavadilová L, Štípková M, Šebková N, Svitáková A. Genetic analysis of clinical 
mastitis data for Holstein cattle in the Czech Republic. Arch. Anim. Breed [Internet]. 





83. Koeck A, Fuerst C, Egger-Danner C. Farmer-observed health data around calving—
Genetic parameters and association with veterinarian diagnoses in Austrian Fleckvieh 
cows. J. Dairy Sci. 2015;98:2753–8.  
84. Koeck A, Loker S, Miglior F, Kelton DF, Jamrozik J, Schenkel FS. Genetic 
relationships of clinical mastitis, cystic ovaries, and lameness with milk yield and somatic 
cell score in first-lactation Canadian Holsteins. J. Dairy Sci. 2014;97:5806–13.  
85. Yin T, Bapst B, von Borstel UU, Simianer H, König S. Genetic analyses of binary 
longitudinal health data in small low input dairy cattle herds using generalized linear 
mixed models. Livest. Sci. 2014;162:31–41.  
86. Rehbein P, Brügemann K, Yin T, v. Borstel UK, Wu X-L, König S. Inferring 
relationships between clinical mastitis, productivity and fertility: A recursive model 
application including genetics, farm associated herd management, and cow-specific 
antibiotic treatments. Prev. Vet. Med. 2013;112:58–67.  
87. Windig JJ, Urioste JI, Strandberg E. Integration of epidemiology into the genetic 
analysis of mastitis in Swedish Holstein. J. Dairy Sci. 2013;96:2617–26.  
88. Haugaard K, Heringstad B, Whist AC. Genetic associations between somatic cell 
score and pathogen-specific subclinical mastitis in Norwegian Red cows. J. Anim. Breed. 
Genet. [Internet]. 2013 [cited 2016 Nov 2];130:98–105. Available from: 
http://doi.wiley.com/10.1111/jbg.12019 




of Clinical Mastitis Incidence and Relationships with Sire Transmitting Abilities for 
Somatic Cell Score, Udder Type Traits, Productive Life, and Protein Yield. J. Dairy Sci. 
Elsevier; 2000;83:2350–60.  
90. Costa CN, Santos GG, Cobuci JA, Thompson G, Carvalheira JG V. Genetic 
parameters for test day somatic cell score in Brazilian Holstein cattle. Genet. Mol. Res. 
[Internet]. 2015 [cited 2016 Nov 2];14:19117–27. Available from: 
http://www.funpecrp.com.br/gmr/year2015/vol14-4/pdf/gmr7440.pdf 
91. Rincón J, Zambrano J, Echeverri J. Estimation of genetic and phenotypic parameters 
for production traits in Holstein and Jersey from Colombia. Rev.MVZ Córdoba. 
2015;20:4962–73.  
92. Lembeye F, Lopez-Villalobos N, Burke JL, Davis SR. Estimation of genetic 
parameters for milk traits in cows milked once- or twice-daily in New Zealand. Livest. 
Sci. 2016;185:142–7.  
93. Zhao F ping, Guo G, Wang Y chun, Guo X yu, Zhang Y, Du L xin. Genetic 
parameters for somatic cell score and production traits in the first three lactations of 
Chinese Holstein cows. J. Integr. Agric. Elsevier; 2015;14:125–30.  
94. Kühn C, Reinhardt F, Schwerin M. Marker assisted selection of heifers improved 
milk somatic cell count compared to selection on conventional pedigree breeding values. 
Arch. Tierz. Dummerstorf. 2008;51:23–32.  




Taiwan. J. Obstet. Gynecol. 2009. p. 89–95.  
96. Pearson TA, Manolio TA. How to Interpret a Genome-wide Association Study. 
JAMA Stat. Res. Methods; Genet. Genet. [Internet]. 2008 [cited 2016 Nov 
2];29929911:1335–44. Available from: http://jama.ama-
assn.org/cgi/content/full/299/11/1335 
97. Vignal A, Milan D, SanCristobal M, Eggen A. A review on SNP and other types of 
molecular markers and their use in animal genetics. Genet. Sel. Evol. [Internet]. 2002 






98. Ziegler A, König IR, Thompson JR. Biostatistical Aspects of Genome-Wide 
Association Studies. Biometrical J. [Internet]. WILEY‐VCH Verlag; 2008 [cited 2016 
Nov 2];50:8–28. Available from: http://doi.wiley.com/10.1002/bimj.200710398 
99. Bush WS, Moore JH. Chapter 11: Genome-Wide Association Studies. 2012;  
100. Wu Y, Fan H, Jing S, Xia J, Chen Y, Zhang L, et al. Wu, Y., Fan, H., Jing, S., Xia, 
J., Chen, Y., Zhang, L., … Ren, H. (2015). A genome-wide scan for copy number 
variations using high-density single nucleotide polymorphism array in Simmental cattle. 




[cited 2016 Nov 2];46:289–98. Available from: http://doi.wiley.com/10.1111/age.12288 
101. Slatkin M. Linkage disequilibrium — understanding the evolutionary past and 
mapping the medical future. Nat. Rev. Genet. [Internet]. Nature Publishing Group; 2008 
[cited 2017 Feb 1];9:477–85. Available from: 
http://www.nature.com/doifinder/10.1038/nrg2361 
102. VanLiere JM, Rosenberg NA. Mathematical properties of the r2 measure of linkage 
disequilibrium. Theor. Popul. Biol. [Internet]. NIH Public Access; 2008 [cited 2017 Oct 
9];74:130–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18572214 
103. Darvasi A. The effect of selective genotyping on QTL mapping accuracy. Mamm. 
Genome [Internet]. Springer-Verlag; 1997 [cited 2017 Jan 5];8:67–8. Available from: 
http://link.springer.com/10.1007/s003359900353 
104. Guey LT, Kravic J, Melander O, Burtt NP, Laramie JM, Lyssenko V, et al. Power in 
the Phenotypic Extremes: A Simulation Study of Power in Discovery and Replication of 
Rare Variants. Genet. Epidemiol. Swedish Res. Counc. (Scania Diabetes Regist. 
2011;35:236–46.  
105. Illumina. Infinium HD Methylation Assay Protocol Guide [Internet]. 2010 [cited 
2017 Mar 24]. p. Available from: https://support.illumina.com/content/dam/illumina-
support/documents/myillumina/05340b1f-c179-495d-b790-
fa91ecbb6ff2/inf_hd_super_assay_ug_11322427_revc.pdf 




High-density SNP Arrays in Genomic Studies of Domestic Animals. Asian-Australasian 
J. Anim. Sci. [Internet]. Asian Australasian Association of Animal Production Societies; 
2010 [cited 2017 Mar 20];23:833–47. Available from: 
http://ajas.info/journal/view.php?doi=10.5713/ajas.2010.r.03 
107. Clark SA, van der Werf J. Genomic Best Linear Unbiased Prediction (gBLUP) for 
the Estimation of Genomic Breeding Values. 2013 [cited 2017 Feb 1]. p. 321–30. 
Available from: http://link.springer.com/10.1007/978-1-62703-447-0_13 
108. Mixed Linear Model Analysis — SNP & Variation Suite v8.7.0 Manual [Internet]. 
[cited 2017 Mar 23]. Available from: 
http://doc.goldenhelix.com/SVS/latest/svsmanual/mixedModelMethods/mlm_analysis.ht
ml#mixedlinearmodelanalysis 
109. Kang HM, Sul JH, Service SK, Zaitlen NA, Kong S, Freimer NB, et al. Variance 
component model to account for sample structure in genome-wide association studies. 
Nat. Genet. [Internet]. Nature Research; 2010 [cited 2017 Mar 23];42:348–54. Available 
from: http://www.nature.com/doifinder/10.1038/ng.548 
110. Segura V, Vilhjálmsson BJ, Platt A, Korte A, Seren Ü, Long Q, et al. An efficient 
multi-locus mixed-model approach for genome-wide association studies in structured 
populations. Nat. Genet. 2012;44.  
111. Hochberg Y, Benjaminit Y. Controlling the False Discovery Rate: A Practical and 
Powerful Approach to Multiple Controlling the False Discovery Rate: a Practical and 




B J. R. Stat. Soc. B [Internet]. 1995 [cited 2017 Feb 1];57:289–300. Available from: 
http://www.jstor.org/stable/2346101 
112. The International HapMap Consortium TIH. A haplotype map of the human 
genome. Nature [Internet]. Nature Publishing Group; 2005 [cited 2017 Mar 
23];437:1299–320. Available from: 
http://www.nature.com/doifinder/10.1038/nature04226 
113. Fadista J, Manning AK, Florez JC, Groop L. The (in)famous GWAS P-value 
threshold revisited and updated for low-frequency variants. Eur. J. Hum. Genet. 
[Internet]. Nature Publishing Group; 2016 [cited 2017 Mar 23];24:1–4. Available from: 
http://www.nature.com/doifinder/10.1038/ejhg.2015.269 
114. Group NW. Replicating genotype–phenotype associations. Nature [Internet]. 2007 
[cited 2017 Mar 23];447:655–60. Available from: 
http://www.nature.com/nature/journal/v447/n7145/pdf/447655a.pdf 
115. Xu Z, Taylor JA. SNPinfo: Integrating GWAS and candidate gene information into 
functional SNP selection for genetic association studies. Nucleic Acids Res. [Internet]. 









Potential etiologic and functional implications of genome-wide association loci for 
human diseases and traits. Proc. Natl. Acad. Sci. U. S. A. [Internet]. 2009 [cited 2017 
Mar 23];106:9362–7. Available from: http://www.pnas.org/content/106/23/9362.full.pdf 
117. Dekkers JCM. Commercial application of marker- and gene-assisted selection in 
livestock: Strategies and lessons. J. Anim. Sci. [Internet]. American Society of Animal 
Science; 2004 [cited 2017 Mar 24];82:E313–28. Available from: 
https://dl.sciencesocieties.org/publications/jas/articles/82/13_suppl/E313 
118. Griesbeck-Zilch B, Osman M, Kühn C, Schwerin M, Bruckmaier RH, Pfaffl MW, et 
al. Analysis of key molecules of the innate immune system in mammary epithelial cells 
isolated from marker-assisted and conventionally selected cattle. J. Dairy Sci. 
2009;92:4621–33.  
119. Hu Z-L, Park CA, Wu X-L, Reecy JM. Animal QTLdb: an improved database tool 
for livestock animal QTL/association data dissemination in the post-genome era. Nucleic 
Acids Res. [Internet]. Oxford University Press; 2013 [cited 2017 Mar 23];41:D871–9. 
Available from: https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gks1150 
120. Verbeke J, Van Poucke M, Peelman L, Piepers S, De Vliegher S. Associations 
between CXCR1 polymorphisms and pathogen-specific incidence rate of clinical 
mastitis, test-day somatic cell count, and test-day milk yield. J. Dairy Sci. [Internet]. 2014 
[cited 2017 Mar 24];97:7927–39. Available from: 
http://linkinghub.elsevier.com/retrieve/pii/S0022030214007085 




specific CXCR1 genotypes potentially related to interleukin-8 receptor functionality. 
Immunogenetics [Internet]. 2007 [cited 2017 Mar 24];59:53–8. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/17119953 
122. Leyva-Baca I, Schenkel F, Martin J, Karrow NA. Polymorphisms in the 5′ Upstream 
Region of the CXCR1 Chemokine Receptor Gene, and Their Association with Somatic 
Cell Score in Holstein Cattle in Canada. J. Dairy Sci. [Internet]. 2008 [cited 2017 Mar 
24];91:407–17. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18096965 
123. Beecher C, Daly M, Childs S, Berry DP, Magee DA, McCarthy T V, et al. 
Polymorphisms in bovine immune genes and their associations with somatic cell count 
and milk production in dairy cattle. BMC Genet. [Internet]. 2010 [cited 2017 Mar 






124. Verbeke J, Piepers S, Peelman L, Van Poucke M, De Vliegher S. Pathogen-group 
specific association between CXCR1 polymorphisms and subclinical mastitis in dairy 
heifers. J. Dairy Res. [Internet]. 2012 [cited 2017 Mar 24];79:341–51. Available from: 
http://www.journals.cambridge.org/abstract_S0022029912000349 




interleukin 8 receptor α gene (CXCR1) and mastitis in dairy cattle. Cent. J. Immunol. 
[Internet]. Termedia Publishing; 2015 [cited 2017 Mar 24];40:153–8. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/26557028 
126. Bagheri M, Moradi-Sharhrbabak M, Miraie-Ashtiani R, Safdari-Shahroudi M, 
Abdollahi-Arpanahi R. Case-control approach application for finding a relationship 
between candidate genes and clinical mastitis in Holstein dairy cattle. J. Appl. Genet. 
[Internet]. 2016 [cited 2017 Mar 24];57:107–12. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/26126595 
127. Verbeke J, Piepers S, Peelman L, Van Poucke M, De Vliegher S. Association of 
CXCR1 polymorphisms with apoptosis, necrosis and concentration of milk neutrophils in 
early lactating dairy heifers. Res. Vet. Sci. [Internet]. 2014 [cited 2017 Mar 24];97:55–9. 
Available from: http://www.ncbi.nlm.nih.gov/pubmed/24934516 
128. Wang X-P, Xu S-Z, Gao X, Li J-Y, Ren H-Y, Luoren Z-M. Cloning and SNP 
screening of the TLR4 gene and the association between its polymorphism and somatic 
cell score in dairy cattle. S. Afr. J. Anim. Sci. [Internet]. 2008 [cited 2017 Mar 24];38. 
Available from: http://www.scielo.org.za/pdf/sajas/v38n2/04.pdf 
129. Mesquita AQ de, Rezende CSM e, Mesquita AJ de, Jardim EAG da V, Kipnis APJ. 
Association of TLR4 polymorphisms with subclinical mastitis in Brazilian holsteins. 
Brazilian J. Microbiol. [Internet]. 2012 [cited 2017 Mar 24];43:692–7. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/24031881 




Correlation with Mastitis in Cattle. J. Genet. Genomics [Internet]. 2007 [cited 2017 Mar 
24];34:406–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17560526 
131. Sharma BS, Leyva I, Schenkel F, Karrow NA. Association of toll-like receptor 4 
polymorphisms with somatic cell score and lactation persistency in Holstein bulls. J. 
Dairy Sci. [Internet]. 2006 [cited 2017 Mar 24];89:3626–35. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/16899698 
132. Huang J, Liu L, Wang H, Zhang C, Ju Z, Wang C, et al. Variants and gene 
expression of the TLR2 gene and susceptibility to mastitis in cattle. Asian J. Anim. Vet. 
Adv. [Internet]. 2011 [cited 2017 Mar 24];6:51–61. Available from: 
www.academicjournals.com 
133. Zhang LP, Gan QF, Ma TH, Li HD, Wang XP, Li JY, et al. Toll-like receptor 2 gene 
polymorphism and its relationship with SCS in dairy cattle. Anim. Biotechnol. [Internet]. 
2009 [cited 2017 Mar 24];20:87–95. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/19544205 
134. Bai J, Lin J, Li W, Liu M. Association of toll-like receptor 2 polymorphisms with 
somatic cell score in Xinjiang Brown cattle. Anim. Sci. J. [Internet]. 2012 [cited 2017 
Mar 24];83:23–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22250735 
135. Pighetti GM, Elliott AA. Gene Polymorphisms: The Keys for Marker Assisted 
Selection and Unraveling Core Regulatory Pathways for Mastitis Resistance. J. 
Mammary Gland Biol. Neoplasia [Internet]. Springer US; 2011 [cited 2016 Dec 




136. Beecher C, Daly M, Berry DP, Klostermann K, Flynn J, Meaney W, et al. 
Administration of a live culture of Lactococcus lactis DPC 3147 into the bovine 
mammary gland stimulates the local host immune response, particularly IL-1β and IL-8 
gene expression. J. Dairy Res. [Internet]. Cambridge University Press; 2009 [cited 2016 
Dec 1];76:340. Available from: 
http://www.journals.cambridge.org/abstract_S0022029909004154 
137. Goldammer T, Zerbe H, Molenaar A, Schuberth H-J, Brunner RM, Kata SR, et al. 
Mastitis increases mammary mRNA abundance of beta-defensin 5, toll-like-receptor 2 
(TLR2), and TLR4 but not TLR9 in cattle. Clin. Diagn. Lab. Immunol. [Internet]. 
American Society for Microbiology; 2004 [cited 2017 Mar 24];11:174–85. Available 
from: http://www.ncbi.nlm.nih.gov/pubmed/14715566 
138. Sodeland M, Grove H, Kent M, Taylor S, Svendsen M, Hayes BJ, et al. Molecular 
characterization of a long range haplotype affecting protein yield and mastitis 
susceptibility in Norwegian Red cattle. BMC Genet. [Internet]. BioMed Central; 2011 
[cited 2016 Dec 5];12:70. Available from: 
http://bmcgenet.biomedcentral.com/articles/10.1186/1471-2156-12-70 
139. Rupp R, Boichard D. Genetic parameters for clinical mastitis, somatic cell score, 
production, udder type traits, and milking ease in first lactation Holsteins. J. Dairy Sci. 







140. Kadri NK, Guldbrandtsen B, Lund MS, Sahana G. Genetic dissection of milk yield 
traits and mastitis resistance quantitative trait loci on chromosome 20 in dairy cattle. J. 
Dairy Sci. 2015;98:9015–25.  
141. Bagheri M, Miraie-Ashtiani R, Moradi-Shahrbabak M, Nejati-Javaremi A, Pakdel 
A, von Borstel UU, et al. Selective genotyping and logistic regression analyses to identify 
favorable SNP-genotypes for clinical mastitis and production traits in Holstein dairy 
cattle. Livest. Sci. [Internet]. 2013 [cited 2017 Mar 24];151:140–51. Available from: 
http://linkinghub.elsevier.com/retrieve/pii/S1871141312004398 
142. Meredith BK, Berry DP, Kearney F, Finlay EK, Fahey AG, Bradley DG, et al. A 
genome-wide association study for somatic cell score using the Illumina high-density 
bovine beadchip identifies several novel QTL potentially related to mastitis 
susceptibility. Front. Genet. [Internet]. Frontiers Media SA; 2013 [cited 2016 Nov 
2];4:229. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24223582 
143. Holmbeg M, Andersson-Eklund L. Quantitative Trait Loci Affecting Health Traits 
in Swedish Dairy Cattle. J. Dairy Sci. 2004;87:2653–9.  
144. Wu X, Lund MS, Sahana G, Guldbrandtsen B, Sun D, Zhang Q, et al. Association 
analysis for udder health based on SNP-panel and sequence data in Danish Holsteins. 





145. Sodeland M, Kent MP, Olsen HG, Opsal MA, Svendsen M, Sehested E, et al. 
Quantitative trait loci for clinical mastitis on chromosomes 2, 6, 14 and 20 in Norwegian 
Red cattle. Anim. Genet. 2011;42:457–65.  
146. Sahana G, Guldbrandtsen B, Thomsen B, Lund MS. Confirmation and fine-mapping 
of clinical mastitis and somatic cell score QTL in Nordic Holstein cattle. Anim. Genet. 
[Internet]. 2013 [cited 2016 Dec 27];44:620–6. Available from: 
http://doi.wiley.com/10.1111/age.12053 
147. Laboratory Handbook on Bovine Mastitis. Revised. Madison, WI: National Mastitis 
Council; 1999.  
148. Wilson DJ, Bartlett PC, Kirk JH, Mellenberger RW, Mather EC. N-acetyl-beta-D-
glucosaminidase as a predictor of milk loss and recovery after clinical mastitis. Am. J. 
Vet. Res. [Internet]. 1991 [cited 2016 Nov 2];52:1110–6. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/1892265 
149. Wilson DJ, Mallard BA, Burton JL, Schukken YH, Grohn YT. Association of 
Escherichia coli J5-specific serum antibody responses with clinical mastitis outcome for 
J5 vaccinate and control dairy cattle. Clin. Vaccine Immunol. [Internet]. American 
Society for Microbiology; 2009 [cited 2016 Nov 2];16:209–17. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/19052158 
150. Gröhn YT, Wilson DJ, González RN, Hertl JA, Schulte H, Bennett G, et al. Effect of 





151. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. 
PLINK: A tool set for whole-genome association and population-based linkage analyses. 
Am. J. Hum. Genet. 2007;81:559–75.  
152. R Core Team RF for SC. R: A Language and Environment for Statistical Computing 
[Internet]. Vienna, Austria; 2016. Available from: https://www.r-project.org 
153. Zimin A V, Delcher AL, Florea L, Kelley DR, Schatz MC, Puiu D, et al. A whole-
genome assembly of the domestic cow, Bos taurus. Genome Biol. [Internet]. 2009 [cited 
2017 Mar 31];10:R42. Available from: 
http://genomebiology.biomedcentral.com/articles/10.1186/gb-2009-10-4-r42 
154. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, et al. dbSNP: 
the NCBI database of genetic variation. Nucleic Acids Res. 2001;29:308–11.  
155. Hu ZL, Park CA, Wu XL, Reecy JM. Animal QTLdb: An improved database tool 
for livestock animal QTL/association data dissemination in the post-genome era. Nucleic 
Acids Res. 2013;  
156. Bonnefont CMD, Toufeer M, Caubet C, Foulon E, Tasca C, Aurel M-R, et al. 
Transcriptomic analysis of milk somatic cells in mastitis resistant and susceptible sheep 
upon challenge with Staphylococcus epidermidis and Staphylococcus aureus. BMC 
Genomics [Internet]. 2011 [cited 2017 Apr 12];12:208. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/21527017 




Comparative expression profiling of E. coli and S. aureus inoculated primary mammary 
gland cells sampled from cows with different genetic predispositions for somatic cell 
score. Genet. Sel. Evol. [Internet]. BioMed Central; 2011 [cited 2016 Nov 14];43:24. 
Available from: http://www.gsejournal.org/content/43/1/24 
158. Ashwell MS, Heyen DW, Weller JI, Ron M, Sonstegard TS, Van Tassell CP, et al. 
Detection of quantitative trait loci influencing conformation traits and calving ease in 
Holstein-Friesian cattle. J. Dairy Sci. [Internet]. 2005 [cited 2017 Apr 12];88:4111–9. 
Available from: http://www.sciencedirect.com/science/article/pii/S0022030205730952 
159. Rupp R, Boichard D. Genetics of resistance to mastitis in dairy cattle. 671 Vet. Res. 
2003;34:671–88.  
160. Seykora AJ, McDaniel BT. Genetics statistics and relationships of teat and udder 
traits, somatic cell counts, and milk production. J. Dairy Sci. [Internet]. Elsevier; 1986 
[cited 2017 Feb 16];69:2395–407. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/3782591 
161. Detilleux JC. Genetic factors affecting susceptibility of dairy cows to udder 
pathogens. Vet. Immunol. Immunopathol. 2002;88:103–10.  
162. Santman-Berends IM, Olde Riekerink RG, Sampimon OC, van Schaik G, Lam TJ. 
Incidence of subclinical mastitis in Dutch dairy heifers in the first 100 days in lactation 
and associated risk factors. J. Dairy Sci. [Internet]. 2012 [cited 2017 Apr 11];95:2476–84. 




163. Schnabel RD, Sonstegard TS, Taylor JF, Ashwell MS. Whole-genome scan to detect 
QTL for milk production, conformation, fertility and functional traits in two US Holstein 
families. Anim. Genet. [Internet]. Blackwell Science Ltd; 2005 [cited 2017 Apr 
12];36:408–16. Available from: http://doi.wiley.com/10.1111/j.1365-2052.2005.01337.x 
164. Philipsson J, Ral G, Berglund B. Somatic cell count as a selection criterion for 
mastitis resistance in dairy cattle. Livest. Prod. Sci. [Internet]. 1995 [cited 2017 Jan 
23];41:195–200. Available from: 
http://linkinghub.elsevier.com/retrieve/pii/030162269400067H 
165. Odegård J, Klemetsdal G, Heringstad B, Beaudeau F, Fourichon C, Seegers H, et al. 
Genetic improvement of mastitis resistance: validation of somatic cell score and clinical 
mastitis as selection criteria. J. Dairy Sci. [Internet]. Elsevier; 2003 [cited 2017 Jan 
23];86:4129–36. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14740854 
166. Sears PM, Smith BS, English PB, Herer PS, Gonzalez RN. Shedding Pattern of 
Staphylococcus aureus from Bovine Intramammary Infections. J. Dairy Sci. [Internet]. 
1990 [cited 2017 Apr 12];73:2785–9. Available from: 
http://linkinghub.elsevier.com/retrieve/pii/S0022030290789643 
167. Reneau JK, Andrews RJ, Kitchen BJ, Kwee WS, Duncalfe F, Appleman RD, et al. 
Effective use of dairy herd improvement somatic cell counts in mastitis control. J. Dairy 
Sci. [Internet]. Elsevier; 1986 [cited 2016 Nov 2];69:1708–20. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/3528248 




using RFLP linkage maps. Genetics. 1989;121:185.  
169. Rupp R, Boichard D. Genetics of resistance to mastitis in dairy cattle. Vet. Res. 
[Internet]. EDP Sciences; 2003 [cited 2016 Nov 11];34:671–88. Available from: 
http://www.edpsciences.org/10.1051/vetres:2003020 
170. Wellnitz O, Kerr DE. Cryopreserved bovine mammary cells to model epithelial 
response to infection. Vet. Immunol. Immunopathol. [Internet]. 2004 [cited 2017 Mar 
6];101:191–202. Available from: http://ac.els-cdn.com/S0165242704001357/1-s2.0-
S0165242704001357-main.pdf?_tid=ce2c9d44-02b0-11e7-8c45-
00000aacb361&acdnat=1488834585_1a79a801f33eb7362582b4788a9b876c 
171. Danowski K, Sorg D, Gross J, Meyer HHD, Kliem H. Innate defense capability of 
challenged primary bovine mammary epithelial cells after an induced negative energy 
balance in vivo. Czech J. Anim. Sci. 2012;57:207–19.  
172. Duell BL, Cripps AW, Schembri MA, Ulett GC. Epithelial cell coculture models for 
studying infectious diseases: Benefits and limitations [Internet]. J. Biomed. Biotechnol. 
Hindawi Publishing Corporation; 2011 [cited 2017 Mar 25]. p. 852419. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/22007147 
173. Pareek R, Wellnitz O, Van Dorp R, Burton J, Kerr D. Immunorelevant gene 
expression in LPS-challenged bovine mammary epithelial cells. J. Appl. Genet. 





174. Goldammer T, Zerbe H, Molenaar A, Schuberth H-J, Brunner RM, Kata SR, et al. 
Mastitis increases mammary mRNA abundance of beta-defensin 5, toll-like-receptor 2 
(TLR2), and TLR4 but not TLR9 in cattle. Clin. Diagn. Lab. Immunol. [Internet]. 
American Society for Microbiology (ASM); 2004 [cited 2017 Jan 24];11:174–85. 
Available from: http://www.ncbi.nlm.nih.gov/pubmed/14715566 
175. Bruckmaier RM. Gene expression of factors related to the immune reaction in 
response to intramammary Escherichia coli lipopolysaccharide challenge. J. Dairy Res. 
[Internet]. Cambridge University Press; 2005 [cited 2017 Jan 24];72:120. Available from: 
http://www.journals.cambridge.org/abstract_S0022029905001159 
176. Griesbeck-Zilch B, Osman M, Kühn C, Schwerin M, Bruckmaier RH, Pfaffl MW, et 
al. Analysis of key molecules of the innate immune system in mammary epithelial cells 
isolated from marker-assisted and conventionally selected cattle. J. Dairy Sci. [Internet]. 
Elsevier; 2009 [cited 2017 Jan 23];92:4621–33. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/19700725 
177. Buehring GC, Bessis M, Weed RI, Buehring GC, Buehring GC, McGrath MF, et al. 
Culture of mammary epithelial cells from bovine milk. J. Dairy Sci. [Internet]. Elsevier; 
1990 [cited 2016 Nov 11];73:956–63. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/1693154 
178. Taylor-Papadimitriou J, Stampfer M, Bartek J, Lewis A, Boshell M, Lane EB, et al. 
Keratin expression in human mammary epithelial cells cultured from normal and 




1989;94 ( Pt 3):403–13.  
179. Moser B, Clark-Lewis I, Zwahlen R, Baggiolini M. Neutrophil-activating properties 
of the melanoma growth-stimulatory activity. J. Exp. Med. [Internet]. The Rockefeller 
University Press; 1990 [cited 2017 Mar 7];171:1797–802. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/2185333 
180. Walz A, Burgener R, Car B, Baggiolini M, Kunkel SL, Strieter RM. Structure and 
neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with 
homology to interleukin 8. J. Exp. Med. [Internet]. 1991 [cited 2017 Jan 27];174:1355–
62. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/1744577%5Cnhttp://www.pubmedcentral.nih.gov/
articlerender.fcgi?artid=PMC2119025 
181. Baggiolini M. Chemotactic and inflammatory cytokines--CXC and CC proteins. 
Adv. Exp. Med. Biol. 1993;351:1–11.  
182. Strieter RM, Belperio JA, Keane MP. CXC chemokines in vascular remodeling 
related to pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. [Internet]. 2003 [cited 2017 
Jan 27];29:S67-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14503558 
183. Eferl R, Hasselblatt P, Rath M, Popper H, Zenz R, Komnenovic V, et al. 
Development of pulmonary fibrosis through a pathway involving the transcription factor 
Fra-2/AP-1. Proc. Natl. Acad. Sci. U. S. A. [Internet]. National Academy of Sciences; 





184. Buitenhuis B, Røntved CM, Edwards SM, Ingvartsen KL, Sørensen P, Bradley A, et 
al. In depth analysis of genes and pathways of the mammary gland involved in the 
pathogenesis of bovine Escherichia coli- mastitis. BMC Genomics [Internet]. BioMed 
Central; 2011 [cited 2016 Dec 5];12:130. Available from: 
http://bmcgenomics.biomedcentral.com/articles/10.1186/1471-2164-12-130 
185. Sorg D, Danowski K, Korenkova V, Rusnakova V, Küffner R, Zimmer R, et al. 
Microfluidic high-throughput RT-qPCR measurements of the immune response of 
primary bovine mammary epithelial cells cultured from milk to mastitis pathogens. 
animal [Internet]. Cambridge University Press; 2013 [cited 2016 Dec 1];7:799–805. 
Available from: http://www.journals.cambridge.org/abstract_S1751731112002315 
186. Xiu L, Fu Y, Deng Y, Shi X, Bian Z, Ruhan A, et al. Deep sequencing-based 
analysis of gene expression in bovine mammary epithelial cells after Staphylococcus 
aureus, Escherichia coli, and Klebsiella pneumoniae infection. funpecrp.com.br Genet. 
Mol. Res. Mol. Res. 2015;14:16948–65.  
187. Sodeland M, Grove H, Kent M, Taylor S, Svendsen M, Hayes BJ, et al. Molecular 
characterization of a long range haplotype affecting protein yield and mastitis 
susceptibility in Norwegian Red cattle. BMC Genet. [Internet]. BioMed Central; 2011 
[cited 2016 Dec 1];12:70. Available from: 
http://bmcgenet.biomedcentral.com/articles/10.1186/1471-2156-12-70 
188. Ruifeng G, Yunhe F, Zhengkai W, Ershun  zhou, Yimeng L, Minjun Y, et al. 




TLR4-mediated NF-κB signaling pathway. Eur. J. Pharmacol. [Internet]. 2014 [cited 
2017 Mar 6];729:54–8. Available from: http://ac.els-cdn.com/S0014299914000168/1-
s2.0-S0014299914000168-main.pdf?_tid=a6d3d93c-0293-11e7-b7ea-
00000aab0f6c&acdnat=1488822064_6d755b1672c8f550c64b03b63d91be58 
189. Sordillo LM, Peel JE. Effect of interferon-gamma on the production of tumor 
necrosis factor during acute Escherichia coli mastitis. J. Dairy Sci. [Internet]. 1992 [cited 
2017 Mar 6];75:2119–25. Available from: 
http://linkinghub.elsevier.com/retrieve/pii/S0022030292779715 
190. Blum JW, Dosogne H, Hoeben D, Vangroenweghe F, Hammon HM, Bruckmaier 
RM, et al. Tumor necrosis factor-?? and nitrite/nitrate responses during acute mastitis 
induced by Escherichia coli infection and endotoxin in dairy cows. Domest. Anim. 




191. Piotrowska-Tomala KK, Bah MM, Jankowska K, Lukasik K, Warmowski P, Galvao 
AM, et al. Lipopolysaccharides, cytokines, and nitric oxide affect secretion of 
prostaglandins and leukotrienes by bovine mammary gland during experimentally 
induced mastitis in vivo and in vitro. Domest. Anim. Endocrinol. [Internet]. 2015 [cited 






192. Wojdak-Maksymiec K, Szyda J, Strabel T. Parity-dependent association between 
TNF-α and LTF gene polymorphisms and clinical mastitis in dairy cattle. BMC Vet. Res. 
[Internet]. 2013 [cited 2017 Mar 6];9:1. Available from: 
http://www.biomedcentral.com/1746-6148/9/114 
193. Seegers H, Fourichon C, Beaudeau F. Production effects related to mastitis and 
mastitis economics in dairy cattle herds [Internet]. Vet. Res. 2003 [cited 2017 Apr 6]. p. 
475–91. Available from: http://www.vetres.org/articles/vetres/pdf/2003/05/V3508.pdf 
194. DeGraves FJ, Fetrow J. Economics of Mastitis and Mastitis Control. Vet. Clin. 
North Am. Food Anim. Pract. [Internet]. 1993 [cited 2017 Apr 6];9:421–34. Available 
from: http://linkinghub.elsevier.com/retrieve/pii/S0749072015306113 
195. Persson Waller K, Colditz IG, Lun S, Östensson K. Cytokines in mammary lymph 
and milk during endotoxin-induced bovine mastitis [Internet]. Res. Vet. Sci. 2003 [cited 
2017 Apr 3]. p. 31–6. Available from: http://ac.els-cdn.com/S0034528802001479/1-s2.0-
S0034528802001479-main.pdf?_tid=a97675aa-18be-11e7-ac8a-
00000aab0f6b&acdnat=1491259462_5084a68141b83e7ff3976cf668a56196 
196. Zavizion B, van Duffelen M, Schaeffer W, Politis I. Establishment and 
characterization of a bovine mammary epithelial cell line with unique properties. Vitr. 
Cell. Dev. Biol. - Anim. [Internet]. Springer-Verlag; 1996 [cited 2016 Nov 11];32:138–




197. Zhao K, Liu H-Y, Zhou M-M, Liu J-X. Establishment and characterization of a 
lactating bovine mammary epithelial cell model for the study of milk synthesis. Cell Biol. 
Int. [Internet]. 2010;34:717–21. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/20214659 
198. Jedrzejczak M, Szatkowska I. Bovine mammary epithelial cell cultures for the study 
of mammary gland functions. In Vitro Cell. Dev. Biol. Anim. [Internet]. Springer; 2014 
[cited 2016 Nov 11];50:389–98. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/24234512 
199. American Veterinary Medical Association. Use of Animals in Research, Testing, 
and Education [Internet]. [cited 2017 Apr 15]. Available from: 
https://www.avma.org/KB/Policies/Pages/Use-of-Animals-in-Research-Testing-and-
Education.aspx 
200. Chen Q, He G, Zhang W, Xu T, Qi H, Li J, et al. Stromal fibroblasts derived from 
mammary gland of bovine with mastitis display inflammation-specific changes. Sci. Rep. 
[Internet]. Nature Publishing Group; 2016 [cited 2017 Apr 3];6:27462. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/27272504 
201. Kandasamy S, Green BB, Benjamin AL, Kerr DE. Between-cow variation in dermal 
fibroblast response to lipopolysaccharide reflected in resolution of inflammation during 
Escherichia coli mastitis. J. Dairy Sci. 2011;94:5963–75.  
202. Kubota C, Yamakuchi H, Todoroki J, Mizoshita K, Tabara N, Barber M, et al. Six 




Acad. Sci. U. S. A. [Internet]. National Academy of Sciences; 2000 [cited 2017 Apr 
3];97:990–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10655472 
203. SAS Statistical Software. Cary, NC: SAS Institute Inc.; 2016.  
204. Boutinaud M, Jammes H. Potential uses of milk epithelial cells: a review. Reprod. 
Nutr. Dev. [Internet]. 2002 [cited 2017 Apr 6];42:133–47. Available from: 
https://hal.archives-ouvertes.fr/hal-00900346/document 
205. Rose MT, Aso H, Yonekura S, Komatsu T, Hagino A, Ozutsumi K, et al. In vitro 
differentiation of a cloned bovine mammary epithelial cell. J. Dairy Res. [Internet]. 
Cambridge University Press; 2002 [cited 2016 Nov 11];69:345–55. Available from: 
http://www.journals.cambridge.org/abstract_S0022029902005551 
206. Hammond SL, Ham RG, Stampfert MR, Prescott DM. Serum-free growth of human 
mammary epithelial cells: Rapid clonal growth in defined medium and extended serial 
passage with pituitary extract (prostaglandin El/cycic 
AMP/ethanolamine/insulin/epidermal growth factor). Cell Biol. [Internet]. 1984 [cited 
2017 Mar 30];81:5435–9. Available from: 
http://www.pnas.org/content/81/17/5435.full.pdf 
207. Sordillo L, Oliver S, Akers R. Culture of bovine mammary epithelial cells in D-
valine modified medium: Selective removal of contaminating fibroblasts. Cell Biol. Int. 





208. Feng S, Salter AM, Parr T, Garnsworthy PC. Extraction and quantitative analysis of 
stearoyl-coenzyme A desaturase mRNA from dairy cow milk somatic cells. J. Dairy Sci. 
[Internet]. 2007 [cited 2017 Apr 4];90:4128–36. Available from: 
http://www.sciencedirect.com/science/article/pii/S0022030207718714 
209. Vangroenweghe F, Dosogne H, Mehrzad J, Burvenich C. Effect of milk sampling 
techniques on milk composition, bacterial contamination, viability and functions of 
resident cells in milk. Vet. Res. [Internet]. 2001 [cited 2017 Apr 4];32:565–79. Available 
from: http://www.vetres.org/articles/vetres/pdf/2001/05/v1603.pdf 
210. Boutinaud M, Rulquin H, Keisler DH, Djiane J, Jammes H. Use of somatic cells 
from goat milk for dynamic studies of gene expression in the mammary gland. J. Anim. 
Sci. [Internet]. 2002 [cited 2017 Apr 6];80:1258–69. Available from: 
https://www.animalsciencepublications.org/publications/jas/abstracts/80/5/1258 
211. Gstraunthaler G. Alternatives to the use of fetal bovine serum: serum-free cell 
culture. ALTEX [Internet]. 2003 [cited 2017 Apr 6];20:275–81. Available from: 
http://www.altex.ch/resources/Altex_2003_4_275_281_Gstraunthaler.pdf 
212. Lechner JF, Haugen A, McClendon IA, Pettis EW. Clonal growth of normal adult 
human bronchial epithelial cells in a serum-free medium. In Vitro [Internet]. 1982 [cited 
2017 Apr 3];18:633–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7141447 
213. Okada H, Ito T, Ohtsuka H, Kirisawa R, Iwai H, Yamashita K, et al. Detection of 
interleukin-1 and interleukin-6 on cryopreserved bovine mammary epithelial cells in 





214. Van Der Valk J, Mellor D, Brands R, Fischer R, Gruber F, Gstraunthaler G, et al. 
The humane collection of fetal bovine serum and possibilities for serum-free cell and 
tissue culture. Toxicol. Vitr. [Internet]. 2004 [cited 2017 Apr 6]. p. 1–12. Available from: 
http://www.sciencedirect.com/science/article/pii/S0887233303001590 
215. Chen Q, He G, Zhang W, Xu T, Qi H, Li J, et al. Stromal fibroblasts derived from 
mammary gland of bovine with mastitis display inflammation-specific changes. Sci. Rep. 
[Internet]. Nature Publishing Group; 2016 [cited 2016 Nov 14];6:27462. Available from: 
http://www.nature.com/articles/srep27462 
216. Kandasamy S, Kerr DE. Genomic analysis of between-cow variation in dermal 
fibroblast response to lipopolysaccharide. J. Dairy Sci. 2012;95:3852–64.  
217. Akkoc A, Kahraman MM, Vatansever A, Gunaydın E, Akdesir E. 
Lipopolysaccharide (LPS) Induces Matrix Metalloproteinase-2 and -9 (MMP-2 and 
MMP-9) in Bovine Dermal Fibroblasts. Pak. Vet. J. 2016;ISSN:253–8318.  
218. Green BB, Kandasamy S, Elsasser TH, Kerr DE. The use of dermal fibroblasts as a 
predictive tool of the toll-like receptor 4 response pathway and its development in 
Holstein heifers. J. Dairy Sci. 2011;94:5502–14.  
219. Yamanaka H, Hisaeda K, Hagiwara K, Kirisawa R, Iwai H. ELISA for bovine 
interleukin-1 receptor antagonist and its application to mastitic sera and whey. J. Vet. 





220. Oviedo-Boyso J, Valdez-Alarcón JJ, Cajero-Juárez M, Ochoa-Zarzosa A, López-
Meza JE, Bravo-Patiño A, et al. Innate immune response of bovine mammary gland to 
pathogenic bacteria responsible for mastitis. J. Infect. 2007;54:399–409.  
221. Rambeaud M, Almeida RA, Pighetti GM, Oliver SP. Dynamics of leukocytes and 
cytokines during experimentally induced Streptococcus uberis mastitis. Vet. Immunol. 




222. Bannerman DD, Paape MJ, Lee J-W, Zhao X, Hope JC, Rainard P. Escherichia coli 
and Staphylococcus aureus elicit differential innate immune responses following 
intramammary infection. Clin. Diagn. Lab. Immunol. [Internet]. American Society for 
Microbiology; 2004 [cited 2017 Apr 6];11:463–72. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/15138171 
223. Wu J, Li L, Sun Y, Huang S, Tang J, Yu P, et al. Altered molecular expression of 
the TLR4/NF-??B signaling pathway in mammary tissue of Chinese Holstein cattle with 
mastitis. PLoS One [Internet]. 2015 [cited 2017 Apr 3];10. Available from: 
http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0118458&type=print
able 




Modifies the Transcriptome of Primary Human Monocytes: Modulation of Novel 
Immune-Related Genes and Identification Of CC-Chemokine Ligand 20 as a New 
Hypoxia-Inducible Gene. J. Immunol. [Internet]. 2006 [cited 2017 Apr 6];177:1941–55. 
Available from: http://www.jimmunol.org/content/177/3/1941.long 
225. Günther J, Koczan D, Yang W, Nürnberg G, Repsilber D, Schuberth HJ, et al. 
Assessment of the immune capacity of mammary epithelial cells: Comparison with 
mammary tissue after challenge with Escherichia coli. Vet. Res. [Internet]. BioMed 
Central; 2009 [cited 2016 Dec 5];40:31. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/19321125 
226. Werner C, Sobiraj A, Sundrum A. Efficacy of homeopathic and antibiotic treatment 
strategies in cases of mild and moderate bovine clinical mastitis. J. Dairy Res. [Internet]. 
2010 [cited 2017 Apr 17];77:460–7. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/20822562 
227. De Vliegher S, Fox LK, Piepers S, McDougall S, Barkema HW. Invited review: 
Mastitis in dairy heifers: nature of the disease, potential impact, prevention, and control. 
J. Dairy Sci. [Internet]. 2012 [cited 2017 Apr 17];95:1025–40. Available from: 
http://www.sciencedirect.com/science/article/pii/S0022030212000628 
228. Bayles KW, Wesson CA, Liou LE, Fox LK, Bohach GA, Trumble WR. Intracellular 
Staphylococcus aureus escapes the endosome and induces apoptosis in epithelial cells. 
Infect. Immun. [Internet]. American Society for Microbiology; 1998 [cited 2016 Nov 




229. Long E, Capuco A, Wood D, Sonstegard T, Tomita G, Paape M, et al. Escherichia 
coli induces apoptosis and proliferation of mammary cells. Cell Death Differ. 
2001;8:808–16.  
230. Yedgar S, Lichtenberg D, Schnitzer E. Inhibition of phospholipase A2 as a 
therapeutic target. Biochim. Biophys. Acta - Mol. Cell Biol. Lipids. 2000;1488:182–7.  
231. Magrioti V, Kokotos G. Phospholipase A2 inhibitors as potential therapeutic agents 
for the treatment of inflammatory diseases. Expert Opin Ther Pat [Internet]. Taylor & 
Francis; 2010 [cited 2017 Apr 17];20:1–18. Available from: 
http://www.tandfonline.com/doi/full/10.1517/13543770903463905 
232. Hanasaki K, Arita H. Biological and pathological functions of phospholipase A(2) 
receptor. Arch. Biochem. Biophys. [Internet]. 1999 [cited 2016 Nov 16];372:215–23. 
Available from: http://www.ncbi.nlm.nih.gov/pubmed/10600158 
233. Seroussi E, Klompus S, Silanikove M, Krifucks O, Shapiro F, Gertler A, et al. 
Nonbactericidal secreted phospholipase A2s are potential anti-inflammatory factors in the 
mammary gland. Immunogenetics [Internet]. Springer Berlin Heidelberg; 2013 [cited 
2016 Nov 16];65:861–71. Available from: http://link.springer.com/10.1007/s00251-013-
0738-1 
234. Burke JE, Dennis EA. Phospholipase A2 structure/function, mechanism, and 
signaling. J. Lipid Res. [Internet]. American Society for Biochemistry and Molecular 





235. Hanasaki K. Mammalian Phospholipase A2: Phospholipase A2 Receptor. Biol. 
Pharm. Bull. [Internet]. The Pharmaceutical Society of Japan; 2004 [cited 2016 Nov 
16];27:1165–7. Available from: 
http://joi.jlc.jst.go.jp/JST.JSTAGE/bpb/27.1165?from=CrossRef 
236. Katoh N. Inhibition by Melittin of Phosphorylation by Protein Kinase C of Annexin 
I from Cow Mammary Gland. J. Vet. Med. Sci [Internet]. JAPANESE SOCIETY OF 
VETERINARY SCIENCE; 2002 [cited 2016 Nov 17];64:779–83. Available from: 
http://joi.jlc.jst.go.jp/JST.JSTAGE/jvms/64.779?from=CrossRef 
237. Miki Y, Yamamoto K, Taketomi Y, Sato H, Shimo K, Kobayashi T, et al. Lymphoid 
tissue phospholipase A2 group IID resolves contact hypersensitivity by driving 
antiinflammatory lipid mediators. J. Exp. Med. [Internet]. The Rockefeller University 
Press; 2013 [cited 2017 Apr 17];210:1217–34. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/23690440 
238. Rot A, Von Andrian UH. CHEMOKINES IN INNATE AND ADAPTIVE HOST 
DEFENSE: Basic Chemokinese Grammar for Immune Cells. Annu. Rev. Immunol 
[Internet]. 2004 [cited 2017 Apr 17];22:891–928. Available from: 
http://www.annualreviews.org/doi/pdf/10.1146/annurev.immunol.22.012703.104543 
239. Yang D, Chen Q, Hoover DM, Staley P, Tucker KD, Lubkowski J, et al. Many 
chemokines including CCL20/MIP-3alpha display antimicrobial activity. J. Leukoc. Biol. 





240. Lourenço AG, Komesu MC, Duarte G, Del Ciampo LA, Mussi-Pinhata MM, 
Yamamoto AY. High Levels of Chemokine C-C Motif Ligand 20 in Human Milk and Its 
Production by Oral Keratinocytes. Breastfeed. Med. [Internet]. 2017 [cited 2017 Apr 
17];12:116–21. Available from: http://online.liebertpub.com/doi/10.1089/bfm.2016.0067 
241. Jiang L, Sorensen P, Rontved C, Vels L, Ingvartsen K. Gene expression profiling of 
liver from dairy cows treated intra-mammary with lipopolysaccharide. BMC Genomics 






242. Sordillo LM. Factors affecting mammary gland immunity and mastitis 
susceptibility. Livest. Prod. Sci. [Internet]. 2005 [cited 2017 Mar 29]. p. 89–99. Available 
from: http://www.ncbi.nlm.nih.gov/pubmed/12463736 
243. Rainard P, Fromageau A, Cunha P, Gilbert FB. www.vetres.org Staphylococcus 
aureus lipoteichoic acid triggers inflammation in the lactating bovine mammary gland. 
Vet. Res [Internet]. 2008 [cited 2017 Apr 17];39. Available from: 
http://www.vetres.org/articles/vetres/pdf/2008/05/v08221.pdf 
244. Lahouassa H, Moussay E, Rainard P, Riollet C. Differential cytokine and chemokine 




coli. Cytokine [Internet]. 2007 [cited 2017 Apr 17];38:12–21. Available from: 
http://www.sciencedirect.com/science/article/pii/S1043466607000853 
245. Zhang K, Zhang D, Jiao X. full-text. Eur Rev Med Pharmacol [Internet]. 2013 [cited 
2017 Apr 17];17:3279–84. Available from: http://www.europeanreview.org/wp/wp-
content/uploads/3279-3284.pdf 
246. Wuyts A, Govaerts C, Struyf S, Lenaerts JP, Put W, Conings R, et al. Isolation of 
the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumor cells and 
leukocytes reveals NH2-terminal heterogeneity: Functional comparison of different 
natural isoforms. Eur. J. Biochem. [Internet]. 1999 [cited 2017 Apr 17];260:421–9. 
Available from: http://www.ncbi.nlm.nih.gov/pubmed/10095777 
247. Rinaldi M, Li RW, Bannerman DD, Daniels KM, Evock-Clover C, Silva MVB, et 
al. A sentinel function for teat tissues in dairy cows: Dominant innate immune response 
elements define early response to E. coli mastitis. Funct. Integr. Genomics [Internet]. 
Springer-Verlag; 2010 [cited 2017 Apr 17];10:21–38. Available from: 
http://link.springer.com/10.1007/s10142-009-0133-z 
248. Zheng J, Watson AD, Kerr DE. Genome-wide expression analysis of 
lipopolysaccharide-induced mastitis in a mouse model. Infect. Immun. [Internet]. 
American Society for Microbiology; 2006 [cited 2017 Apr 17];74:1907–15. Available 
from: http://www.ncbi.nlm.nih.gov/pubmed/16495566 
249. Peterson DG, Matitashvili EA, Bauman DE. The inhibitory effect of trans-10, cis-12 




activation of the transcription factor SREBP-1. J. Nutr. [Internet]. 2004 [cited 2017 Nov 
15];134:2523–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15465741 
250. Swanson KM, Stelwagen K, Dobson J, Henderson H V, Davis SR, Farr VC, et al. 
Transcriptome profiling of Streptococcus uberis-induced mastitis reveals fundamental 
differences between immune gene expression in the mammary gland and in a primary 




251. Huynh HT, Robitaille G, Turner JD. Establishment of bovine mammary epithelial 
cells (MAC-T): An in vitro model for bovine lactation. Exp. Cell Res. [Internet]. 1991 




252. An P, Sáenz Robles MT, Pipas JM. Large T antigens of polyomaviruses: amazing 
molecular machines. Annu. Rev. Microbiol. [Internet]. 2012 [cited 2017 Apr 18];66:213–
36. Available from: www.annualreviews.org 
253. Ali SH, DeCaprio JA. Cellular transformation by SV40 large T antigen: interaction 
with host proteins. Semin Cancer Biol [Internet]. 2001 [cited 2017 Apr 18];11:15–23. 




254. Kawatani M, Imoto M. Deletion of the BH1 domain of Bcl-2 accelerates apoptosis 
by acting in a dominant negative fashion. J. Biol. Chem. [Internet]. American Society for 
Biochemistry and Molecular Biology; 2003 [cited 2017 Apr 18];278:19732–42. 

























Table 12: Single nucleotide polymorphisms suggestive of genome-wide significance for 
bovine mastitis resistance. The allele associated with mastitis resistance is shown. 
Marker Chr Position -log10(P-Value) Protective Allele 
     
rs43358044 3 91840020 3.996653467 G 
rs137266495 3 91852910 3.996653467 A 
rs109319807 4 101537884 3.980910125 T 
rs136808611 27 42783896 3.97700887 A 
rs136937812 X 57802477 3.975335219 A 
rs110284739 10 27951935 3.974500075 A 
rs109526058 12 84803111 3.964518728 C 
rs134217424 15 51068247 3.952684594 G 
rs111020787 10 15230978 3.939244754 T 
rs109587178 10 34260761 3.936591969 C 
rs135295512 9 53003499 3.929227883 C 
rs110055960 15 3927915 3.9101623 C 
rs109308232 10 34184801 3.903017995 G 
rs43506128 7 32204119 3.894230637 C 
rs134337435 18 43565043 3.869328826 T 
rs135850795 18 43566644 3.869328826 C 
rs41879780 18 43568721 3.869328826 G 
rs42748473 27 151528 3.866788625 C 
rs135442750 17 41733436 3.843632627 A 
rs110555626 17 41739893 3.843632627 G 
rs109816246 17 41753937 3.843632627 T 
rs42781654 17 41758421 3.843632627 T 
rs43616389 10 14261766 3.839667402 T 
rs110785064 14 40832903 3.835638804 C 
rs133822572 14 40834978 3.835638804 G 
rs109701184 2 135044225 3.826885025 A 
rs134262073 2 135061232 3.826885025 G 
rs110866096 10 34482573 3.826134783 T 
rs41604830 26 28196945 3.815561566 G 
rs43354976 3 92983189 3.802056534 A 
rs135734418 10 29032168 3.77771954 T 
rs43700325 11 29205354 3.763347317 G 
rs43701535 11 29206310 3.763347317 A 
rs109119871 11 29207614 3.763347317 G 
rs43701552 11 29208446 3.763347317 G 
rs43048540 11 29228506 3.763347317 A 
rs42306995 17 41702459 3.761873315 G 
rs135443516 9 65859392 3.753918619 A 
rs133087401 9 65860153 3.753918619 C 
rs134332052 9 65861243 3.753918619 C 
rs135270243 9 65879171 3.753918619 G 
rs133800930 9 65889358 3.753918619 T 




rs136293798 9 65891235 3.753918619 T 
rs136979275 9 65895727 3.753918619 G 
rs109202959 19 7514783 3.746281982 A 
rs134340673 10 15144718 3.7416025 C 
rs109711228 15 50978021 3.719140182 T 
rs135987526 28 18520683 3.714851977 G 
rs136467850 15 54649868 3.704686149 T 
rs43618989 10 11496248 3.701449371 G 
rs111023847 16 20608750 3.694447987 C 
rs110918390 16 20609335 3.694447987 G 
rs110001905 16 20610171 3.694447987 A 
rs109403663 16 20612167 3.694447987 A 
rs108942580 16 20614885 3.694447987 A 
rs109726329 16 20615451 3.694447987 C 
rs110132689 16 20616455 3.694447987 A 
rs109513395 16 20617139 3.694447987 A 
rs110663077 10 39854351 3.693917704 C 
rs42435974 26 28877559 3.677934056 T 
rs137733108 12 12976126 3.675972311 G 
rs42422111 3 90823349 3.675190282 A 
rs42422098 3 90825605 3.675190282 C 
rs42422096 3 90826586 3.675190282 C 
rs110502897 6 45848609 3.668025217 C 
rs109139712 10 11478732 3.666290057 T 
rs135391817 10 11482238 3.666290057 T 
rs43488809 6 109419395 3.661360545 C 
rs109048873 17 37988898 3.653290211 T 
rs109752781 17 37999567 3.653290211 T 
rs135575219 17 41741046 3.651960319 T 
rs41611251 17 41742069 3.651960319 T 
rs109407328 17 41742777 3.651960319 T 
rs110264878 17 41746116 3.651960319 T 
rs109199653 17 41747600 3.651960319 G 
rs137323892 19 11786116 3.64943487 T 
rs136457662 29 28578533 3.648974591 A 
rs41856186 18 5214466 3.648636063 A 
rs109442613 18 5225895 3.648636063 A 
rs110805371 10 34407598 3.64764349 T 
rs134256203 29 46072112 3.640522943 A 
rs42230220 10 29751247 3.638958744 G 
rs110803408 9 103674333 3.637892378 C 
rs41708297 13 61537602 3.631269978 G 
rs109484288 6 108468990 3.628915132 C 
rs109133788 18 49684020 3.627804715 T 
rs136768665 3 91342794 3.623859956 T 
rs109699387 11 42600063 3.622735086 G 
rs43617435 10 14229935 3.617247186 T 
rs43616344 10 14279631 3.617247186 T 
rs42179869 7 89788219 3.604189492 A 




rs42179853 7 89808465 3.604189492 T 
rs42179846 7 89816912 3.604189492 A 
rs42179845 7 89820454 3.604189492 G 
rs136757535 7 89821932 3.604189492 T 
rs42178916 7 89831709 3.604189492 A 
rs42178892 7 89842459 3.604189492 A 
rs109533174 16 62901191 3.59584457 G 
rs110257587 12 12918128 3.583356138 A 
rs110745310 12 12925593 3.583356138 A 
rs109716027 12 12935119 3.583356138 A 
rs135512574 12 12941960 3.583356138 C 
rs110541423 12 12946676 3.583356138 T 
rs210940686 12 12950359 3.583356138 C 
rs110770556 12 12959938 3.583356138 T 
rs109138785 12 12980738 3.583356138 A 
rs109474774 12 13002261 3.583356138 A 
rs110219834 12 13008208 3.583356138 A 
rs110094067 12 13020618 3.583356138 A 
rs109450381 26 26296160 3.577415756 C 
rs43418248 26 27874379 3.575512545 T 
rs43418238 26 27878019 3.575512545 G 
rs43418237 26 27879888 3.575512545 T 
rs109126903 11 46523735 3.575329135 G 
rs137303803 21 21173650 3.567662303 C 
rs110079373 11 96756491 3.56603655 G 
rs110796580 11 96777054 3.56603655 A 
rs136932995 26 25658416 3.5653789 C 
rs137549287 3 5770104 3.554231467 G 
rs132946079 17 10716265 3.552360613 C 
rs41573750 17 10726289 3.552360613 T 
rs110260876 17 10727750 3.552360613 G 
rs42572201 4 91124601 3.547840315 T 
rs42572206 4 91127591 3.547840315 T 
rs110741324 4 91130350 3.547840315 A 
rs109847541 4 91136670 3.547840315 T 
rs109527045 4 91158590 3.547840315 G 
rs43019584 4 91161129 3.547840315 T 
rs43019591 4 91163203 3.547840315 G 
rs42957734 4 91180659 3.547840315 C 
rs42956722 4 91181932 3.547840315 T 
rs42956709 4 91183368 3.547840315 T 
rs42573425 4 91311286 3.547840315 G 
rs110656903 21 21893359 3.545937526 A 
rs109351174 3 56556783 3.544667915 A 
rs109747432 3 56570552 3.544667915 A 
rs109256407 3 56585697 3.544667915 C 




rs135942451 4 90401943 3.53243049 A 
rs43061363 4 90407999 3.53243049 G 
rs134862481 4 90414075 3.53243049 C 
rs42953972 4 90415012 3.53243049 T 
rs42954026 4 90422526 3.53243049 A 
rs110623899 4 90425762 3.53243049 G 
rs135621455 4 90428930 3.53243049 A 
rs136015399 4 90431785 3.53243049 T 
rs42954434 4 90456245 3.53243049 A 
rs42436989 4 90502505 3.53243049 T 
rs42954027 19 11469210 3.53243049 T 
rs110459211 15 22583487 3.531664681 A 
rs132635669 10 11663811 3.527354767 A 
rs110383759 2 135067905 3.52190773 C 
rs110296238 2 135069441 3.52190773 T 
rs137654606 11 30120909 3.519420207 G 
rs110578425 10 34260119 3.517448796 T 
rs110822305 10 34269720 3.517448796 G 
rs110174252 10 34271375 3.517448796 A 
rs109718130 10 34278604 3.517448796 A 
rs135485607 15 3936865 3.510710974 G 
rs110521330 27 43792463 3.509502691 G 
rs109247220 27 43795174 3.509502691 G 
rs134139377 15 46032011 3.503671841 T 
rs136575211 27 25015766 3.502020606 T 
rs109202339 10 27908334 3.501847277 T 
rs134911710 10 27913156 3.501847277 T 
rs109630946 10 27923467 3.501847277 A 
rs135108032 10 27926282 3.501847277 A 
rs110174162 10 27948713 3.501847277 A 
rs137223718 10 27949701 3.501847277 G 
rs136175781 10 27950452 3.501847277 C 
rs133857484 10 27951385 3.501847277 A 
rs109055367 10 27953197 3.501847277 G 
rs109712672 10 27969361 3.501847277 A 
rs135060899 10 27971131 3.501847277 G 
rs109834818 10 27975781 3.501847277 A 
rs109929709 10 27976538 3.501847277 A 
rs137395442 10 27978253 3.501847277 C 
rs110948714 10 27981920 3.501847277 C 
rs109276009 10 27983389 3.501847277 T 
rs109119406 10 27987774 3.501847277 T 
rs109393053 10 27989220 3.501847277 G 
rs110741778 10 27990512 3.501847277 C 
rs109718041 10 27991328 3.501847277 A 
rs110676082 10 27993659 3.501847277 A 




rs110968891 10 27998032 3.501847277 A 
rs109263205 10 27998826 3.501847277 C 
rs110438571 10 28000036 3.501847277 T 
rs110061866 10 28001148 3.501847277 A 
rs109345446 10 28001876 3.501847277 G 
rs109406918 10 28002566 3.501847277 C 
rs137404908 X 106584624 3.491051617 C 
rs134000682 X 106601943 3.491051617 G 
rs41641989 19 7511302 3.49066656 G 
rs135723042 17 42173612 3.48390421 T 
rs109491704 17 42186164 3.48390421 T 
rs109795284 17 42189018 3.48390421 T 
rs136231792 17 42190919 3.48390421 T 
rs110808681 10 34182291 3.47996144 A 
rs41623451 10 34193887 3.47996144 T 
rs134408007 10 34201327 3.47996144 G 
rs110049315 12 76826267 3.479667966 C 
rs137547770 12 76832234 3.479667966 T 
rs135018781 28 43884340 3.479083948 G 
rs109004955 10 15226746 3.477491518 G 
rs110644177 10 15231607 3.477491518 C 
rs137247805 28 30866421 3.458749724 A 
rs136227126 28 30867142 3.458749724 T 
rs110234333 10 34393478 3.458190041 C 
rs137236292 21 8053012 3.457490709 T 
rs41963113 21 8061425 3.457490709 T 
rs41963125 21 8062897 3.457490709 T 
rs110332445 21 8065472 3.457490709 G 
rs41963076 21 8071325 3.457490709 T 
rs135664235 26 25265647 3.45634136 T 
rs110429039 9 97571198 3.455458218 C 
rs109503693 9 97572172 3.455458218 A 
rs134754035 9 97573217 3.455458218 T 
rs110418388 9 97574028 3.455458218 C 
rs137051476 3 24671921 3.452247361 G 
rs134675792 16 80383679 3.448342703 T 
rs136087996 16 80385720 3.448342703 A 
rs134310314 15 47264048 3.448021966 C 
rs41766844 15 47264872 3.448021966 T 
rs41766852 15 47266773 3.448021966 T 
rs41766857 15 47268306 3.448021966 A 
rs41631859 15 47274125 3.448021966 T 
rs41766870 15 47274957 3.448021966 A 
rs41766877 15 47275830 3.448021966 T 
rs41766891 15 47278941 3.448021966 T 
rs110616111 15 47279621 3.448021966 A 




rs135331709 15 47283531 3.448021966 T 
rs41764625 15 47290269 3.448021966 G 
rs41764630 15 47290932 3.448021966 G 
rs41765840 15 47294915 3.448021966 T 
rs41765850 15 47297442 3.448021966 T 
rs135103940 15 47298250 3.448021966 A 
rs41765859 15 47299091 3.448021966 C 
rs41765876 15 47302403 3.448021966 T 
rs41765898 15 47304572 3.448021966 A 
rs41765904 15 47305423 3.448021966 C 
rs41765907 15 47306109 3.448021966 T 
rs109916280 15 47307206 3.448021966 G 
rs41765913 15 47307914 3.448021966 C 
rs42669165 15 47336499 3.448021966 G 
rs42669195 15 47357365 3.448021966 C 
rs42669201 15 47358546 3.448021966 G 
rs42669211 15 47359452 3.448021966 A 
rs42669215 15 47360926 3.448021966 A 
rs110650579 15 47363154 3.448021966 T 
rs110477122 16 20611330 3.437492686 G 
rs134322109 10 35133400 3.436990559 A 
rs135507523 10 35134070 3.436990559 T 
rs42976756 3 5907195 3.435443723 T 
rs42976790 3 5909921 3.435443723 T 
rs137400107 2 118870999 3.430142009 C 
rs109940736 11 102335697 3.427253851 C 
rs109462487 26 26358551 3.423511281 T 
rs43418314 26 27866959 3.421461295 A 
rs43418304 26 27867615 3.421461295 A 
rs43418296 26 27868998 3.421461295 A 
rs43418241 26 27875295 3.421461295 C 
rs136871582 25 29026876 3.418423118 C 
rs134778236 25 29028549 3.418423118 G 
rs109296602 25 29029462 3.418423118 T 
rs133195919 25 29030397 3.418423118 T 
rs134990112 25 29032886 3.418423118 A 
rs29026849 25 29033600 3.418423118 T 
rs134505616 10 14915348 3.417097085 C 
rs134775008 10 14992318 3.417097085 G 
rs135993868 11 36693585 3.41288933 T 
rs109550935 10 14509430 3.410021525 A 
rs800022227 18 49707682 3.406825082 C 
rs110936103 18 49826315 3.406825082 A 
rs109752915 18 49827804 3.406825082 T 
rs110052628 18 49829235 3.406825082 G 
rs109584832 18 49830124 3.406825082 T 




rs110721957 18 49831451 3.406825082 C 
rs109371909 18 49832385 3.406825082 A 
rs136730838 5 68586107 3.4002011 T 
rs43615154 10 14374841 3.399155241 T 
rs41973031 21 21202324 3.397541583 T 
rs41972130 21 21203119 3.397541583 A 
rs41972127 21 21205862 3.397541583 T 
rs29011369 2 116210744 3.396737757 A 
rs43326486 2 116261117 3.396737757 T 
rs43326515 2 116317216 3.396737757 C 
rs43327275 2 116368014 3.396737757 T 
rs43327284 2 116379355 3.396737757 A 
rs43328231 2 116433069 3.396737757 A 
rs136608836 2 116443823 3.396737757 T 
rs110463452 2 116450940 3.396737757 A 
rs134877611 2 116481181 3.396737757 T 
rs134785162 2 116502303 3.396737757 C 
rs110836924 2 116515561 3.396737757 C 
rs42350539 3 91406267 3.396283165 T 
rs109276053 17 37366043 3.38905385 C 
rs42822799 4 91392323 3.388029393 G 
rs42822793 4 91401157 3.388029393 A 
rs42822797 4 91410156 3.388029393 G 
rs110781216 11 16185893 3.38300674 A 
rs110700817 17 39991047 3.379336817 T 
rs137095327 23 42900015 3.377386947 T 
rs132738542 11 43746272 3.371605441 T 
rs109954573 2 97056987 3.369612574 A 
rs110583355 3 20726185 3.367102737 A 
rs110891235 2 135043582 3.362086163 C 
rs134075027 16 80373783 3.360130724 C 
rs29012884 16 80375118 3.360130724 T 
rs137539857 16 80380895 3.360130724 T 
rs134130295 11 96300378 3.356836108 A 
rs137130502 17 42379744 3.355224205 G 
rs110952236 28 14587431 3.352891958 A 
rs110529357 27 3587344 3.347190698 G 
rs136309760 27 3603082 3.347190698 C 
rs136752551 27 3603744 3.347190698 T 
rs137721609 27 3605490 3.347190698 C 
rs109053110 27 3606725 3.347190698 G 
rs133569944 27 3613160 3.347190698 A 
rs135112745 27 3619112 3.347190698 A 
rs109004577 27 3621325 3.347190698 C 
rs133566198 27 3632970 3.347190698 A 
rs109288278 1 9155528 3.343575742 C 




rs132926852 1 9173252 3.343575742 T 
rs137188372 1 9174446 3.343575742 G 
rs109367978 1 9180914 3.343575742 T 
rs109114614 1 9191421 3.343575742 A 
rs110149968 1 9196480 3.343575742 A 
rs134043952 9 103827095 3.338846162 C 
rs132692297 9 96392290 3.337454701 G 
rs133696224 18 51793677 3.332942754 T 
rs110030120 18 51795302 3.332942754 T 
rs137178064 18 51798613 3.332942754 G 
rs135147402 18 51800010 3.332942754 T 
rs41665411 9 97377573 3.331594763 G 
rs134859031 12 76761791 3.327441429 G 
rs109206774 28 20301025 3.324366482 G 
rs137374997 28 20301881 3.324366482 C 
rs110611090 28 20303194 3.324366482 G 
rs109913025 28 20307480 3.324366482 T 
rs109964809 28 20313646 3.324366482 G 
rs109577685 28 20329418 3.324366482 G 
rs136797470 28 20330518 3.324366482 T 
rs110075596 28 20332119 3.324366482 A 
rs109137280 16 20617894 3.320623615 C 
rs134411715 16 20619357 3.320623615 A 
rs110533869 16 20623978 3.320623615 A 
rs43306722 10 39537032 3.317268784 A 
rs43306706 10 39546139 3.317268784 T 
rs109817054 10 15265576 3.316082909 T 
rs109344511 10 15267025 3.316082909 A 
rs109679240 10 15269153 3.316082909 A 
rs109755527 10 15272047 3.316082909 G 
rs109793858 10 15274224 3.316082909 G 
rs109985287 10 15291183 3.316082909 A 
rs133459576 10 15295267 3.316082909 C 
rs42620822 27 42776720 3.312793511 A 
rs135051801 18 5113990 3.305450691 A 
rs109846857 11 15610039 3.30211409 A 
rs42743027 4 91044644 3.299742379 T 
rs42743021 4 91045511 3.299742379 G 
rs135959622 4 91086150 3.299742379 C 
rs42741696 4 91090805 3.299742379 G 
rs137081039 4 91095329 3.299742379 C 
rs41706372 13 61992391 3.299725575 C 
rs110493658 10 34438367 3.298523546 C 
rs137347983 10 34447107 3.298523546 A 
rs136416791 10 34449394 3.298523546 G 
rs134051160 10 34451675 3.298523546 C 




rs109477546 27 9014873 3.294251483 G 
rs134296530 15 3805680 3.286903941 G 
rs42188223 29 46051097 3.286597099 C 
rs135076653 29 46069381 3.286597099 T 
rs137786194 29 46071340 3.286597099 A 
rs135523988 29 46073378 3.286597099 A 
rs133850293 18 49844762 3.285519188 A 
rs137429611 18 49846906 3.285519188 T 
rs134644515 18 49854465 3.285519188 T 
rs42625901 6 108569050 3.285445958 A 
rs136596415 18 51803425 3.283718544 C 
rs134480471 18 51808317 3.283718544 T 
rs136382907 18 51810825 3.283718544 C 
rs110216131 27 2537760 3.283312314 T 
rs110326002 27 2538848 3.283312314 C 
rs109126345 X 120798197 3.281319397 A 
rs110770536 26 27897409 3.280053399 A 
rs135171829 4 91013071 3.272038183 C 
rs42743846 4 91025117 3.272038183 G 
rs134940524 4 91029900 3.272038183 T 
rs42743839 4 91030631 3.272038183 G 
rs41571562 4 91051469 3.272038183 A 
rs42742989 4 91053740 3.272038183 G 
rs109212509 4 91054564 3.272038183 T 
rs42742950 4 91056364 3.272038183 G 
rs42742955 4 91057950 3.272038183 A 
rs42742959 4 91059678 3.272038183 C 
rs42742963 4 91060347 3.272038183 C 
rs42742969 4 91060986 3.272038183 C 
rs42742974 4 91061839 3.272038183 G 
rs42742985 4 91064044 3.272038183 C 
rs137402389 4 91074086 3.272038183 C 
rs133246170 4 91114783 3.272038183 G 
rs109558636 21 5418214 3.271931695 G 
rs110195286 21 5421568 3.271931695 C 
rs109620070 21 5422909 3.271931695 C 
rs133390385 21 5430195 3.271931695 T 
rs134693433 21 5432530 3.271931695 A 
rs137550200 21 5433346 3.271931695 G 
rs109326223 21 5440289 3.271931695 T 
rs110785020 21 5442814 3.271931695 T 
rs133787467 21 5444628 3.271931695 T 
rs42307500 17 41682839 3.268182182 A 
rs110950041 10 15240169 3.268062731 G 
rs134759074 10 15240747 3.268062731 T 
rs110608086 10 15241322 3.268062731 T 




rs110774021 10 15245376 3.268062731 A 
rs110954734 10 15262140 3.268062731 A 
rs110353392 11 102319320 3.266517518 T 
rs133980943 4 91528967 3.265842726 T 
rs136842498 6 10677303 3.261761701 T 
rs134993675 27 43799710 3.261477609 C 
rs109829168 27 43801103 3.261477609 T 
rs42434777 9 62300403 3.260836335 C 
rs133369187 6 108463671 3.259525167 T 
rs43706008 12 68755240 3.257897754 C 
rs136633863 X 17647347 3.252831054 C 
rs137201853 28 20353894 3.249712305 C 
rs133190904 11 102309223 3.249568667 G 
rs134715529 11 102310272 3.249568667 T 
rs136173225 17 10404541 3.246660635 T 
rs132676958 9 65909445 3.245590821 G 
rs110893833 17 41778376 3.243968586 G 
rs110946010 9 103692309 3.242853175 T 
rs109631568 9 103692964 3.242853175 G 
rs110789880 9 103697889 3.242853175 A 
rs132729670 9 103722885 3.242853175 A 
rs110277541 9 103724091 3.242853175 A 
rs110296542 6 45833672 3.237847779 G 
rs110860625 7 89520670 3.233998582 C 
rs109391677 9 98238057 3.233200069 C 
rs41667147 17 41720570 3.227988184 A 
rs41667178 17 41723453 3.227988184 T 
rs41679969 12 76906934 3.227322103 G 
rs135237762 9 97532057 3.22542096 T 
rs132843341 9 97532971 3.22542096 T 
rs43354180 3 92472331 3.22451027 T 
rs43354182 3 92484809 3.22451027 T 
rs43354191 3 92500456 3.22451027 T 
rs43354201 3 92505029 3.22451027 A 
rs42199706 7 31224439 3.224271457 G 
rs42890503 29 28662664 3.218625428 C 
rs134551478 18 49841563 3.214677758 T 
rs110499373 27 24803258 3.213846196 A 
rs41703808 13 60739302 3.209255175 C 
rs41703814 13 60740826 3.209255175 A 
rs135915757 2 72801094 3.208396431 A 
rs135464279 12 67062990 3.207516544 A 
rs42094261 26 26098742 3.206601056 A 
rs42309434 4 118211468 3.204172924 T 
rs109072712 27 30671561 3.201586133 C 
rs137813779 15 6996317 3.200806888 G 




rs41571435 11 102331407 3.200555935 T 
rs136400600 11 102333185 3.200555935 G 
rs109104765 11 102336231 3.200555935 G 
rs134244722 11 102347819 3.200555935 C 
rs110950384 10 34633682 3.199509483 C 
rs110976214 10 34636005 3.199509483 C 
rs133491211 28 18509947 3.199087297 A 
rs133796959 28 18515950 3.199087297 A 
rs134041938 7 98557529 3.197304808 A 
rs109354718 7 98566391 3.197304808 C 
rs110620868 14 37960177 3.195762246 G 
rs109588849 4 9155979 3.194702115 A 
rs134925464 4 9157466 3.194702115 T 
rs110747955 4 9169373 3.194702115 G 
rs108978929 4 9171340 3.194702115 G 
rs109200993 4 9175665 3.194702115 A 
rs109550058 4 9176248 3.194702115 A 
rs110782546 4 9180014 3.194702115 C 
rs110766969 4 9181924 3.194702115 G 
rs110542894 4 9184443 3.194702115 A 
rs109872926 4 9186322 3.194702115 G 
rs109555021 4 9187560 3.194702115 T 
rs133113391 4 9188973 3.194702115 G 
rs110008785 4 9190080 3.194702115 T 
rs109830573 4 9192487 3.194702115 A 
rs136833626 4 9193149 3.194702115 C 
rs110227344 4 9194698 3.194702115 T 
rs137741495 4 9195864 3.194702115 C 
rs109582833 4 9196384 3.194702115 C 
rs110996175 4 9202160 3.194702115 C 
rs41649756 4 9203380 3.194702115 T 
rs109304683 4 9203946 3.194702115 C 
rs135642012 4 90507887 3.192964556 C 
rs110508072 4 90510460 3.192964556 C 
rs135728603 4 90522341 3.192964556 T 
rs110807111 4 90525031 3.192964556 T 
rs134895773 4 90525835 3.192964556 C 
rs110041213 4 90529431 3.192964556 G 
rs109847272 4 90533691 3.192964556 C 
rs135236859 4 90535585 3.192964556 G 
rs133775221 4 90540601 3.192964556 C 
rs109172349 4 90541223 3.192964556 G 
rs136148020 4 90545284 3.192964556 G 
rs110575673 11 42584714 3.191254642 G 
rs109447838 11 42585516 3.191254642 T 
rs109438861 11 42593606 3.191254642 C 




rs42287596 7 33883766 3.189005816 T 
rs133957935 4 19344855 3.188761105 T 
rs135986439 4 19346351 3.188761105 T 
rs132639525 4 19347907 3.188761105 G 
rs134542151 4 19350451 3.188761105 T 
rs132948098 3 91375387 3.187737698 G 
rs136849824 11 37467110 3.183881606 G 
rs137255173 11 37487155 3.183881606 G 
rs109278103 11 37493130 3.183881606 A 
rs110025285 11 37494839 3.183881606 A 
rs132976440 7 31015249 3.183524696 A 
rs43579588 8 105240087 3.181751899 A 
rs110453415 24 53850563 3.181485439 G 
rs135719064 16 20502906 3.179219707 A 
rs109920725 16 20509935 3.179219707 A 
rs110536976 16 20547179 3.179219707 T 
rs41255381 11 102372360 3.176418169 G 
rs108986684 11 102384045 3.176418169 G 
rs109581668 24 54495215 3.176163505 A 
rs110134632 24 54495934 3.176163505 C 
rs137033644 X 90821291 3.174601939 T 
rs135644841 26 25671490 3.171533024 G 
rs42097093 26 25675473 3.171533024 G 
rs109399466 10 28046636 3.16912882 G 
rs41668105 12 76851725 3.169066788 C 
rs41884306 18 49803763 3.166440454 G 
rs109818611 4 17256442 3.165984424 C 
rs137621015 4 17265172 3.165984424 G 
rs110756908 4 17265949 3.165984424 T 
rs110291582 4 17266853 3.165984424 T 
rs109783538 4 17267806 3.165984424 A 
rs133565311 4 17271497 3.165984424 A 
rs110884608 4 17273366 3.165984424 G 
rs109154308 4 17274912 3.165984424 G 
rs109585036 19 8240893 3.161083557 A 
rs41666998 12 68271937 3.159651103 A 
rs136402214 23 40834768 3.159447603 T 
rs133897861 23 40836579 3.159447603 A 
rs41569491 10 13373269 3.157691601 C 
rs41619924 17 11367675 3.151175936 A 
rs41619926 17 11391752 3.151175936 A 
rs42880540 17 11407035 3.151175936 C 
rs42691544 15 5058540 3.150457207 T 
rs42415316 10 39028282 3.150169767 C 
rs136359869 10 39029090 3.150169767 A 
rs42415320 10 39029787 3.150169767 T 




rs109328536 10 39037912 3.150169767 T 
rs43618980 10 11495213 3.149188625 G 
rs133096287 11 69539045 3.148441969 G 
rs109986884 11 69540272 3.148441969 A 
rs41604688 3 90770539 3.148305403 G 
rs42423304 3 90765771 3.148305403 A 
rs42423302 3 90769435 3.148305403 A 
rs41836702 26 28192862 3.144206218 C 
rs41604826 26 28193472 3.144206218 A 
rs41836713 26 28194285 3.144206218 G 
rs41837632 26 28195737 3.144206218 G 
rs41837646 26 28197815 3.144206218 A 
rs41837651 26 28199991 3.144206218 C 
rs134942554 26 28200869 3.144206218 A 
rs41837664 26 28202542 3.144206218 G 
rs41837665 26 28203265 3.144206218 A 
rs109135855 6 45845263 3.144023491 T 
rs135890677 6 45853339 3.144023491 G 
rs110858846 6 45861086 3.144023491 T 
rs136076532 9 97586690 3.142161648 G 
rs132952962 10 14658435 3.137810362 G 
rs109180951 28 31204958 3.136475937 T 
rs136456101 28 31206165 3.136475937 G 
rs136341552 X 92725516 3.134137478 A 
rs42584654 6 4888244 3.134052041 G 
rs110946154 5 97426617 3.129526615 T 
rs110729080 5 97435197 3.129526615 A 
rs136811150 7 39875547 3.12811969 G 
rs109542089 11 78673403 3.128089748 A 
rs136068749 11 78679962 3.128089748 G 
rs110792012 11 78687979 3.128089748 A 
rs109788835 11 78693214 3.128089748 A 
rs42718765 3 93811195 3.127079567 T 
rs133304868 17 33892418 3.126364031 C 
rs137641657 27 309276 3.12223744 A 
rs29013678 2 119390554 3.122146871 C 
rs110184871 2 119404166 3.122146871 A 
rs110397335 2 119405235 3.122146871 C 
rs110037371 18 49703830 3.119651106 C 
rs134829952 26 8468758 3.117604293 A 
rs136971417 4 20277122 3.11717339 T 
rs136177868 8 7488870 3.116148286 T 
rs42914113 10 90274472 3.113837034 T 
rs137408584 10 90294811 3.113837034 C 
rs43619617 10 31072492 3.11062073 C 
rs43619619 10 31079958 3.11062073 C 




rs43769813 10 31100363 3.11062073 A 
rs137148762 17 37971352 3.108355235 T 
rs135668452 17 37974917 3.108355235 A 
rs110458553 17 37975827 3.108355235 C 
rs134482616 17 37976731 3.108355235 G 
rs133316400 17 37991827 3.108355235 T 
rs41567083 17 38001105 3.108355235 A 
rs137692466 29 22208092 3.106706804 A 
rs133730050 10 18557936 3.105290125 C 
rs42307494 17 41686505 3.102338037 A 
rs136937470 17 41687319 3.102338037 T 
rs42306997 17 41701959 3.102338037 T 
rs42306988 17 41710220 3.102338037 G 
rs41594602 17 41710814 3.102338037 G 
rs42306972 17 41714001 3.102338037 G 
rs110262369 11 80363995 3.101961624 G 
rs110066674 11 80365976 3.101961624 C 
rs109072977 7 33452602 3.099882435 T 
rs43618994 10 11498562 3.096714343 T 
rs43619004 10 11502981 3.096714343 A 
rs108947346 10 11504567 3.096714343 G 
rs109320019 10 11505110 3.096714343 C 
rs136837752 2 77402401 3.095079099 A 
rs134898712 2 77408791 3.095079099 G 
rs43114451 2 77410104 3.095079099 A 
rs133646028 9 96369957 3.092594656 A 
rs137193544 20 12386335 3.089779692 A 
rs135048392 4 9321332 3.089742433 G 
rs109123301 27 3808044 3.089295934 C 
rs110915880 27 3809006 3.089295934 C 
rs110727594 27 3810639 3.089295934 T 
rs109338247 27 3820475 3.089295934 T 
rs41971212 21 21547822 3.087393124 G 
rs134446726 13 61484398 3.083348862 T 
rs109300977 16 21376068 3.082209646 T 
rs137292613 15 23175841 3.08175322 G 
rs110258423 10 29718121 3.079582163 C 
rs43616376 10 14258096 3.078740179 T 
rs109609662 10 14264457 3.078740179 T 
rs110956596 10 14271326 3.078740179 C 
rs137608138 27 20504395 3.076785852 T 
rs133261547 27 20505934 3.076785852 C 
rs41598713 10 11571743 3.07580214 A 
rs29022854 4 106321900 3.070621877 A 
rs136741195 4 106328752 3.070621877 G 
rs136442787 5 41037898 3.069245785 A 




rs137793969 5 41051042 3.069245785 G 
rs41619458 17 10396137 3.067403711 G 
rs109460994 7 32226154 3.066312091 A 
rs110338491 9 20446443 3.06585316 C 
rs137384335 9 20474683 3.06585316 C 
rs41566638 11 94071468 3.061720153 G 
rs41566639 11 94095363 3.061720153 G 
rs41566640 11 94101466 3.061720153 T 
rs137848095 11 94103660 3.061720153 C 
rs137111321 11 94125261 3.061720153 A 
rs135844990 11 94126990 3.061720153 C 
rs133488368 11 94130741 3.061720153 A 
rs135362767 11 94137569 3.061720153 G 
rs133163960 11 94142045 3.061720153 C 
rs133228922 11 94157282 3.061720153 C 
rs137261893 11 94161778 3.061720153 A 
rs41566641 11 94446742 3.061720153 T 
rs136735251 11 94458546 3.061720153 A 
rs134890269 22 38209582 3.060969843 G 
rs110151708 24 53584633 3.059266467 G 
rs134469680 24 53647985 3.059266467 C 
rs41587428 3 20727422 3.058836777 A 
rs133503031 17 41750810 3.055687311 G 
rs109685974 6 1646307 3.054860245 C 
rs42998566 6 1712714 3.054860245 G 
rs42873303 6 1776509 3.054860245 G 
rs109101146 11 37436464 3.052703378 T 
rs135507951 11 37499319 3.052703378 T 
rs134539773 1 9136608 3.051983047 G 
rs134476953 3 90818585 3.050303974 A 
rs134508681 27 25171321 3.047656763 T 
rs42633912 26 36608784 3.046595379 G 
rs43120804 17 11784143 3.045144937 C 
rs134112858 4 91304669 3.04413363 G 
rs110363109 4 91305332 3.04413363 T 
rs132996808 4 91307320 3.04413363 A 
rs42574539 4 91308203 3.04413363 G 
rs135393323 4 91309151 3.04413363 G 
rs133214867 4 91310256 3.04413363 G 
rs135925889 11 80423078 3.044019522 A 
rs135415596 11 80432266 3.044019522 T 
rs110562044 11 80440180 3.044019522 G 
rs135752409 9 35835329 3.040729485 A 
rs41668076 12 76871379 3.038966693 C 
rs109250741 17 41738251 3.035858125 C 
rs42174547 29 25876364 3.035625358 A 




rs132896883 29 25878907 3.035625358 G 
rs133952565 26 25665978 3.034792469 A 
rs137389486 X 56899350 3.032715962 C 
rs42358070 16 64382007 3.03201204 G 
rs135141127 5 55223818 3.031366658 C 
rs110079960 4 14382671 3.030198654 T 
rs136816057 8 103151786 3.03013748 C 
rs109933177 18 49804652 3.030089291 A 
rs133858057 18 49806791 3.030089291 G 
rs109833294 18 49808001 3.030089291 T 
rs110634591 18 49808532 3.030089291 T 
rs110700417 18 49810196 3.030089291 A 
rs42550173 9 57878818 3.029814845 C 
rs109073837 9 57938963 3.029814845 A 
rs133836094 16 52097690 3.029701627 A 
rs42435944 26 28854387 3.028548934 A 
rs109106349 4 15641166 3.02742991 T 
rs133633650 9 85232186 3.026904167 G 
rs135320876 17 46212141 3.021482544 T 
rs132870941 17 46214774 3.021482544 T 
rs134152512 17 46215571 3.021482544 C 
rs135356708 17 46217001 3.021482544 A 
rs133010301 17 46218318 3.021482544 A 
rs132770494 9 87270703 3.021111305 A 
rs135200117 X 142871442 3.018211447 C 
rs136742797 29 22180284 3.017631735 T 
rs137115882 3 105906013 3.016694846 C 
rs133218184 1 13753312 3.016631115 A 
rs135399735 1 13879534 3.016631115 G 
rs109400802 1 13899013 3.016631115 A 
rs110695322 1 13901306 3.016631115 A 
rs136598771 1 13997990 3.016631115 G 
rs41620921 7 32655349 3.015837284 A 
rs42065895 7 32664122 3.015837284 A 
rs110391851 7 35805518 3.015837284 A 
rs109830170 7 35814180 3.015837284 T 
rs133228921 3 90794047 3.015756824 A 
rs137161699 X 105051845 3.015376242 C 
rs135689626 10 35112151 3.015309983 A 
rs110868693 17 41718080 3.014450931 A 
rs109973902 10 15367638 3.013635399 T 
rs43410902 4 91099205 3.013601801 C 
rs42179558 29 28584509 3.01279943 C 
rs110521499 3 88708244 3.00966213 T 
rs134331064 2 72885823 3.007280514 T 
rs110713433 2 135120564 3.006187294 C 




rs135870948 2 135130866 3.006187294 C 
rs136792452 2 135131655 3.006187294 T 
rs134612066 2 135132299 3.006187294 C 
rs135740697 2 135132854 3.006187294 T 
rs110581623 1 15591002 3.004488715 T 
rs133956665 24 54038094 3.004295257 A 
rs109346861 13 564192 3.004100587 T 
rs109531470 13 576926 3.004100587 T 
rs109645110 13 584808 3.004100587 A 
rs134953798 13 599841 3.004100587 T 
rs110838698 3 86361340 3.00152615 G 
rs109496760 12 79248382 3.001163077 T 









JACQUELINE PATRICE KURZ 
97 S 100 W 







American College of Veterinary Pathologists Board-certified veterinary anatomic 
pathologist. Currently working as a Clinical Assistant Professor (Temporary) and 
Extension Veterinary Pathologist for the Utah Veterinary Diagnostic Laboratory, Utah 
State University. PhD in animal molecular genetics at Utah State University.  Veterinary 
graduate of the University of Edinburgh, Scotland.  Supporting BS degree in in animal 
science, and experience in veterinary research, regulated laboratory procedures, and 
livestock husbandry.  Member of the Royal College of Veterinary Surgeons (United 





Veterinary Anatomic Pathology Residency – 2011 to 2017 
Utah Veterinary Diagnostic Laboratory, Utah State University – Logan, UT 
 
PhD, Animal Molecular Genetics – 2012 to 2017 
Utah State University – Logan, UT 
 
BVM&S, with Distinction – 2010 
University of Edinburgh, Royal (Dick) School of Veterinary Studies – Edinburgh, UK 
AVMA-accredited veterinary degree. 
 
BS, Animal Science, magna cum laude – 2006 














UTAH STATE UNIVERSITY      2017-Present 
             
Clinical Assistant Professor, Temporary, Animal, Dairy, and Veterinary Science 
American College of Veterinary Pathologists Board-certified anatomic veterinary 
pathologist with extension veterinary pathologist (70%), teaching (25%), and 
departmental service (5%) duties. Extension veterinary pathologist duties include 
performance, interpretation, and reporting of necropsies, histopathology, and ancillary 
testing. Teaching responsibilities include assistance of primary instructors for general and 
systemic veterinary pathology courses in the USU veterinary school, resident training, 
and organization and teaching of resident seminar series. Departmental service duties 
encompass service on departmental committees. 
 
UTAH STATE UNIVERSITY      2011-2017 
         
Veterinary Anatomic Pathology Residency 
Veterinary residency working toward eligibility for Board certification under the American 
College of Veterinary Pathologists. Duties involved primary case responsibility for animals 
submitted for necropsy and samples submitted for surgical pathology, and graduate 
teaching assistant assignments in Microscopic Anatomy, General Pathology, and Systemic 
Pathology at the veterinary school level. 
 
UNIVERSITY OF EDINBURGH AND AVIAGEN – Edinburgh, UK  2010 
 
Poultry Medicine Elective Rotation 
 
Veterinary rotation working with the poultry veterinary service at the University of 
Edinburgh and the global poultry genetics company Aviagen.  Duties performed included 
poultry handling, health and welfare assessment, disease detection and treatment, post 











Member of scientific research team investigating causes of mortality in red squirrels in 
Scotland, contributing to knowledge vital to wildlife conservation efforts.  Lead author on 
resulting publication. 
VETERINARY PRACTICES AND SERVICES – UK and USA 2008-2010 
 
Clinical Veterinary Extramural Work 
Placements 
Clinical veterinary work external to university schooling included placements in small 
animal practice (10 weeks), farm animal practice (2 weeks), farm assurance assessment (2 
weeks), equine hospital/intensive care (2 weeks), exotics/wildlife hospital (1 week), and 
abattoir (1 week).  Duties included assistance with client consultations, clinical 
examination, patient monitoring and treatment, disease diagnosis, surgery, post mortem 
examination, herd health evaluation, and welfare assessment. 
 
 
ADVION BIOSERVICES – Ithaca, NY 2001-2006 
Laboratory Technician Intern 
 
Performed and documented instrument and laboratory maintenance, sample custody, and 
clinical supply logistics in a regulated bioanalytical laboratory. 
 
 
CORNELL UNIVERSITY SHEEP RESEARCH & TEACHING 








HEGDALE FARM – Cumbria, UK 2004 
 
Resident Farm Worker 
 
Responsible for the daily husbandry and management of sheep, calves, pigs, and free-range 






Diplomate, American College of Veterinary Pathologists 
 
Licensed veterinarian, state of Utah 
 




A.J. Van Wettere, J. P. Kurz, A. Wilhelm, and J. D. Ipsen. Opisthotonos and unilateral 
internal hydrocephalus associated with aberrant migration of Serratospiculum spp. in a 
prairie falcon (Falco mexicanus). Journal of Veterinary Diagnostic Investigation, 
accepted 2017. 
 
D. J. Wilson and J. P. Kurz. (2017) Genetic sequencing using 16S rRNA for pathogen 
identification in retropharyngeal lymph nodes from wild elk. Human-Wildlife Interactions 
11(1), 19-21. 
 
J. P. LaRose, A.L. Meredith, D.J. Everest, C. Fiegna, C.J. McInnes, D.J. Shaw, and E.M. 
Milne. (2010) Epidemiological and post-mortem findings from 262 red squirrels (Sciurus 




2014 College of Agriculture and Applied Sciences Graduate Student Teacher of the Year.  
Utah State University, Logan, Utah.  18 September 2014. 
 
2013 Utah State University Animal, Dairy, and Veterinary Science Department Graduate 
Student Symposium, 1st place PhD track oral presentation.  Utah State University, Logan, 






“Genetic Markers of Bovine Mastitis Resistance.” Animal, Dairy, and Veterinary 
Science/Center for Integrated Biotechnology Seminar Series. Utah State University, 
Logan, UT. 7 September 2017. 
 
“Lecture Series: Lower GI System: Intestine, Parts I, II, and III.” Systemic Pathology, 






“Lecture series: Ruminant Stomach, Parts I and II.”  Systemic Pathology, VM 7546.  Utah 
State University, Logan, UT.  September 2017, September 2016, September 2015, and 
September 2014. 
 
“Case Study: Hyperkalemic Periodic Paralysis in a Quarter Horse.”  Veterinary Physiology 
I, VM 7519.  Utah State University, Logan, UT.  October 2015 and October 2014. 
 
“Digestive System: Intestine.” Microscopic Anatomy, VM 7510.  Utah State University, 




2014-2015: Molecular characterization of the involvement of phospholipid A2 (PLA2) in 
the immune response to mastitis pathogens in dairy cattle in vivo and in vitro.  PI: Z. Wang.  
Utah Agriculture Experiment Station Grants Program, $9,004.52 awarded. 
 
2013-2014: Differences in production of IL-1β, IL-6, and TNF-α by cultured bovine 
mammary epithelial cells from mastitis-resistant and mastitis-susceptible Holstein dairy 
cows.  PI: D.J. Wilson, Co-PI: J. LaRose.  Utah Agriculture Experiment Station Grants 
Program, $10,000 awarded. 
 
 
